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CHAPTER 1 – INTRODUCTION  
 Six hundred million years ago, the first multicellular organisms, the earliest 
metazoans, evolved from their unicellular ancestors, the colonial flagellate 
eukaryotes. Development of multicellularity was attained when unicellular organisms 
began to stick together, work together, and specialize. The presence of intercellular 
junctions partitioned the new multicellular organism, generating internal 
compartments. Each newly created compartment would further evolve a unique 
composition benefitting the organism, allowing it to adapt to different environments, 
and evolve into more complex species. Intercellular junctions contribute to the 
ascension, diversification, and transformation of unicellular organisms into the 
diverse animal kingdom.  
The primary purpose of early intercellular junctions in metazoans was to 
protect the organism from the external environment. As multicellular organisms 
increased in complexity, intercellular junctions developed specialized functions, 
while retaining their most basic function of forming a barrier. Today, intercellular 
junctions have evolved to adhere cells together, preserve structural integrity, allow 
remodeling to occur in changing environments, and permit passage of select 
molecules. Three main categories of intercellular junctions have evolved: adherens, 
gap, and tight junctions.  
Diversity of intercellular junctions permits functional specialization 
Intercellular junctions, which are of four major categories, function to maintain 
a physical association between cells, allow intercellular communication, and 
participate in tissue organization. The first type of intercellular junction, the adherens 
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junction, molds the shape of multicellular structures by indirectly linking their actin 
cytoskeletons. All intercellular junctions are comprised of three basic structural 
proteins: integral membrane proteins, cytoplasmic proteins, and cytoskeletal proteins. 
The integral proteins of adherens junctions are largely comprised of the cadherin 
family of type-1 transmembrane proteins (Yoshida and Takeichi, 1982; Yoshida-
Noro et al., 1984). The extracellular domains of cadherins interact with either trans 
(opposing) or cis (neighboring) cadherins forming dimers or tetramers. The 
cytoplasmic domains of cadherins bind to members of the catenin family of 
cytoplasmic proteins. These protein complexes are anchored to actin filaments, 
thereby stabilizing the junction in the membrane.  
The second category of adhesive junction is the desmosome, which provides 
focal mechanical strength to epithelial and endothelial cell layers by attaching the 
plasma membrane to intermediate filaments. Desmosomes are comprised of 
cadherins and integral membrane proteins known as desmogleins and desmocollins 
(Buxton et al., 1993; Holton et al., 1990; Koch et al., 1990). These single-pass 
transmembrane proteins interact in trans with neighboring desmogleins and 
desmocollins at their extracellular domains. The cytoplasmic domains bind to 
anchoring proteins such as plakoglobin, plakophilin, or desmoplakin, which in turn 
are bound to intermediate filaments. While desmosomes function to adhere two cells 
together, hemidesmosomes anchor each cell to the basement membrane or 
extracellular matrix (Borradori and Sonnenberg, 1999).  
Gap junctions are the third type of intercellular junctions that interact in trans 
to form channels between cells and permit direct cell-to-cell communication. These 
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junctions are comprised of the connexin family of polytopic four transmembrane 
domain proteins. Connexins interact in cis to form hexamers known as connexons. 
Opposing connexons form the characteristic gap junction, allowing small metabolites 
and water to freely pass, thereby coupling the cells chemically and electrically 
(Alberts et al., 2008).  
The hypotheses developed and examined within this dissertation work 
revolve around the function of tight junctions, which are the final category of 
intercellular junctions. Tight junctions were first observed in the 1960s and form 
circumferential bands between plasma membranes of apposing cells by interactions 
in trans that focally fuse the cell membranes and eliminate the paracellular space 
(Farquhar and Palade, 1963). Tight junctions are permeable to water and selectively 
permeable to ions but otherwise seal the extracellular spaces between cells and 
serve to generate two compartments, the contents of which can be independently 
regulated (Angelow and Yu, 2007; Furuse and Tsukita, 2006; Van Itallie and 
Anderson, 2004, 2006). Tight junctions are the principal component for establishing 
and maintaining the apical and basolateral domains of polarized epithelial and 
endothelial cell layers (Mugnaini and Schnapp, 1974; Shin et al., 2006). In addition 
to the archival tight junctions between apposing cells, which are known as 
heterotypic junctions, autotypic tight junctions are found between bilayers of a single 
cell such as the membrane sheaths of myelinating cells in the central and peripheral 
nervous systems (Dermietzel, 1974; Tetzlaff, 1978). The functional characterization 
of autotypic tight junctions in CNS myelin sheaths is the foundation for this 
dissertation work.  
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Claudins constitute the principal integral membrane protein of tight junctions 
Probing cultured rat fibroblasts, cardiac muscle, and epithelial cells from small 
intestine and liver identified a candidate integral membrane protein of tight junctions. 
The probe was comprised of a fusion protein containing cDNA of zonula occludens 
(ZO-1). The ZO family of proteins comprises a major component of the cytoplasmic 
proteins of tight junctions (Itoh et al., 1993). The fusion protein interacted with a 
novel 65 kDa transmembrane protein designated occludin. Using immunoelectron 
microscopy and freeze-fracture replica electron microscopy, occludin was localized 
at tight junctions in epithelial and endothelial cells (Fujimoto, 1995; Furuse et al., 
1993). Transfection studies demonstrated that newly synthesized chick occludin can 
be delivered and incorporated into existing human and bovine epithelial cell tight 
junctions (Furuse et al., 1994) and increased transepithelial resistance (McCarthy et 
al., 1996). However, knockout studies in mice show that occludin is not the main 
integral membrane protein of tight junctions (Gow et al., 1999; Morita et al., 1999b). 
Two key experiments extensively investigating the function of occludin refuted 
the hypothesis that occludin is necessary for tight junction formation. First, when 
peptides raised against occludin were transfected into epithelial cells, occludin was 
excluded from tight junction strands. Interestingly, epithelial cell morphology 
remained unaltered (Wong and Gumbiner, 1997). Second, deletion of the occludin 
gene by homologous recombination in embryonic stem cells yielded a mouse with 
morphological normal tight junctions in many tissues (Saitou et al., 1998). 
Reassessing the original cell fraction in which occludin was identified, Furuse et al. 
(1998) discovered a novel 22 kDa protein. When sequenced, the putative 
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transmembrane protein had disparate sequence to occludin and was designated 
claudin (Cldn), from the Latin word ‘to close.’ This protein was quickly found to be a 
member of a large family of proteins with broad and overlapping expression patterns 
in polarized cells (Fanning et al., 1998; Furuse et al., 1998; Morita et al., 1999a; 
Morita et al., 1999c; Simon et al., 1999). 
The claudin family of proteins has increased to at least 24 members in 
mammals with similar structures, divergent sequences, and hallmark conserved 
elements (Angelow et al., 2008; Furuse and Tsukita, 2006; Van Itallie and Anderson, 
2006). Claudins are polytopic membrane proteins consisting of four transmembrane 
domains with amino and carboxyl termini both located in the cytoplasm and two 
extracellular domains. Conserved features include a GLWxxC (8 – 10 aa) motif 
within the first cytoplasmic domain and a PSD95 / Dlgs1 / ZO-1 (PDZ) domain near 
the carboxyl-terminus for binding the cytoplasmic tight junction proteins: ZO-1, -2, 
and -3.  
The expression of claudins is essential for tight junction function, whereas 
occludin is considered an accessory protein (reviewed in Alberts et al., 2008; Nelson 
and Fuchs, 2010). Evaluation of genetic knockout or mutations reiterates the 
indispensible function of claudin family members, in vivo, for tight junction formation 
(reviewed in Furuse, 2009). The loss of Cldn1 leads to an epidermal barrier deficit 
resulting in water loss and neonate death (Furuse et al., 2002); altered ionic 
permeability and subsequent hair cell degeneration and congenital deafness arise 
from to the loss of Cldn14 (Ben-Yosef et al., 2003; Wilcox et al., 2001); the absence 
of Cldn15 in produces megaintestine (Tamura et al., 2008); loss of Cldn16 
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(paracelllin-1) results in hypomagnesaemia, hypercalciuria and nephrocalcinosis 
(Weber et al., 2000); and finally, renal magnesium wasting and renal failure are seen 
in the absence of Cldn 19 (Konrad et al., 2006). The first claudin shown to 
demonstrate dysfunction of tight junction in several tissues, Cldn11, is the primary 
focus of this dissertation work. 
Functional role of Claudin 11 homotypic tight junctions  
Claudin11 forms parallel tight junction strands in several tissues including 
Sertoli cells of the testis, basal cells of the stria vascularis, and CNS myelin sheaths 
(Bronstein et al., 1997; Gow et al., 2004; Gow et al., 1999; Kitajiri et al., 2004; Morita 
et al., 1999b). Functional analyses assessing the role of Cldn11 tight junctions has 
been simplified by the tendency for Cldn11 to form single claudin tight junctions 
(Gow et al., 1999).  
Studies exploring the function of Cldn11 tight junctions were first completed in 
Sertoli cells of the testis. The loss of Cldn11 results in disappearance of the 
characteristic parallel tight junction intramembranous strands, hypogonadism and 
azoospermia (Gow et al., 1999). Arrested spermatogenesis and abnormal 
morphology of seminiferous tubules were excluded as the source for male sterility; 
instead, the phenotype originates from disruption of the tightly controlled blood-testis 
barrier, causing early spermatocyte death (Gow et al., 1999).  
Within the inner ear, Cldn11 expression is restricted to basal cells of the stria 
vascularis (Gow et al., 2004; Kitajiri et al., 2004). Claudin11 knockout (Cldn11-/-) 
mice were characterized to elucidate the function of tight junctions on audition. 
Cldn11-/- mice lack an endocochlear potential with minimal disruption to potassium 
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ion homeostasis in the endolymph or perilymph. Morphometric analyses reveal mice 
have normal inner ear cellular morphology, inner and outer hair cell organization, 
and a normal compliment of spiral ganglion neurons. Psychoacoustic analysis 
confirmed the critical function of the endocochlear potential on hearing sensitivity 
and demonstrates that Cldn11-/- mice have increased hearing thresholds to 
approximately 70 dB SPL by six weeks of age (Gow et al., 2004).  
Structure and composition of CNS myelin membrane 
The dissertation work herein centers on the function of Cldn11 tight junctions 
within CNS myelin sheaths. Pre-myelinating oligodendrocytes extend numerous 
processes that contact nearby axons, expand into large trapezoid membrane sheets, 
and wrap segments of the axons in multiple layers (Figure 1.1A). Initially these 
sheets contain cytoplasm (Figure 1.1A, light grey), which is extruded during 
membrane compaction and confined to an outer channel (Figure 1.1A, dark grey). 
The asymmetric trapezoid shape of the flattened myelin sheath generates distinct 
compartments once myelination compaction has occurred (Figure1.1C). At the 
lateral edges, membrane loops containing the cytoplasm comprise the paranodal 
region. The compact myelin region, known as the internode, spans from paranode to 
paranode (Figure 1.1A, dark grey). Lastly, unmyelinated segments between myelin 
sheaths are known as nodes of Ranvier at which voltage-gated Na+ channels are 
localized to propagate action potentials (Figure1.1C).  
Myelin sheaths are an extension of the plasma membrane of 
oligodendrocytes. The composition of myelin is 40 % water; the dry mass is 
comprised of 70 % lipids and cholesterol and 30 % protein, more than half of which 
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is proteolipid protein (PLP) (Folch and Lees, 1951). The function of PLP within the 
myelin membrane remains unknown, however it is thought to involve adhesion and 
stabilization of compact myelin (Boison et al., 1995; Boison and Stoffel, 1994; Greer 
and Lees, 2002). Myelin basic protein (MBP), accounts for 30 % of total myelin 
protein, is localized to the major dense line (MDL) observed in transmission electron 
micrographs of compact myelin and is thought to stabilize opposing membrane 
layers (Omlin et al., 1982). The MDL is formed from the cytoplasmic faces of 
apposing plasma membranes. The two external surfaces of the plasma membrane 
form the minor dense line, or intraperiod line (IPL) in electron micrographs. The 
protein with the third largest concentration in CNS myelin is Cldn11, comprises 7 % 
of total protein. As extensively described above, Cldn11 forms autotypic in myelin 
and comprises the diffusion barrier that forms the intramyelinic compartment (Figure 
1.1, red) (Gow et al., 1999; Morita et al., 1999b). Remaining minor protein 
components include 2’,3’-Cyclic Nucleotide 3’ Phosphodiesterase (CNP), myelin 
associated glycoprotein (MAG), myelin oligodendrocyte basic protein (MOBP), 
myelin oligodendrocyte glycoprotein (MOG), Nogo (Chen et al., 2000), OMGP, 
Sirtuin 2 (SirT2), and stathmin. 
Claudin 11 tight junctions in CNS myelin 
For half a century, myelin tight junction were known morphologically as the 
radial component which appears as rod-like thickenings within the intraperiod lines 
(IPLs) of compact myelin has been documented from transmission and freeze 
fracture electron microscopy (Peters, 1961, 1964; Reale et al., 1975; Staehelin, 
1974; Tabira et al., 1978). Recently, Cldn11 was confirmed to comprise the only 
 9 
Figure 1.1 – Schematic illustrating key features of the myelin membrane 
 
(A) A CNS myelin sheath is unraveled revealing the structure and organization of the 
multilayered myelin membrane. Myelin begins as a flat trapezoid sheet filled with 
cytoplasm extruded to an outer channel along the perimeter upon maturation and 
compaction. (B) Cross section through the internode showing myelin wraps, 
paranodal loops, and Cldn11 tight junctions (red) forming the electrically tight barrier 
between successive layers of myelin. (C) Location of membrane domains on the 
axon are also shown: node of Ranvier, paranodal myelin, juxtaparanodal region (JP), 
and the remaining axon internode (Axon) The location of Cldn11 tight junctions are 
indicated in red. This figure was modified and reprinted with permission from the 
corresponding author (Gow, 2008) 
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family member in the radial component (Gow et al., 1999). Claudin 11 tight junctions 
are also present in the paranode, forming a continuous barrier between apposing 
layers of myelin membrane. Elimination of Cldn11 in CNS myelin has revealed the 
contribution of tight junctions to myelin sheath function. 
Ultrastructural analyses indicate that the absence of Cldn11 tight junctions 
neither perturbs compaction and thickness of myelin sheaths, nor disrupts axoglial 
junctions. Phenotypic assessment reveals a slight tremor which does not arise from 
neuronal loss or axonal degeneration (Gow et al., 1999). Interestingly, an increase in 
latency of the visual evoked potentials (VEPs) from Cldn11-/- mice suggests slowed 
conduction velocity (Michaelson et al., 1996; Strain and Tedford, 1993). These 
findings recapitulate more recent studies in the auditory pathway.  
The loss of Cldn11 in the stria vascularis of the cochlea accounts for the 
observable increase in hearing threshold, however the well-differentiated waveforms 
of the auditory brainstem response (ABR) suggest overall preservation of the 
auditory pathway with dysfunction being limited to a delay in the latency of Wave V 
latency. Wave V latency is a commonly used proxy for conduction velocity along 
central myelinated fibers of the auditory pathway (Gow et al., 2004). Thus the ABR 
data suggest slowed conduction in the auditory brainstem, data from visual and 
auditory pathways demonstrate global dysfunction of myelinated axons within the 
CNS of Cldn11-/- mice.  
Function of CNS myelin 
The high lipid and low water content of myelin generates a high resistance / 
low capacitance structure that insulates axons. During axon depolarization, the 
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electrically tight myelin membrane reduces current leakage into the compact myelin 
region, restricting depolarization events to the nodes of Ranvier. Electrical signals 
propagate from node to node, depolarizing the axonal membrane at these regions 
compared to the entire axonal length in a process known as saltatory conduction. 
Conduction velocity along myelinated fibers is proportional to the axonal diameter, 
unlike unmyelinated axons, for which conduction velocity is proportional to the 
square root of the diameter. The influence myelin has on conduction velocity is 
functionally equivalent to increasing axonal thickness by100 (Kandel et al., 2000). 
The passive properties of neurons, tau (time constant) and lambda (length 
constant), specify action potential propagation. Lambda is the critical component 
determining the distance along an axon a depolarizing event can travel and still 
trigger a subsequent depolarizing event. Lambda is thought of as a safety factor 
specifying the integrity of conduction along an axon in the absence of internodes or 
presence of dysfunctional internode segments. If lambda is smaller than the distance 
between myelin internodes, signal propagation becomes impaired. This 
consequence is commonly seen in multiple sclerosis (MS) when demyelination leads 
to the absence of several internodes along an axon, reducing action potential 
propagation. 
The time constant, tau, is the calculated time it takes the membrane potential 
of a neuron to reach 63 % of its steady state value. Tau regulates temporal 
summation by dictating the time course of synaptic potentials. A shorter tau 
represents a quicker change in membrane potential resulting from a stimulus. 
Additionally, a shorter tau increases the likelihood that two consecutive inputs will 
 12 
summate and depolarize the cell membrane enough to fire an action potential 
(Kandel et al., 2000).  
Function of Claudin 11 tight junctions in CNS myelin membrane 
Initial hypotheses from several studies posited that Cldn11 tight junctions in 
CNS myelin stabilize the myelin membrane and generate an immune privileged 
compartment (Mugnaini and Schnapp, 1974; Tabira et al., 1978). These hypotheses 
have proved untenable, and more recent data indicate that Cldn11 tight junctions 
preserve electrochemical gradients in similar fashion to epithelia (Devaux and Gow, 
2008; Gow et al., 2004; Kitajiri et al., 2004). Noteworthy electrophysiology 
experiments conducted in Cldn11-/- mice established the mechanism by which 
Cldn11 tight junctions function in CNS myelin (Devaux and Gow, 2008; Gow et al., 
2004; Gow and Devaux, 2008). 
Slowed conduction velocity in the visual and auditory pathways has been 
demonstrated in Cldn11-/- mice (Gow et al., 2004; Gow et al., 1999; Kitajiri et al., 
2004). Compound action potentials (CAPs) measuring electrical potential from ex 
vivo optic nerves of Cldn11+/+ and Cldn11-/- mice demonstrate the loss of tight 
junctions significantly impacts CAP velocities along myelinated fibers (Figure 1.2) 
(Devaux and Gow, 2008). Three components of the CAP are visible, corresponding 
to large (1st), medium (2nd), and small (3rd) diameter fibers, respectively. The onset 
delay in medium and small diameter fibers is unmistakable in Cldn11-/- mice 
compared to controls, with significant reductions in conduction velocity of 20 and 
50 %, respectively. Axon diameters of the medium and small components were 
estimated to be approximately 1.2 and 0.7 µm. Conduction velocity along large 
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diameter fibers, estimated at > 2 µm, are not significantly impacted (Devaux and 
Gow, 2008).  
The absence of Cldn11 tight junctions does not alter the ultrastructure of 
myelin sheaths except for the absence of radial components. Detailed analyses 
reveal myelin thickness, compaction, and internode length are preserved. The 
distribution of voltage-gated ion channels within nodes, or underneath the myelin 
sheaths remain normal (Devaux and Gow, 2008). In view of this preservation of 
architecture, a novel computational model was developed to describe conduction 
along small diameter myelinated fibers, accounting for the critical contribution of tight 
junctions within the myelin membrane.  
Early computational models describing saltatory conduction in myelinated 
fibers are depicted as a double-cable circuit comprised of resistors (longitudinal 
component of the fiber) and capacitors (axonal surface) (Brill et al., 1977; Halter and 
Clark, 1991; Hartline and Colman, 2007; Waxman and Bennett, 1972). These 
models were simple and predominantly based on large diameter myelinated axons 
of the peripheral nervous system (PNS), rather than the vast number of small 
diameter myelinated fibers of the CNS (Blight, 1985). Compared to such double 
cable models (DCM) (Halter and Clark, 1991; McIntyre et al., 2002), the revised tight 
junction model (TJM), specifies tight junctions as a series resistance with myelin 
membrane to reduce capacitive charging of the membrane. Scaling the DCM to the 
electrophysiological and morphological dimensions of optic nerve axons does not 
yield a conducting model. However, the addition of tight junctions in the TJM better 
reflects the experimental data obtained. This finding suggests that tight junctions
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Figure 1.2 – Compound action potentials from Cldn11-/- mice indicate slowed 
conduction velocity in small diameter fibers 
 
Representative compound action potentials (CAPs) collected from isolated optic 
nerves in Cldn11+/+ and Cldn11-/- mice showing three components (arrows) elicited 
by square voltage pulses with varied amplitudes. The components correspond to 
large, medium, and small diameter axons, respectively, within the optic nerve fiber 
bundles. This figure was modified and reprinted with permission from the 
corresponding author (Devaux and Gow, 2008).  
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play an important role in action potential propagation for small diameter fibers 
(Devaux and Gow, 2008; Gow and Devaux, 2008).  
Small diameter myelinated fibers are found throughout the brain, especially in 
grey matter regions (Aboitiz et al., 1992). The majority of neural circuits require 
signal information integration via small myelinated fibers, from multiple sensory 
modalities, as well as refinement from feed forward / back networks. If slowed 
conduction velocity occurs along these fibers, errors in information processing and 
synchrony will likely arise and may lead to the development of behavioral 
abnormalities. The disconnection hypothesis discussed in Chapter 2 is consistent 
with disrupted communication along small diameter myelinated fibers as an etiology 
of cognitive disease.  
Cognitive diseases such as Schizophrenia (SZ) are thought to originate from 
altered neural connectivity and disconnection of brain regions (Benes, 2000; Friston, 
1999; Nuechterlein and Dawson, 1984). Reduced in white matter volume and 
integrity are apparent from functional magnetic resonance imaging (fMRI) and 
diffusion tensor imaging (DTI) scans, and in molecular analyses of post mortem 
tissue (Camchong et al., 2011; Davis et al., 2003; Flynn et al., 2003; Lawrie and 
Abukmeil, 1998). Surprisingly, reduced myelin protein and gene transcripts are the 
most prominent changes detected in post mortem patients (Haroutunian et al., 2007; 
Katsel et al., 2005; McCullumsmith et al., 2007; Tkachev et al., 2003). Not 
surprisingly, many symptoms plaguing SZ patients are common in other neurological 
disorders (Davis et al., 2003; Denier et al., 2007; Feinstein et al., 1992; Kopala et al., 
2000), which suggests a fundamental deficit.  
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Investigating the consequence of dysfunctional myelin on neural processing 
Many published studies suggest that white matter dysfunction, neural 
processing deficits, and myelin gene misregulation may play a role in cognitive 
diseases. However, because of the complex etiology of cognitive disorders, the 
specific contribution of dysfunctional myelin cannot be determined from clinical 
studies. Therefore, the overall goal of this dissertation is to elucidate the phenotype 
associated with dysfunctional myelin in Cldn11-/- mice, focusing on neural processing 
and the development of behavior abnormalities. 
The second chapter of this dissertation examined anesthesia regimes needed 
for subsequent experiments using evoked potentials to characterize a neural circuit 
in the auditory brainstem. This circuit is employed as a model of neural processing 
because it is a well-characterized system, easy to interrogate, and has been studied 
in depth for decades. Information gained from this simple model system can be 
extrapolated to higher order brain networks that are more challenging to investigate 
directly. To obtain acoustic information from animal models, a straightforward 
approach is to use an anesthetic cocktail, allowing for uninterrupted signal 
measurement with minimal noise influence from awake activity. 
Various anesthetics confer differing levels of sedation and alter recorded 
brain wave activity. The potential for altering neural circuitry and interfering with 
evoked responses is significant and is addressed in Chapter 2. Previous work in our 
laboratory and others has determined that one of the oldest anesthetics, 2,2,2-
tribromoethanol, is a safe agent effective well below lethal doses and minimally 
influences evoked brainstem responses (Gow et al., 1999; Zheng et al., 1999). The 
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challenge in Chapter 2 was to develop a new anesthetic regime that increases 
anesthesia time without sacrificing data quality or altering waveform characteristics.  
Once established, the new anesthetic cocktail is used for more advanced 
acoustic studies, which is the focus of Chapter 3. Here, the consequence of 
dysfunctional myelin on neural processing is examined using the Cldn11-/-Tg+/- 
mouse model. Using the auditory brainstem as a model, neural processing is 
investigated by measuring sound lateralization in azimuth plane. Two primary 
auditory features, intensity and timing, are relayed from each ear and are first 
processed in the superior olivary complex (SOC). Due to the head size and position 
of the ears in mice, sound intensity differences between left and right wars are 
principally used for localization 
The focus of Chapter 3 is to measure the output of the signal integrators in 
the SOC when differing sound intensities are presented to each ear. Altering 
intensity cues played to each ear simulates the lateralization of a sound source from 
the perspective of neural processing in the LSO. Herein, we find that Cldn11-/-Tg+/- 
respond abnormally to intensity differences suggesting altered in sound lateralization 
circuitry. Unexpectedly, the output generated by LSO allow us to comment on a 
debate in the auditory field regarding models that account for neural processing in 
the SOC. Our data support the contemporary two-neuron hypothesis (Dingle et al., 
2012; Phillips, 2008; Phillips and Hall, 2005; Phillips et al., 2012; Yost, 1974), rather 
than the classical Jeffress model (Jeffress, 1948). Because small diameter, 
myelinated fibers are found along the auditory pathway, we hypothesize that slowed 
conduction velocity along small diameter ipsilateral fibers between the cochlear 
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nucleus and SOC can disrupt the integration of auditory signals. These data 
demonstrate that dysfunctional myelin can alter neural processing which has 
significant implications for higher order brain function in general. 
If dysfunctional myelin alters neural processing in the auditory brainstem, then 
probing higher order integration networks, such as those responsible for behavior, 
should also reveal deficits. Chapter 4 explores this hypothesis in a quantifiable 
manner through behavioral testing of Cldn11-/- Tg+/- mice. Behavior is the observed 
response of an animal to an environmental cue or stimulation, typically through 
integration of sensory signals. Because small diameter myelinated fibers are 
prevalent in sensory integration networks, we hypothesize that Cldn11-/-Tg+/- mice 
will exhibit abnormal behavioral phenotypes. Through anecdotal evidence and the 
use of several behavioral tasks to assess behavior, we find that Cldn11-/-Tg+/- mice 
are less anxious than controls. However this conclusion is somewhat uncertain 
because of technical difficulties encountered during testing. The most unexpected 
finding from Chapter 4 is the possibility that dysfunctional myelin may also perturb 
neurotransmitter levels in the ventral hippocampus. These data, combined with the 
neural processing abnormalities in the brainstem suggest that dysfunctional myelin 
could underlie some behavioral disorders.  
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CHAPTER 2– increased anesthesia time with low impact on 
auditory evoked potentials using and avertin-chloral hydrate 
cocktail  
 
INTRODUCTION 
In 1929, a German physiologist and psychiatrist, Hans Berger, published the 
first-ever recorded spontaneous brain activity from a human (Berger, 1929). This 
groundbreaking discovery and newly developed technique established the 
fundamentals of electroencephalography (EEG) as we know it today. Further 
progress was made when sensory stimulation of the brain during sleep was shown 
to have consistent alterations to the EEG (Davis, 1939), however the magnitude of 
baseline activity far exceeded that of the sensory evoked activity. To combat this, 
the process known as signal averaging was introduced (Clark et al., 1961). The 
premise of averaging uses the fact that sensory evoked responses have a temporal 
relationship with the stimulus, whereas baseline neural activity is random and does 
not. Thus, baseline EEGs could be mathematically removed from an averaged trace 
and what remains was the neural response to a sensory evoked stimulus (Jacobson, 
1994).  
Evoked potentials can be induced using visual, somatosensory, and auditory 
stimuli 
There are three types of sensory stimuli that can be used to elicit an evoked 
response: visual, somatosensory and auditory. Visual evoked potentials (VEPs) use 
light stimulus to induce photic electroretinograms (Adrian and Matthews, 1934), 
whereas somatosensory evoked potentials (SEPs) use electrical stimulation of 
peripheral nerves and muscles to measure action potential volleys along sensory 
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and motor fibers (Dawson, 1947). All three techniques of sensory evoked potentials 
have been extensively studied and routinely used in clinical settings for diagnostic 
purposes. The remainder of this chapter will focus on the use of auditory evoked 
potentials (AEPs). Readers are directed elsewhere for excellent descriptions of the 
two aforementioned evoked potentials (Chiappa, 1997; Niedermeyer and Lopes da 
Silva, 2005). 
The basis of AEPs is contingent on the ability to audiologically stimulate and 
record electrical activity in the brain. As previously mentioned, the change a sensory 
stimulus elicits in baseline EEGs is small. To enhance signal detection, a number of 
techniques that modify the EEG have been employed. For instance, signal 
averaging allows for subtraction of baseline neural activity, pre-amplification of 
signals allows for enhanced detection when responses are small (microvolts), and 
the use of a band pass filters can eradicate unwanted noise, optimizing collection 
results.  
To further enhance and define different types of auditory responses which 
occur in the brain, AEPs can be divided into three categories based on the latency 
each response occurs: short (0 – 10 msec), middle (10 – 40 msec) and long / late (> 
50 msec). These are known as the auditory brainstem response (ABR), middle 
latency response (MLR) and the long latency response (LLR) respectively.  
Each of the three AEPs is not only defined by the latency of occurrence, but 
also by the characteristic series of waves (or peaks) and troughs (valleys) elicited. 
Waveforms of AEPs can be named based on the polarity of the wave, the latency of 
occurrence, or sequential order (Jacobson, 1994). The ABR has five, sometimes six, 
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distinct waves that present 0 to 10 msec post stimulus. Standard nomenclature used 
to identify ABR waves comes independently from two groups in which Roman 
numerals I through V (sometimes VI) were used to label positive waves, preventing 
confusion if a waveform was either missing or altered in a disease state (Jewett and 
Williston, 1971; Lev and Sohmer, 1972). The first wave occurs approximately 1.2 – 2 
msec post stimulus, depending upon electrode placement. Each succeeding waves 
occurs in approximately 1 msec intervals thereafter. 
Contrasting nomenclature of the ABR, MLR wave identification is commonly 
described by the polarity of the waves: N for negative and P for positive. Polarity is 
combined with a lower case letter in alphabetical order. Earlier alphabetical letters 
designate earlier wave latency (Goldstein and Rodman, 1967). At best, optimal filter 
settings will differentiate six waveforms: V (retained from the ABR), P0, Na, Pa, Nb 
and Pb. In contrast to the crisp, sharp waveforms of the ABR, MLR waves tend to be 
broader, spanning a greater latency range, thus, naming waves based on the 
latency they occur would become varied and problematic. The Na trough spans 
approximately 15 – 30 msec, the Pa peak between 30 – 40 msec, and the Pb peak 
between 46 – 55 msec (Hall, 1992).  
Similar to MLRs, LLRs waveform nomenclature is based on the polarity of the 
waveforms. To differentiate from MLRs, polarity is combined with numerical digits, 
indicating wave order appearance (Williams et al., 1962). At the earliest latencies, 
wave Pb from the MLR is sometimes present, followed by characteristic LLR waves 
P1, N1, P2, N2 and P3 (sometimes referred to as P300 under certain stimulus 
conditions). Wave P1 is typically present between 40 – 70 msec, followed N1 
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ranging from 90 – 150 msec, P2 between 160 – 300 msec, N2 around 275 msec, 
and finally P3 at approximately 300 msec (Hall, 1992). Of these waves, N1 and P2 
are seen most reliably.  
Auditory evoked responses waveforms are generated from nuclei along the 
ascending auditory pathway 
All three categories of auditory evoked responses have characteristic 
waveforms that arise at somewhat predictable latencies post stimulus. Therefore, it 
is reasonable to conclude that these signals are being generated from brain 
structures along the ascending auditory pathway and cortical regions. Determination 
of specific signal generators for the longer AEPs (MLRs and LLRs) are difficult to 
assign because as nerve signals traverse along the ascending pathway, information 
becomes widely dispersed within and between auditory cortices, integrated with 
information from other sensory systems, and further processed in a more complex 
manner, such as language recognition. What little information we do know about the 
signal generators of these waveforms has come from examining patients with 
auditory lesions, and yet, data is still controversial and discordant between patients. 
Interrogating the auditory cortices experimentally is more challenging due to the 
location of structures and the nature of auditory information integration. In contrast, 
the ABR is the best characterized and most AEP and will be the focus of scrutiny for 
this thesis. 
A combination of techniques have allowed for the anatomical and 
physiological characterization of ABR waveforms. Early studies employed far and 
near field recordings in animals and humans. More recently, refined techniques such 
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as surgical lesioning, single unit recordings, and targeted ablation of neurons has 
uncovered the ABR waveform generators. Wave I in humans and animals is 
generated from the distal portion of the auditory nerve as it leaves the cochlea and 
enters the internal auditory canal (Hashimoto et al., 1981; Jewett and Williston, 
1971; Moller and Jannetta, 1981, 1982, 1983a; Sohmer and Feinmesser, 1967). 
Because of its long length in humans, the proximal portion of the auditory nerve 
additionally gives rise to Wave II (Moller, 1985; Moller and Jannetta, 1981, 1982, 
1983a; Moller et al., 1988; Moller et al., 1995).  
In smaller animals commonly used in audiology studies (cats, bats, and 
rodents), the short length of the auditory nerve cannot account for Wave II 
generation, and thus, Wave II most likely arises from within the cochlear nucleus 
(Fisch and Ruben, 1962; Moller and Jannetta, 1983b). As a consensus, the cochlear 
nucleus also gives rise to Wave III of the ABR in humans, whereas MNTB principle 
cells are responsible for Wave III generation in rodents (Jalabi et al., 2013).  
The third-order neurons in the superior olivary complex are responsible for 
the generation of Wave IV in both humans and small animals. Driving factors include 
intracranial recordings, as well as consideration of wave amplitude, broadness of 
waves, known orientation of neurons in major nuclei, and approximate relay times 
along fiber tracts (Moore, 1987).  
Wave V originates from the lateral lemniscus (LL) fibers terminating in the 
inferior colliculus (IC) (Moller et al., 1995). Uncertainty still remains about the precise 
signal generators of the occasional ABR waves (V – VI), due to the auditory 
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pathway’s heavy contralateral trajectory and strong decussation of fibers across the 
midline. 
With a general consensus for the ABR signal generators in humans and 
animals, more complex studies interrogating the auditory pathway and the resulting 
changes to the ABR can be quite informative. One crucial element in the collection 
and interrogation of AEPs that must be reviewed is the use of anesthesia during 
acquisition.  
Anesthesia drugs are frequently administered in AEP studies 
The use of rodent models for AEP studies has increased markedly in recent 
decades. In contrast to clinical and research studies of audition in humans using 
surface electrodes, many simple animal experiments are performed using subdermal 
electrodes under anesthesia. The least invasive method for examining the auditory 
pathway is to administer a short-term anesthetic, which avoids more complex 
surgical procedures involving the insertion of intracranial electrodes, and the 
subsequent complications associated with recovery and postoperative infection. 
Injectable anesthetics are typically administered via venous, peritoneal, muscular or 
subcutaneous routes depending on the differing properties of the drugs and their 
absorption rates (2008; Flecknell, 1996). The most commonly recommended 
anesthetics for use in rodents include inhaled agents, barbiturates, and dissociative 
agents. 
Anesthetic drugs most commonly used for auditory studies in rodents have 
been limited to a combination of a dissociative anesthetic with a powerful sedative / 
analgesic such as ketamine / xylazine, which confers effective anesthesia over a 
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period of 1 – 2 hrs. However, when compared with AEP measures in awake mice, 
ketamine / xylazine anesthesia has been shown to alter waveform structure, 
increase wave latencies by as much as 1 msec, and decrease wave amplitudes up 
to 20 % (McGee et al., 1983; van Looij et al., 2004), Additionally, if injected at high 
doses, it causes significant respiratory depression in rodents and requires prolonged 
post-procedure recovery (2008). Similarly, volatile inhaled anesthetics such as 
isoflurane have been also reported to alter ABR waveform morphology, decrease 
wave amplitudes and increase wave latencies and hearing thresholds in rodents 
(Santarelli et al., 2003; Stronks et al., 2010). The centrally derived waveforms 
(Waves III – V) are predominantly affected in a dose dependent manner. 
Alternatively, more mild fast acting drugs such as 2,2,2-tribromoethanol (TBE) have 
also been employed (Forrest et al., 1996; Gow et al., 2004; Zheng et al., 1999). 
Tribromoethanol is an effective anesthesia with rapid onset and recovery 
times. A major advantage of this drug is its safety in rodents, with therapeutic doses 
far below the lethal dose. Furthermore, it neither impairs ABR nor MLR evoked 
responses nor significantly suppresses respiration (Gow et al., 2004). However, TBE 
is a relatively short-acting drug at doses useful for AEPs, which confines auditory 
experiments to 25 – 30 min in duration, thereby limits experimental complexity and 
the extent of data collection. 
The goal of this chapter has been to develop an anesthesia regimen that 
increases the effective anesthesia time in mice, compared to a single dose of TBE, 
without significantly compromising the quality of ABRs acquired using subdermal 
electrodes. Accordingly, we compared our standard regimen of 375 mg / kg TBE 
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with a drug combination comprising 375 mg / kg TBE followed after 5 min by 200 mg 
/ kg chloral hydrate (CH). Our data show that we can increase effective anesthesia 
almost two-fold without compromising ABR quality. 
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MATERIALS AND METHODS 
Mice 
The Department of Laboratory and Animal Resources at Wayne State 
University maintained all mice in this study. All experiments on mice were performed 
in accordance with an Institutional Animal Care and Use Committee protocol 
approved by the Wayne State University Animal Investigation Committee. The mice 
used in this study were between six weeks and four months of age and were on a 
randomly mixed background strain comprised of C57BL / 6J and 129. We observed 
only mild age – dependent ABR threshold increases, which were consistent with 
previous studies on this mixed background (Gow et al., 2004). 
Chemicals 
A 40 x stock solution of TBE (Sigma, St Louis, MO) (100 % weight / volume) 
was prepared by dissolving 10 grams (g) of TBE in 6.2 ml of 2-methylbutan-2-ol 
(Sigma, St Louis, MO) and adjusting to 10 milliliters (ml). The stock was aliquoted at 
250 µl in 1.5 ml plastic tubes (Thermo Fisher Scientific, Waltham, MA) and stored at 
- 20°C. Working solutions of 2.5 % TBE were prepared from a fresh aliquot of stock 
dissolved by vortexing in 9.75 ml sterile PBS, pH 7.4 (Cellgro, Mannassas, VA). 
Working solutions were stored away from light at 4°C up to two weeks.  
Chloral hydrate (Sigma, St Louis, MO) was prepared as a 2 % working 
solution by dissolving 0.5 g in 25 ml of sterile PBS. Working solutions were stored 
sterile and away from light at 25°C. The PBS was filter – sterilized using a 10 ml 
disposable syringe (Luer-Lok tip, BD Falcon, Franklin Lakes NJ) with a 0.22 µm filter 
attachment (Millipore, Carrigtwohill, Ireland). 
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Anesthesia 
Mice were anesthetized by intraperitoneal (IP) injection with fresh TBE in 
sterile PBS at a dose of 375 mg / kg (TBE cohort) as previously described (Gow et 
al., 2004), and placed on a 39°C heating pad for experimentation. The mice were 
monitored for the absence of tail, foot, and ear reflexes, as well as reduced 
respiratory rate, which are all indications of effective anesthesia. Alternatively, mice 
received a combination of fresh 375 mg / kg, IP, TBE in sterile PBS followed by 200 
mg / kg, IP, CH in sterile PBS (TBE-CH cohort) five min after TBE anesthesia was 
confirmed. After the completion of experiments, the mice were allowed to recover in 
a separate cage on a 39°C heating pad until they regained normal activity and could 
be placed back in their home cage. The mice were monitored periodically in their 
home cage for 24 hrs to ensure they remained active and healthy. 
Auditory brainstem response measurements 
After confirming anesthesia, the fur along the top of the head and middle of 
the back of each mouse was sterilized / moistened with alcohol prep pads (Triad 
Group, INC, Hartland WI). Exposing the eyes to the alcohol pad was avoided. 
Subdermal platinum electrodes (Grass Technologies, West Warwick, RI) were then 
placed at the right and left mastoids (negative), vertex (reference) and hindquarters 
along the midline (ground). Ten min post TBE injection, and at subsequent 10 min 
intervals, mice were presented with 1,024 pure-tone stimuli in 10 dB SPL 
decrements from 80 – 20 dB SPL at 32 kHz (102 µsec duration; Blackman envelope 
– constant rise and fall similar to a Gaussian curve) and a stimulus rate of 29.1 / sec. 
Both right and left ears were tested successively and ipsilateral 
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electroencephalography recordings were pre-amplified (100,000 x), band pass 
filtered (0.3 – 3 kHz) and recorded for 12.5 msec (Sepwin software version 5.1, 
Intelligent Hearing Systems, Miami, FL).  
Amplitudes of the ABR waves were measured from the first derivative of the 
wave peak to that of the following trough and latencies were measured from the 
stimulus onset to the first derivative of each wave peak. Plots of ABR wave 
amplitude or latency versus stimulus intensity exhibited negative slopes for all mice, 
as expected. Hearing thresholds were approximated as the lowest stimulus intensity 
that could evoke an ABR Wave I response.  
To examine the amplitudes of Waves I, III and V as functions of anesthesia 
time, we initially plotted absolute amplitudes. Although we observed low inter – 
animal variability for Wave I data, there was significant stochastic variability for 
Waves III and V that was not correlated with anesthesia time or stimulus intensity. 
Alternate plots of sensation level (defined as SL = Astim – Athres, where Astim is the 
stimulus amplitude and Athresh is the threshold amplitude) as a function of anesthesia 
time did not resolve this variability (Wave III: Appendix B.1; Wave V: Appendix B.2).  
Peritoneal cavity examination 
Mice received two IP injections, one day apart, of sterile PBS, 375 mg / kg 
TBE in sterile PBS or TBE followed by 200 mg / kg CH in sterile PBS. The 
anesthetized mice were allowed to fully recover on a 39°C heating pad then placed 
back in their home cages and monitored for 24 hrs. Three days after the second 
injection, the mice were sacrificed and their peritoneal cavities were immediately 
exposed and photographed (Coolpix 950, Nikon, Melville, NY) followed by a detailed 
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analysis of the abdominal organs for signs of persistent anesthesia – induced 
pathology. Two independent observers blinded to the injected agent evaluated the 
organs using several criteria: general appearance, organ color and size relative to 
one another, signs of inflammation, vasodilation and the presence or absence of 
ascites. Eight mice were examined including two sterile PBS injected controls, three 
TBE and three TBE-CH injected mice.  
Statistics 
Statistical analyses were performed using GraphPad Prism (version 5, La 
Jolla, CA). The latency / intensity data comparing TBE and TBE-CH in Figure 2.3A 
and B were fit with a one-phase exponential decay algorithm. Regression 
coefficients, R2, were also calculated. The data for each 10 min interval were 
analyzed using a one-way ANOVA with Bonferroni post-hoc testing to compare 
matching intensities between the anesthetic treatments. For Figures 2.4 – 2.9, 
normalized (to the 50 min time point) amplitudes or latencies of Waves I, III and V 
from each animal, and the average values from the cohort, were fit using linear 
regression constrained at (50,1). F-tests were used to identify significant deviances 
of the regression line slopes from zero. In Figure 2.10, normalized (to the Day 0 data 
point) average weights were fit using linear regression constrained at (0,1). F-test 
was used to determine if the slope of the regression line differs from zero. 
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RESULTS 
Minimal differences in ABR thresholds and Wave latencies for TBE versus 
TBE-CH anesthesia 
To ascertain the impact of a TBE-CH anesthetic cocktail on mouse AEPs, we 
verified several characteristic features of the ABRs (Figure 2.1A). First, the five 
characteristic peaks and troughs of the ABR arising from generators are evoked 
during anesthesia: spiral ganglion neurons, cochlear nucleus, MNTB, SOC, and 
termination of lateral lemniscus fibers into the inferior colliculus (Buchwald and 
Huang, 1975). Second, the latency of each of these waves occurs at characteristic 
intervals. The first wave (Wave I) arises approximately 1.5 msec post-stimulus, 
followed by Waves II – V at roughly one msec intervals thereafter. Third, the latency 
of each wave increases slightly as the stimulus intensity is progressively decreased 
(i.e. ABRs are right-shifted as stimulus intensity decreases).  
Fourth, the lowest stimulus intensity that elicits an identifiable ABR Wave I 
approximates the hearing threshold of the mice (Figure 2.1B), the time course of 
which is not statistically different between mice anesthetized with TBE (ANOVA; F2,10 
= 0.6410, p = 0.5471) or TBE-CH (ANOVA; F4,25 = 1.190 p = 0.3393). Regression 
lines for these threshold series have positive slopes (p < 0.05); however, the 
average threshold change is negligible at < 7 %. Finally, there are no statistical 
differences in the Wave I latencies between the anesthesia groups at any stimulus 
intensity (Table 2.1), indicating that both drug regimens have similar initial effects on 
the ABRs. Moreover, we find no statistical differences from an ANOVA (Table 2.2, 
Figure 2.2) between the cohorts for interpeak latencies of the total ABR (Waves V –
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I; F5,26 = 0.2966, p = 0.91), the peripherally derived ABR components (Waves III – I; 
F5,25 = 0.8094, p = 0.55), or centrally derived components (Waves V – III; F5,25 = 
0.4545, p = 0.81).  
We also compared Wave I latencies as a function of stimulus intensity at 10 
min intervals between 10 – 30 min for the TBE and TBE-CH cohorts (Figure 2.3A), 
after which the TBE group regain consciousness. The average latencies of Wave I 
for all intensities (80 – 30 dB SPL) are adequately described by a one-phase 
exponential decay model using non-linear regression (0.66 < R2 < 0.83). The 
regression lines for each group converge with time, but never differ by more than 
4 % on the ordinate axis at any stimulus intensity or time point, and the ordinate 
intercepts are not statistically significant at any time point (p > 0.37). Moreover, the 
Wave I latencies between the 10 and 30 min time points differ by no more than 4 % 
within each cohort. In addition, we examined the central Wave V latencies as a 
function of stimulus intensity at 10 min intervals from 10 – 30 min between 
anesthetic groups (Figure 2.3B, Table 2.3). The average latencies of Wave V for all 
intensities (80 – 30 dB SPL) can be similarly described using a one-phase 
exponential decay model using non-linear regression (0.41 < R2 < 0.63), similar to 
Wave I. Taken together, these data indicate that there are negligible differences in 
ABR waveforms, latencies or hearing thresholds between the treatment groups over 
the time course of the experiment.  
ABR amplitudes and latencies are modestly altered by TBE-CH 
To determine the effects of TBE-CH on Wave I amplitudes with time, we 
measured ABRs in anesthetized mice at 10 min intervals for 50 min at 32 kHz. Our 
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Figure 2.1 – ABR threshold series from TBE and TBE-CH anesthetized mice  
 
 (A) Representative ABR intensity series from TBE (TBE) or TBE-CH (TBE-CH) 
anesthetized mice measured at 10 min intervals post-injection anesthesia. (B) ABR 
hearing thresholds from TBE (TBE) and TBE-CH (TBE-CH) anesthetized mice 
measured at 10 min intervals post-anesthesia.  
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Table 2.1 – F and p values for one-way ANOVAs comparing Wave I latencies 
between the TBE and TBE-CH cohorts (Figure 2.3A).  
Intensity 
dB SPL 
10 min 20 min 30 min 
F11,48 p F11,42 p F11,42 p 
80 1.524 >0.05 1.170 >0.05 1.016 >0.05 
70 1.560 >0.05 1.170 >0.05 0.811 >0.05 
60 1.923 >0.05 1.188 >0.05 0.982 >0.05 
50 2.431 >0.05 1.476 >0.05 1.076 >0.05 
40 1.742 >0.05 1.476 >0.05 1.529 >0.05 
30 2.468 >0.05 1.257 >0.05 0.154 >0.05 
Bonferroni post hoc reveals no statistically significant differences between 
corresponding intensities. 
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Figure 2.2 – Interpeak latencies from TBE and TBE-CH at 10 min intervals 
 
Interpeak latencies were calculated for Waves V – I, V – III, and III – I at 10 min 
intervals for 30 min comparing TBE and TBE-CH anesthesia affects. There are no 
statistically significant changes for any interpeak latency (Table 2.3).  
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Table 2.2 – Interpeak latencies of TBE (TBE) and TBE-CH (TBE-CH) 
anesthetized mice at 10 min intervals.  
Anesthesia 
Time (min) 
V – I III – I V – III 
TBE TBE-CH TBE TBE-CH TBE TBE-CH 
10 3.75 ± 0.13 3.60 ± 0.14 1.64 ± 0.09 1.64 ± 0.10 2.11 ± 0.14 1.95 ± 0.19 
20 3.70 ± 0.19 3.59 ± 0.20 1.67 ± 0.07 1.64 ± 0.11 2.03 ± 0.21 1.96 ± 0.22 
30 3.68 ± 0.22 3.60 ± 0.16 1.64 ± 0.05 1.69 ± 0.07 2.04 ± 0.23 1.91 ± 0.07 
40  3.63 ± 0.13  1.74 ± 0.10  1.89 ± 0.11 
50  3.56 ± 0.14  1.65 ± 0.09  1.91 ± 0.16 
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Figure 2.3 – ABR Wave I and V latency / intensity graphs from TBE and TBE-
CH anesthetized cohorts 
 
 (A) Quantified latency – intensity series of ABR Waves I under TBE (TBE) or TBE-
CH (TBE-CH) anesthesia at 10 min post-injection intervals. Data are plotted as 
mean ± SD for five mice per treatment. See Table 1 for corresponding one-way 
ANOVA p values (B) Quantified latency-intensity series ABR Waves V under TBE 
(TBE) or TBE-CH (TBE-CH) anesthesia at 10 min post-injection intervals. Data are 
plotted as mean ± SD for five mice per treatment. See Table 2.2 for corresponding 
one-way ANOVA p values. 
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Table 2.3 – F and p values for one-way ANOVAs comparing Wave V latencies 
between the TBE and TBE-CH cohorts (Figure 2.3B).  
Intensity 
dB SPL 
10 min 20 min 30 min 
F11,48 p F11,42 p F11,42 p 
80 1.524 >0.05 1.170 >0.05 1.016 >0.05 
70 1.560 >0.05 1.170 >0.05 0.811 >0.05 
60 1.923 >0.05 1.188 >0.05 0.982 >0.05 
50 2.431 >0.05 1.476 >0.05 1.076 >0.05 
40 1.742 >0.05 1.476 >0.05 1.529 >0.05 
30 2.468 >0.05 1.257 >0.05 0.154 >0.05 
Bonferroni post hoc reveals no statistically significant differences between 
corresponding intensities.  
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previous studies have shown this to be the optimal stimulus frequency for hearing 
experiments, providing greatest amplitudes and lowest thresholds (Gow et al., 2004). 
Amplitudes of the waves were obtained from 80 dB SPL to approximately 30 dB SPL, 
depending on the hearing threshold of individual mice. At a stimulus intensity of 80 
dB SPL (Figure 2.4A), we observe consistent and statistically significant reductions 
in Wave I amplitudes (α = 0.05; Table 2.4) at early time points during anesthesia, as 
indicated by the positive slopes of the regression lines for all mice. Regression lines 
at other stimulus intensities between 70 – 30 dB SPL also have positive slopes for 
most of the mice (Figure 2.4B – F). Furthermore, the regression lines for the average 
amplitudes differ statistically from zero (α = 0.05; Table 2.4).  
Despite these non-zero slopes, the physiological effect of TBE-CH on Wave I 
amplitudes is relatively small. Thus, the average amplitude we observe at 80 dB SPL 
after 10 min of anesthesia is reduced by 19 %, compared to the 50 min time point 
when the mice are beginning to regain consciousness. At lower stimulus intensities, 
average reductions in amplitudes are 12 % at 70 dB SPL (Figure 2.4B) and at most 
6 % for 60 – 30 dB SPL stimuli. Around the hearing threshold of 30 dB SPL, the 
anesthesia has little affect on Wave I amplitudes.  
Similar to Wave I amplitudes, the regression lines for normalized Wave I 
latencies (Figure 2.5) are statistically non-zero for most individual mice (α = 0.05; 
Table 2.5), and all of the averaged data down to the hearing threshold have negative 
slopes. Nevertheless the absolute changes in the latencies, which are increased at 
early time points, are minimal. Thus, for all stimulus intensities between 80 – 30 dB 
SPL, we observe an increase of 3 % or less compared to the 50 min time point.
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Figure 2.4 – Normalized amplitudes of Wave I from TBE-CH anesthetized mice 
 
ABR threshold series were obtained at 10 min intervals during anesthesia for 50 min. 
Normalized Wave I amplitudes are plotted as a function of time for stimulus 
intensities of 80 dB SPL (A), 70 dB SPL (B), 60 dB SPL (C), 50 dB SPL (D) 40 dB 
SPL (E) and 30 dB SPL (F). The data for each mouse are normalized to amplitude at 
50 min and the average linear regression line constrained at (50,1) is shown (solid 
line) ± 95 % CI (dashed lines). See Table 2.4 for corresponding linear regression p 
values.  
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Table 2.4 – Tabulated p values of normalized Wave I amplitudes from TBE-CH 
anesthetized mice (Figure 2.4).  
Stimulus 
(dB SPL) 
  p values, F1,3  
Mouse 1 Mouse 2 Mouse 3 Mouse 4 Mouse 5 Group 
80 0.006 0.004 0.001 0.001 <0.001 <0.001 
70 0.030 0.005 0.054 0.006 0.009 0.003 
60 0.542 0.005 0.732 0.112 <0.001 0.051 
50 0.060 0.051 0.139 0.588 0.137 0.022 
40 0.004 0.977 0.006 0.006 0.030 <0.001 
30 0.127 0.009 0.090 1.000 0.010 0.239 
F-tests were used to identify statistically significant differences between the null 
hypothesis (m = 0), that regression line slopes do not differ from zero, for several 
mice (bold, italicized). 
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Together, these data demonstrate that the TBE-CH anesthesia causes at most, 
minor reductions in Wave I ABR amplitudes and negligible changes in latencies.  
The size and stability of Waves I provide the greatest sensitivity for measuring 
changes in ABRs, but anesthetics typically have less impact on Wave I compared to 
subsequent waves, particularly those derived from central signal generators. Thus, 
to determine the effect of TBE-CH anesthesia on the major centrally derived 
components, we examined normalized amplitudes and latencies of ABR Waves III 
(Figure 2.6, Table 2.6 and Figure 2.7, Table 2.7) and Waves V (Figure 2.8, Table 2.8 
and Figure 2.9, Table 2.9). 
The Wave III amplitudes (Figure 2.6) are qualitatively similar to the Wave I 
data in that the slopes of the regression lines are positive; however the rates of 
change with time are much greater. Thus, maximal average amplitudes at 10 min 
are 1.5 – 3 fold smaller than those at 50 min, which suggests that Wave III may be 
strongly affected by TBE-CH. Unexpectedly, the magnitudes of the amplitude data 
are independent of stimulus intensity, which suggests a stochastic effect of the 
combination anesthesia. In contrast to the amplitude changes, the normalized 
average Wave III latencies (Figure 2.7) are invariant with stimulus intensity or 
anesthesia time and the slopes of the regression lines are zero (α = 0.05). Together, 
these data suggest that the Wave III amplitudes vary in a stochastic rather than 
systematic manner, which may argue against a strong suppression and more toward 
increased amplitude variability during anesthesia. Indeed, this variability is reflected 
in the large 95 % confidence intervals in the 80 – 30 dB SPL data. 
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Figure 2.5 – Normalized latencies of Wave I from TBE-CH anesthetized mice 
 
ABR threshold series were obtained at 10 min intervals during anesthesia for 50 min. 
Normalized Wave I latencies are plotted as a function of time for stimulus intensities 
of 80 dB SPL (A), 70 dB SPL (B), 60 dB SPL (C), 50 dB SPL (D) 40 dB SPL (E) and 
30 dB SPL (F). The data for each mouse are normalized to the latency at 50 min and 
the average linear regression line constrained at (50,1) is shown (solid line) ± 95 % 
CI (dashed lines). See Table 2.5 for corresponding linear regression p values. 
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Table 2.5 – Tabulated p values for normalized Wave I latencies from TBE-CH 
anesthetized mice (Figure 2.5).  
Stimulus 
(dB SPL) 
p values, F1,3  
Mouse 1 Mouse 2 Mouse 3 Mouse 4 Mouse 5 Group 
80 0.001 0.166 0.004 0.236 0.166 <0.001 
70 0.001 0.001 0.002 0.670 0.689 0.002 
60 0.005 0.166 0.001 0.261 0.099 0.004 
50 0.001 0.010 0.112 0.193 0.001 0.005 
40 0.046 0.004 0.003 0.052 0.014 0.148 
30 0.004 0.031 0.002 0.501 0.166 <0.001 
F-tests were used to identify statistically significant differences between the null 
hypothesis (m = 0), that regression line slopes do not differ from zero, for several 
mice (bold, italicized). 
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Figure 2.6 – Normalized amplitudes of Wave III from TBE-CH anesthetized mice 
 
ABR threshold series were obtained at 10 min intervals during anesthesia for 50 min. 
Normalized Wave V amplitudes are plotted as a function of time for stimulus 
intensities of 80 dB SPL (A), 70 dB SPL (B), 60 dB SPL (C) 50 dB SPL (D) 40 dB 
SPL (E) and 30 dB SPL (F). The data for each mouse are normalized to amplitude at 
50 min and the average linear regression line constrained at (50,1) is shown (solid 
line) ± 95 % CI (dashed lines). See Table 2.6 for corresponding linear regression p 
values. 
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Table 2.6 – Tabulated p values of normalized Wave III amplitudes from TBE-CH 
anesthetized mice (Figure 2.6).  
Stimulus 
(dB SPL) 
  p values, F1,3 
Mouse 1 Mouse 2 Mouse 3 Mouse 4 Group 
80 <0.001 <0.001 <0.001 <0.001 <0.001 
70 <0.001 0.662 0.025 0.701 0.002 
60 <0.001 0.008 0.002 0.028 <0.001 
50 0.002 0.132 0.010 0.619 0.874 
40 <0.001 0.270 0.724 0.007 0.551 
30 0.021 0.503 0.258 0.198 0.789 
F-tests were used to identify statistically significant differences between the null 
hypothesis (m = 0), that regression line slopes do not differ from zero, for several 
mice (bold, italicized). 
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Figure 2.7 – Normalized latencies of Wave III from TBE-CH anesthetized mice 
 
ABR threshold series were obtained at 10 min intervals during anesthesia for 50 min. 
Normalized Wave V latencies are plotted as a function of time for stimulus intensities 
of 80 dB SPL (A), 70 dB SPL (B), 60 dB SPL (C) 50 dB SPL (D) 40 dB SPL (E) and 
30 dB SPL (F). The data for each mouse are normalized to amplitude at 50 min and 
the average linear regression line constrained at (50,1) is shown (solid line) ± 95 % 
CI (dashed lines). See Table 2.7 for corresponding linear regression p values. 
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Table 2.7 – Tabulated p values of normalized Wave III latencies from TBE-CH 
anesthetized mice (Figure 2.7).  
Stimulus 
(dB SPL) 
p values, F1,3  
Mouse 1 Mouse 2 Mouse 3 Mouse 4 Mouse 5 Group 
80 0.001 0.026 0.002 1 0.002 0.453 
70 0.001 0.541 0.015 0.070 <0.001 0.644 
60 0.002 0.566 0.015 0.010 <0.001 0.600 
50 0.008 0.752 0.028 0.020 0.003 0.872 
40 0.391 0.823 0.020 0.004 0.007 0.250 
30 0.261 0.076 0.232 0.004 0.013 0.324 
F-tests were used to identify statistically significant differences between the null 
hypothesis (m = 0), that regression line slopes do not differ from zero, for several 
mice (bold, italicized). 
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Figure 2.8 shows normalized amplitudes of Waves V at 10 min intervals up to 
50 min under combination TBE-CH anesthesia, and normalized amplitudes are 
shown from 80 – 30 dB SPL. The regression lines of the averaged amplitude data 
between 80 – 50 dB SPL have non-zero slopes (α = 0.05), with maximum amplitudes 
of 10 – 21 % greater than the 50 min time point. At 40 and 30 dB SPL, average 
Waves V regression line slopes was zero, attributable to the variable increase or 
decrease of amplitudes as time progressed. However, in contrast to the Wave I 
(Figure 2.4) and Wave III data (Figure 2.6), slopes of the regression lines in Figure 
2.8 are negative, which indicates that Wave V amplitudes are supernormal at early 
anesthesia time points and decrease as the mice approach consciousness. In 
addition, the magnitudes of these changes are independent of stimulus intensity. 
These data suggest that TBE-CH does not depress Wave V amplitudes but rather 
enhances them, which differs from other common anesthetic combinations used in 
the hearing field such as ketamine / xylazine. However, we cannot rule out the 
possibility of stochastic anesthesia effects, similar to the Wave III amplitudes, 
because of the large variability in the amplitudes between mice. 
Wave V latencies for 80 – 30 dB SPL are shown in Figure 2.9. The average 
regression line for the 80 – 30 dB SPL latencies have a zero slope (α = 0.05). The 
greatest variation in Wave V latency occurs at 30 dB SPL, however the latencies are 
2 % greater at 10 min than at 50 min. These data demonstrate that there is little 
effect of TBE-CH on Wave V latencies even though the drug combination generally 
increases the amplitudes of these waves in our study cohort. 
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Figure 2.8 – Normalized amplitudes of Wave V from TBE-CH anesthetized mice 
 
ABR threshold series were obtained at 10 min intervals during anesthesia for 50 min. 
Normalized Wave V amplitudes are plotted as a function of time for stimulus 
intensities of 80 dB SPL (A), 70 dB SPL (B), 60 dB SPL (C) 50 dB SPL (D) 40 dB 
SPL (E) and 30 dB SPL (F). The data for each mouse are normalized to amplitude at 
50 min and the average linear regression line constrained at (50,1) is shown (solid 
line) ± 95 % CI (dashed lines). See Table 2.8 for corresponding linear regression p 
values. 
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Table 2.8 – Tabulated p values of normalized Wave V amplitudes from TBE-CH 
anesthetized mice (Figure 2.8).  
Stimulus 
(dB SPL) 
  p values, F1,3 
Mouse 1 Mouse 2 Mouse 3 Mouse 4 Group 
80 0.006 0.787 0.002 0.197 0.026 
70 0.001 0.053 0.011 0.073 0.417 
60 0.097 0.021 0.094 0.729 0.089 
50 0.152 0.099 0.168 0.658 0.009 
40 0.100 0.325 0.290 0.009 0.700 
30 0.065 0.118 0.004 0.005 0.716 
F-tests were used to identify statistically significant differences between the null 
hypothesis (m = 0), that regression line slopes do not differ from zero, for several 
mice (bold, italicized). 
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Figure 2.9 – Normalized latencies of Wave V from TBE-CH anesthetized mice 
 
ABR threshold series were obtained at 10 min intervals during anesthesia for 50 min. 
Normalized Wave V latencies are plotted as a function of time for stimulus intensities 
of 80 dB SPL (A), 70 dB SPL (B), 60 dB SPL (C) 50 dB SPL (D) 40 dB SPL (E) and 
30 dB SPL (F). The data for each mouse are normalized to amplitude at 50 min and 
the average linear regression line constrained at (50,1) is shown (solid line) ± 95 % 
CI (dashed lines). See Table 2.9 for corresponding linear regression p values. 
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Table 2.9 – Tabulated p values of normalized Wave V latencies from TBE-CH 
anesthetized mice (Figure 2.9).  
Stimulus 
(dB SPL) 
p values, F1,3  
Mouse 1 Mouse 2 Mouse 3 Mouse 4 Mouse 5 Group 
80 0.001 0.178 0.006 0.477 <0.001 0.257 
70 0.002 0.288 0.004 0.099 <0.001 0.180 
60 0.003 0.145 0.006 0.448 0.001 0.095 
50 <0.001 0.914 0.006 0.757 0.002 0.292 
40 0.011 0.256 0.006 0.004 0.001 0.546 
30 0.005 1 0.046 0.830 0.009 0.216 
F-tests were used to identify statistically significant differences between the null 
hypothesis (m = 0), that regression line slopes do not differ from zero, for several 
mice (bold, italicized). 
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Rapid recovery of mice from TBE-CH anesthesia and normal weight 
maintenance 
In addition to determining the effect of TBE-CH anesthesia on ABRs, we 
examined post-anesthesia recovery times and the safety of the anesthesia in terms 
of mouse weight over the subsequent two days. Consciousness was judged to 
coincide with several coincident behavioral characteristics: the reappearance of tail 
and ear pinch reflexes, an increase in respiratory rate and attempts to ambulate. 
Normal activity coincided with the reacquisition of persistent exploring, foraging, 
eating and drinking behaviors.  
Figure 2.10B shows average times taken for six mice to regain consciousness 
and resume normal activity in the cage following TBE or TBE-CH anesthesia. 
Although the time to consciousness doubles from 30 min for TBE to 60 min for the 
combination anesthetic, there is a modest 20 % increase in the time to regain normal 
activity for the combination cocktail. Thus, the addition of choral hydrate extends 
anesthesia but does not markedly increase recovery time from consciousness to 
normal activity. 
A useful indication of the short and medium term effects of anesthesia on 
mouse health is obtained by monitoring changes in weight during the post 
anesthesia period. Figure 2.10A shows the weights of six animals anesthetized with 
TBE-CH normalized to the weight of the mice just prior to injection (Day 0). An 
average weight gain of 5 % was observed for most mice after two days, and none of 
them lost more than 1.2 % of their pre-anesthesia body weight in the post-
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anesthesia period. Accordingly, we conclude that the acute after effects of the TBE-
CH combination is not detrimental to the normal behavior or health of the mice. 
Mild peritoneal vasodilation following TBE-CH anesthesia 
Finally, we examined the comparative medium term effects of two doses of 
anesthetic, one day apart, on peritoneal cavity appearance in mice injected with PBS, 
TBE, or TBE-CH. Figure 2.11 shows the peritoneal cavities of representative mice 
before (Figure 2.11A, C, and E) and following (Figure 2.11B, D, and F) detailed 
examination of the abdominal organs. Both observers were in agreement that the 
superficial appearance of the abdominal organs from the TBE and TBE-CH cohorts 
are indistinguishable from the controls at three days post-injection and gut content 
and color indicates that all three cohorts were actively feeding. Further, ascites is 
absent in all three cohorts, which suggests there is little or no inflammation, and the 
organs have normal size, shape and color.  
The observers identified several areas of apparent vasodilation in the 
intestinal vasculature for both TBE and TBE-CH cohorts compared to the controls, 
but the anesthesia cohorts were indistinguishable from each other. Accordingly, we 
observe persistent damage to the peritoneal cavity of mice following a single dose of 
TBE or the TBE-CH cocktail, although the pathology is mild and non-inflammatory. 
This vasodilation likely stems from mild irritation caused by TBE and / or the solvent 
2-methylbutan-2-ol because of the similarity of the changes in both anesthetized 
cohorts. 
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Figure 2.10 – Post anesthesia effect on recovery time and weight 
 
(A) Average times for mice to become conscious from anesthesia and resume 
normal activity. Averages are for six mice (mean ± SD) for awake and fully 
recovered states. TBE-CH (TBE-CH) anesthetic combination persists for 60 min with 
full recovery observed by two hrs, where as TBE alone persists for 30 min with full 
recovery by an hr and a half. (B) The weights of six mice are normalized to their 
weight on the day of anesthesia. There is no statistically significant change in weight 
for this cohort over three days following anesthesia (ANOVA; p = 0.272). 
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Figure 2.11 – Mild acute vasodilation in TBE-CH injected abdomens  
 
Saline injected (A and B), TBE injected (C and D) and TBE-CH injected (E and F) 
abdominal cavities post sacrifice indicate normal coloration, morphology and shape 
of abdominal structures. Control (B), TBE injected (E), and TBE-CH injected (F) 
intestines upon further examination highlight differences in vasodilation along 
intestines and septum. Black arrowheads indicate increased vasodilation in the 
peritoneal cavity.  
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DISCUSSION 
For decades, studies in rodents have employed TBE anesthesia for AEPs 
because of its ease of preparation and use; TBE is not a controlled substance 
subjected to State and Federal regulations, is readily available, easily prepared, is 
safe and rapid-onset anesthetic that can be used over a wider dosage range 
(Gaertner et al., 2008; Papaioannou and Fox, 1993; Weiss and Zimmermann, 1999). 
Anesthesia with this drug causes loss of righting reflexes, absence of responses to 
tail and ear pinching, muscle relaxation and decreased skeletal respiratory activity 
within 1 – 2 min (Gaertner et al., 2008; Norris and Turner, 1983; Papaioannou and 
Fox, 1993).  
Concerns about the use of TBE have arisen in the past because this drug has 
been associated with contradictions including intestinal ileus, peritonitis, muscle 
necrosis, serositis of abdominal organs, and death (Tarin and Sturdee, 1972; Zeller 
et al., 1998). Detailed examination of previous studies lacked crucial information 
regarding the preparation, monitoring, and storage conditions of both the stock and 
working solutions (Buetow et al., 1999; Gaertner et al., 2008; Weiss and 
Zimmermann, 1999). TBE has a short half-life and can break down into hydrobromic 
acid and dibromoacetaldehyde. These compounds are hypothesized to decrease the 
pH of the solution below 5 and likely cause the aforementioned contradictions 
(Lieggi et al., 2005; Nicol et al., 1965; Norris and Turner, 1983; Papaioannou and 
Fox, 1993). To minimize complications and increase the efficacy of the anesthetic, 
TBE should be dissolved in 2-methylbutan-2-ol, stored at 4°C and away from light for 
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no longer than two weeks, and the pH of the solution checked before use (Lieggi et 
al., 2005; Weiss and Zimmermann, 1999).  
Nevertheless, a single dose of TBE provides only 25 – 30 min of anesthesia, 
which limits the scope of experiments that can be performed. Our interest in 
characterizing binaural hearing in mice prompted a search for anesthetics that 
increase anesthesia time to one hr. Rather than a major change to different drugs, 
which would yield results that may be difficult to compare with our previous studies, 
we opted to test a novel cocktail using TBE as a base anesthetic overlaid with low 
dose CH to extend effective anesthesia time while minimally changing the 
fundamental characteristics of the centrally derived ABR waveforms.  
The routine dose of TBE that is used for AEP studies in our lab is 375 mg / kg 
(Gow et al., 2004). We have previously observed that significantly increasing the 
dose to 500 mg / kg, as used by other groups, extends anesthesia time, but at the 
cost of significant reductions in ABR amplitudes (Zheng et al., 1999). Repeated IP 
injections of 375 mg / kg within the same testing period are impractical considering 
the sensitivity of electrode and sound tube placement and lingering anesthesia from 
the initial dose of TBE can alter the level of overall anesthesia affecting waveforms.  
Chloral hydrate has been used as a reliable sedative for more than a century 
(Gaertner et al., 2008; Hetzler and Dyer, 1984). It is often considered to be a 
suboptimal anesthetic for rodents because it has poor analgesic properties and, 
indeed, most contemporary surgical procedures involve anesthetics with strong 
analgesic properties (Flecknell, 1996). Typical doses of CH for rodents with which a 
surgical level of anesthesia is induced ranges from 300 – 400 mg / kg and confers 
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effective anesthesia for 1 – 2 hrs. Numerous studies have demonstrated that the 
dose of CH has a linear relationship to anesthesia time (Field et al., 1993; Flecknell, 
1996; Smith and Kraus, 1987). At greater dosages, above 350 mg / kg, or with 
repeat injections, CH has been shown to have a proportional impact on various 
electroencephalography recordings by increasing waveform latencies and altering 
amplitudes (Field et al., 1993; Smith and Kraus, 1987). However, at low to moderate 
doses, ≤	 300 mg / kg, CH preserves the electroencephalography waveforms in rats, 
which is an important consideration for psychoacoustic studies (Sisson and Siegel, 
1989). 
The least invasive method to collect AEP measurements is via short-term 
anesthesia. Surgical implantation of a recording device is not required, thus 
alleviating any deleterious effects from surgery, data collection can begin without 
delay, and a greater number of data points (animals) can be gathered more 
efficiently. One compromise by using an acute anesthetic versus a surgically 
implanted device is the inherent decrease in the signal-to-noise ratio (SNR). 
Classically defined as SNR = Signal / Noise, this ratio relates the detectability of 
desired signal in background noise where a greater numerical SNR value indicates 
increased detectability of signal. To compensate for low SNR in anesthetized 
animals arising from the use of subdermal electrodes rather than implants, a greater 
number of recordings can be averaged together.  
All forms of anesthesia have their advantages and disadvantages that must 
be taken into account for specific applications. Herein, our goal was to extend 
anesthesia time in mice without compromising AEP measurements, however, this 
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did not seem attainable with the aforementioned alternative anesthetic compounds. 
Barbiturates tend to increase hearing thresholds, variably affect amplitudes, or 
strongly suppress EEG waveforms compared to awake animals (Feng et al., 2007; 
Shaw, 1986; Smith and Kraus, 1987). Likewise, the dissociative agent cocktail 
ketamine / xylazine, although most commonly employed has been shown to 
suppress ABR amplitudes by 20 % and increase wave latencies by 1 msec in 
rodents when compared to awake recordings (McGee et al., 1983; Santarelli et al., 
2003; Stronks et al., 2010; van Looij et al., 2004). Using the combination TBE-CH 
anesthesia, we observe negligible changes in wave latencies and non-systematic 
changes in amplitude, when compared to TBE alone.  
Herein, we demonstrate that 375 mg / kg TBE followed after five min by 200 
mg / kg CH is safe for mice, roughly doubles the anesthesia time to around 60 min, 
and has non-systematic effects on the ABR amplitudes (Maheras and Gow, 2013). A 
more reliable measure of these waves is to examine latencies as shown in Figures 
2.5, 2.7 and 2.9. The regression lines for the averaged latencies have slightly 
negative or zero slope indicating consistency throughout anesthetic time. Because of 
the tight relationship between ABR wave amplitudes and latencies, it is reasonable 
to conclude that variability in amplitude we observe stem from inter-subject effects, 
such as technical placement of the subdermal electrodes, rather than systematic 
suppression of the ABRs by the anesthetic combination.  
In light of our data, TBE-CH anesthesia is superior to other commonly used 
anesthetics in AEP studies. Amplitudes and latencies of ABRs measured from 
awake mice are similar to the values we observed under TBE anesthesia alone (van 
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Looij et al., 2004). Using the combination TBE-CH anesthesia, we observe negligible 
increases in wave latencies and non-systematic changes in amplitude, which is a 
preferable and more consistent method for collecting and analyzing AEPs.  
We find that the timing for the administration of TBE and CH to mice is 
important. Initial experiments involved injecting these anesthetics in quick 
succession, first TBE then CH. However, this protocol leads to acute gasping and 
body twitching in some mice and occasionally a failure to induce effective anesthesia. 
However, administration of TBE to rapidly induce unconsciousness at a level where 
reflexes are absent, followed by CH, yields no adverse effects. Typically, we use a 
time delay between TBE and CH injections of approximately 5 min.  
The most common side effects from IP injected anesthetics include transient 
weight loss and peritoneal irritation or inflammation (Gaertner et al., 2008). In Figure 
2.10A, we demonstrate using ANOVA that there are no statistically significant 
changes in weight for TBE-CH injected mice over the three days following 
anesthesia (p = 0.272). Figure 2.11 shows that the peritoneal cavities of these mice 
sacrificed three days post injection with TBE-CH (Figure 2.11E and F), TBE alone 
(Figure 2.11C and D) and even saline injected controls (Figure 2.11A and B) exhibit 
mild signs of vasodilation around the intestines and normal abdominal organ color 
and morphology. The similar extent of vasodilation between the TBE and TBE-CH 
cohorts suggests that CH contributes minimally to peritoneal irritation. Finally, there 
is no evidence of ascites in the peritoneal cavity of the anesthetized mice, which 
indicates that inflammatory responses are minimal.   
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CHAPTER 3 – slowed conduction velocity impacts neural 
processing  
 
INTRODUCTION 
Sensory perception is governed through five classic modalities: vision, 
hearing, taste, touch, and smell. All five senses begin as a physical event that 
stimulates receptors, transforming stimulation into electrical impulses that travel to 
the brain. As a result, the brain forms a perception or conscious experience from the 
initial stimuli event. When triggered, each sensory modality encodes four elemental 
characteristics of the stimulus: modality, location, intensity, and timing. Combined 
with diverse receptors and a fine-tuned network, complex experiences develop in 
each modality (Kandel et al., 2000). For instance, vivid images can be envisaged, a 
classical symphony perceived, a delicate touch felt, and bold flavors entertained. 
This chapter focuses on audition detailing and interrogating key features of sound 
utilized within this modality. 
The auditory pathway differentiates characteristics of sound for processing 
Sound perception relies on the ability to localize the spatial positioning of a 
sound source. Being able to isolate the necessary cues and eliminate redundant or 
irrelevant sound information improves clarity and aids in the survival instinct, such as 
the fight or flight response. Sound cues are non-redundant and provide spectral, 
timing, and intensity information about the sound source. These features have 
differing levels of importance depending upon the species.  
Critical factors determining which sound features are optimally exploited 
include head shape and relative ear location. The auricle, or outer ear, and shape of 
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the head filter incoming stimuli that must then be dissociated from the actual spectral 
information emitted. These physical features are advantageous: the size of the head 
can cause a shadowing effect, distorting sounds and creating a perceivable intensity 
difference between ears, and the difference in path length between ears can 
generate delays in the arrival of a sound to each ear. These physical attributes of an 
animal generate non-redundant sound cues and increase resolution of the spatial 
location for a sound source (Schnupp et al., 2011).  
There are two major axes pertaining to the head and the location of a sound 
source: the vertical plane (front / back, above / below) and the horizontal plane, or 
azimuth (left / center / right). Auditory cues used to isolate the origin of a sound 
along the vertical axis originate from the frequency and phase of the sound, together 
with interference patterns generated by the head, torso, and auricle. These physical 
outer structures produce differential stimulating patterns on inner ear structures, and 
thereby preserving sound cue information.  
The representation of location for the origin of a sound source along the 
azimuth plane must be computed from the input of signals from both ears. First 
proposed in the late 1800s, the duplex theory of binaural hearing states that the 
primary acoustic cues used to lateralize sounds (pure tones) are discrepancies in 
the arrival (timing) and level (intensity) of signals that reach each ear. As proposed, 
differences in sound intensity are best discriminated at higher frequencies, whereas 
timing disparities are best differentiated at lower frequencies (Rayleigh, 1907). 
These features are known as interaural level differences (ILDs) and interaural timing 
differences (ITDs) respectively. The generation of intensity and timing differences 
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arises from the shielding effect of the head, altering the physical dimension of the 
auditory cue. The head creates a shadowing effect upon the ear farthest away from 
the sound source, diminishing the sound intensity and delaying its arrival. 
Sound information is encoded and relayed through the auditory pathway  
The earliest encoding of timing and intensity cues begins in the peripheral 
auditory pathway with the basilar membrane, which, like most regions of the auditory 
pathway, is tonotopically structured. Its tapered structure generates a stiffer 
membrane near the narrow base, and a more relaxed, wider structure near the apex. 
High frequency sounds cause maximal deflection of the membrane near the base, 
and low frequency sounds maximally deflect near the apex. Resting on the basilar 
membrane is the organ of Corti in which inner hair cells reside. These cells further 
promote the encoding of auditory cues by electrically depolarizing at their best 
characteristic frequency, or frequency which elicits the greatest response. When an 
inner hair cell depolarizes, it stimulates the spiral ganglion neurons that innervate 
each hair cell. The axons of spiral ganglion neurons carry the frequency specific 
stimulus information established in the periphery to the central auditory pathway via 
their collective axons, known as the auditory or VIIIth nerve. When the auditory nerve 
enters the cochlear nucleus, it bifurcates and innervates each division: dorsal (DCN), 
posteroventral (PVCN), and anteroventral (AVCN) along their tonotopic axes.  
Within the AVCN, there are two main cells types that preserve encoded 
information: stellate and bushy cells (Kandel et al., 2000; Webster and Trune, 1982). 
As with the majority of classification schemes, gross morphology and 
electrophysiological properties differentiate these two populations (Oertel, 1983; 
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Oertel et al., 1990; Webster and Trune, 1982; Wu and Oertel, 1984). Stellate cells 
have several asymmetrical dendrites and regularly spaced action potentials. They 
are thought to be the origin of the chopper response by which auditory nerve inputs 
cause the cells to fire at regular rates despite noise and variations in stimulus 
frequency. Conversely, bushy cells have a single dendrite with modest branching 
and elicit only one action potential. Bushy cells receive direct input from the auditory 
nerve fibers forming the sizeable, quick-response synapse known as the endbulb of 
Held (Cant and Morest, 1979; Fekete et al., 1984; Tolbert and Morest, 1982). Two 
classes of bushy cells, spherical and globular, have distinct physiological properties 
and projections to the pons for binaural processing. Helping to preserve auditory 
stimulus information, the bushy cells have a unique ability to phase lock with high 
precision, causing increased synchronization for auditory nerve fibers with similar 
characteristic frequencies (Joris et al., 1994; Smith et al., 1991; Smith et al., 1993).  
From the AVCN, afferents from both the spherical and globular bushy cells 
innervate principle cells in three key nuclei of the superior olivary complex (SOC): 
the medial nucleus of the trapezoid body (MNTB), the medial superior olive (MSO) 
and the lateral superior olive (LSO). Principle cells in the MSO and LSO act as 
coincidence detectors and process the preserved sound encoded electrical signals 
from each ear to represent the sound source location on the azimuth plane; the 
MNTB principle cells act as a signal relay and sign inverter for signals being relayed 
to the LSO.  
The MSO is specialized to process minute differences in the timing of signals 
arriving from each ear to aid in sound lateralization in the azimuth plane. Three 
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different cells types are known to exist in the MSO: multipolar, marginal and principle 
cells. The principle cells are most likely to be the coincidence detecting cell because 
of a vast dendritic arbor extending in the medial / lateral direction (coronal view), as 
well as along the rostral / caudal axes (Kiss and Majorossy, 1983). The principle 
cells receive excitatory glutamatergic input from spherical bushy cells of both the 
ipsilateral and contralateral AVCN. Ipsilateral spherical bushy cell axons synapse 
onto the lateral side of the dendritic arbor, whereas contralateral axons synapse 
towards the midline (Lindsey, 1975; Stotler, 1953). Termed EE (for excitatory-
excitatory) cells, the principle cells in the MSO process incoming signals by 
summation; if the added depolarization from both ears is great enough, the principle 
cells will fire.  
Lateral superior olive principle cells receive ipsilateral information directly 
from the ipsilateral AVCN (Cant and Benson, 2003; Doucet and Ryugo, 2003), but 
information from the contralateral cochlea is relayed through afferents that first 
synapse in the MNTB (Cant and Casseday, 1986; Kandler and Friauf, 1993; Kil et al., 
1995; Kuwabara and Zook, 1991). To help preserve the temporal accuracy of 
contralateral signal transmission to the LSO, giant specialized synapses known as 
calyces of Held are located within the MNTB (Guinan and Li, 1990; Held, 1893; 
Kopp-Scheinpflug et al., 2008; Morest, 1968; Smith et al., 1991; Wu and Kelly, 1993). 
These synapses form between the presynaptic axon terminals of globular bushy 
cells in the contralateral AVCN and principle cell perikarya in the ipsilateral MNTB. 
The afferents form a giant cup-like structure with finger-like processes, which 
surround over half of the principle cell area. Additionally, principle cells of the MNTB 
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are approximately five times the size of other cells in the mammalian brain. These 
unique features enable the rapid transmission of signals, with precision, for sound 
processing in the LSO.  
The LSO is specialized to process differences in intensity for sound 
localization in the azimuth plane. Detection of intensity differences is complimentary 
to timing differences (MSO specialty), both of which are utilized for sound 
discrimination in the form of electrical signals from each cochlea arriving onto 
principle cells. Lateral superior olive principle / binaural cells receive direct, 
excitatory, intensity encoded, ipsilateral information from spherical bushy cell axons 
originating in the ipsilateral AVCN (Cant and Benson, 2003; Doucet and Ryugo, 
2003). Information from globular bushy cells in the contralateral AVCN starts out 
glutamatergic when synapsing in the MNTB, however MNTB principle cells invert the 
signal to inhibitory when projecting onto the LSO. Thus, LSO principle cells are EI 
(excitatory-inhibitory) in nature and depolarization and subsequent firing depends 
upon overcoming the inhibitory hyperpolarization of these neurons.  
Binaural sound information in the azimuth plane is processed by SOC nuclei 
To determine the spatial directionality of a sound source in the azimuth plane, 
incoming electrical signals from both ears that synapse on SOC principle cells are 
processed. Two main hypotheses describe how neurons differ in their azimuth 
coding frequencies and are known as the population and hemifield models (Phillips, 
2008). First characterized in barn owls, the population model posits that individual 
neurons are focally tuned to narrow ranges of ITDs or ILDs, spanning the relevant 
frequency range for that animal. Responsiveness or sensitivity arises from the 
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differing path lengths between the two ears and the selective neurons that respond 
to sound stimuli. This hypothesis supports a coincidence detection model to describe 
the arrival and processing of sound in MSO principle neurons and is known as the 
Jeffress model for neural processing (Jeffress, 1948). The model relies on a series 
of coincidence detecting cells (principle cells) and neural delay lines to these cells, 
comprised of serial connections of each axon to adjacent coincidence-detecting cells. 
Coincidence detecting cells receive excitatory neural signals from both the left and 
right ears and uses the delay lines to equalize the differing distances signals must 
traverse from each ear. Based on this output, the location of the sound in the 
azimuth plane can be determined. Importantly, depolarization of a principle cell only 
occurs when inputs from both neural pathways arrive in near coincidence. Excitatory 
information synapsing from a single delay line axon from one side is insufficient to 
generate action potentials; signals must arrive from both ears almost coincidently to 
depolarize the principle cell.  
The Jeffress model is the generally accepted model for neural processing in 
birds and mammalian MSO, however this hypothesis is controversial. For example, 
McAlpine and colleagues (2001) used single neuron recordings in guinea pigs to 
show that some tuning frequencies of the ITD were inconsistent with the Jeffress 
model and many of the calculated best ITDs were beyond the physiological range of 
detection. The authors hypothesized this may stem from uncharacterized inhibitory 
projections that were targeting the MSO neurons. Additional studies that blocked 
these inhibitory projections from the MNTB and the lateral nucleus of the trapezoid 
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body (LNTB) were shown to alter ITD tuning curves, once again, shifting peaks 
outside of their physiological range (Brand et al., 2002).  
Modeling how binaural information is processed in the LSO has been more 
challenging than the MSO. Lateral superior olive principle neurons have a chopper-
like response in which a highly regular discharge pattern of repetitive firing is seen. 
Due to the extensive dendritic arborization of principal cells and diffuse synaptic 
inputs from the AVCN, MNTB and other nuclei, a simple linear relationship between 
bilateral inputs and subsequent output is implausible. Rather than passive 
membrane properties, LSO principle neurons are thought to have active membrane 
properties allowing for rapid temporal firing patterns (Adam et al., 2001). Thus, the 
specification of a universal principle cell binaural model for lateralizing sound in 
space is misleading. An alternate hypothesis, the hemifield model, appears to be 
more suited for describing binaural information processing in the LSO.  
Auditory evoked potential studies in humans and animals have demonstrated 
that interaural level and timing differences are major determinants for high fidelity 
acoustic perception near the midline (McAlpine and Grothe, 2003; Mills, 1958; 
Phillips and Brugge, 1985). In humans, this relationship is linear for small and 
medium level and timing differences but is non-linear for larger differences (Yost, 
1974, 1981). Such data suggest neuronal subpopulations capable of precise 
acoustic perception along the midline and distinguishing broad hemifield level and 
timing differences more laterally. 
In contrast to the narrow range of intensity differences proposed by the 
Jeffress model, the hemifield model posits that neurons are tuned to a broad range 
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of interaural timing and intensity variations, but a subset of neurons are also 
specialized for sound detection near the midline, or medial boarder between 
hemifields. A sound source emanating from the midline of the azimuth plane will 
activate two distinct channels of neurons, in either the left or right hemifield, and 
those spanning the medial boarder. Contrasting the Jeffress model, where the timing 
or spike rate of neuronal firing encodes the magnitudes of timing and intensity 
differences between left and right ears, the responsiveness or sensitivity of neurons 
in the hemifield model arises from the distribution of firing activity across a small 
number of neural channels. (Dingle et al., 2012; Phillips, 2008; Phillips and Hall, 
2005). A number of recent psychoacoustic studies support the hemifield model of 
neural processing with two populations of neurons. 
Inaccuracies in the perceptual representation of a sound source can be 
elicited under specific conditions. For example, a phenomenon known as the 
auditory saltation illusion occurs when the processing of sound from one side of the 
head interferes with a subsequent sound on the opposite side, causing signal 
contamination. The perceived sound source is neither from the left nor the right, but 
along the midline (Bremer et al., 1977; Phillips and Hall, 2005; Shore et al., 1998). 
Further, a similar illusion is evoked during selective adaptation when a population of 
neurons within the LSO adapts to a tone at a specific frequency. Once saturated, 
further stimulation with the adapter tone and frequency causes a shift in perception 
(Phillips et al., 2006; Phillips and Hall, 2005). Additional support for the hemifield 
model comes from studies employing gap detection (Boehnke and Phillips, 1999) 
and spatial release from masking (Phillips et al., 2003) paradigms.  
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The classic Jeffress model of neural processing posits that neurons are 
focally tuned to narrow ranges of timing and intensity delays that span the relevant 
frequency range for that animal. The spatial location in the azimuth can be 
determined depending upon which principle cells fire maximally. Single cell 
electrophysiological recordings of MSO principle cells support this population model 
of neural processing; however firing patterns of LSO principle cells is drastically 
different. Auditory evoked response recordings from humans and animals propose a 
two-neuron model to describe how LSO principle cells process differences in level 
intensities. This model describes two different populations of neurons: those 
optimized for firing when sound originates from the left or right hemifield, and a 
second population that spans the midline between the hemifields.  
In both models of sound processing, the transmission of auditory signals from 
both ears to integration centers in the SOC is critical. To achieve temporal fidelity of 
signal transmission, fibers in the auditory brainstem are myelinated, increasing 
propagation speed and accuracy of dissemination. Herein, we investigate the 
consequence of dysfunction myelin on sound lateralization. A decrease in myelin 
membrane resistance due to the absence of electrically sealing Claudin11 tight 
junctions produces dysfunctional myelin, most notably for small diameter myelinated 
fibers. Larger diameter fibers have a greater number of wraps, increasing resistance 
and offsetting the tight junctions (Devaux and Gow, 2008). Using the Cldn11-/-Tg+/- 
mouse model, we conclude that sound lateralization mirrors a two-neuron 
hypothesis. Stimulating sound near the midline elicits a steep, linear pattern neural 
response, whereas and a non-linear gradual response is perceived as sound is 
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lateralized to a hemifield. Data collected from dysfunctional myelin mutant mice 
highlight the importance of small diameter myelinated axons in the auditory pathway. 
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MATERIALS AND METHODS 
Generation of transgenic mice 
The Osp20 transgene construct (GS605) comprises a 22 kb Sau3A I 
fragment of genomic sequence from 5 kb upstream of the transcription start site in 
exon 1 to 1.9 kb downstream of the first polyadenylation site in exon 3. The unique 
Acc65 I site near the 5’ end of intron 1 was blunted – out distinguishing the 
transgene from the endogenous Cldn11 gene during qPCR analysis. The genomic 
fragment was cloned between two Not I sites in a pUC18 – based vector (Gow et al., 
1992) and was excised and phenol : chloroform – purified from an agarose gel slice 
for male pronuclear injection. This allele is referred to as Tg(Cldn11)605Gow 
(MGI:5306245), and for the purposes of this dissertation as Tg+/-. Transgene 
expression was demonstrated for the testis and inner ear, but not brain (Wu et al., 
2012). Additionally, this transgene restored the known male sterility phenotype in 
Cldn11-/- mice (Gow et al., 1999) and the premature hearing loss stemming from 
diminished endocochlear potential (Gow et al., 2004) (unpublished data).  
Double mutant F1 Cldn11+/-:Tg(Cldn11)605GowTg/+ (Cldn+/-:Tg+/-) mice were 
generated by breeding males from Tg(Cldn11)605Gow with Cldn11-/- females. These 
mice were sib-mated to generate F2 (and beyond) Cldn11-/-Tg+/- mice (as well as 
control Cldn11+/-Tg+/-) for experiments. These mice were used for all experiments 
except where noted. 
Auditory brainstem responses (ABRs) and interaural level delays (ILDs) 
Mice were anesthetized by intraperitoneal (i.p.) injection of freshly prepared 
2,2,2-tribromoethanol in sterile phosphate buffered saline (PBS) (Cellgro, Manassas, 
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VA) at a dose of 375 mg / kg. Mice were monitored for the absence of tail, foot, and 
ear reflexes, as well as reduced respiratory rate, all of which are indicative of 
effective anesthesia. Once confirmed, mice were injected i.p. with 200 mg / kg 
chloral hydrate (Sigma, St Louis, MO) in sterile phosphate buffered saline to 
maximize anesthesia time (Chapter 1), and placed on a 39°C pad (Maheras and 
Gow, 2013). The fur along the top of the head and middle of the back of each mouse 
was sterilized / moistened with alcohol pre pads (Triad Group, INC, Harland WI) and 
subdermal platinum electrodes (Grass Technologies, West Warwick, RI) were 
positioned at the left and right mastoids (negative), vertex (reference) and 
hindquarters along the midline (ground) for recording.  
For auditory brainstem responses (ABR), mice were presented with 512 pure-
tone stimuli in 10 dB SPL decrements from 80 – 20 dB SPL at 32 kHz (102 µsec 
duration; Blackman envelope) at a stimulus rate of 29.1 / sec. Both right and left ears 
were tested successively and ipsilateral EEGs were pre-amplified (x 100,000), band 
pass filtered (0.3 – 3 kHz), and recorded for 12.5 msec (Sepwin software version 5.1, 
Intelligent Hearing Systems, Miami, FL). Interaural level delay (ILD) measurements 
were collected once a symmetrical hearing threshold of ≤	 40 dB SPL was confirmed.  
For ILDs, mice were presented with 2,048 pure-tone stimuli at 32 kHz (102 
µsec duration; Blackman envelope) and a stimulus rate of 29.1 / sec. All EEGs were 
pre-amplified (x 200,000), band pass filtered (10 – 3000 Hz), and recorded for 25 
msec (Sepwin software version 5.1, Intelligent Hearing Systems, Miami, FL). The 
advanced module was utilized to present ipsilateral and bilateral stimuli of differing 
intensities to each ear. First, midline level delays were obtained by playing 70 dB 
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SPL to either the left ear or right ear, then simultaneously. Subsequently, left ear 
stimulus intensity was decreased to 68, 65, 60, 50, then 40 dB SPL in conjunction 
with and without a 70 dB SPL stimulus presented to the right ear. This process was 
reversed and right ear stimuli were reduced to 68, 65, 60, 50, then 40 dB SPL in 
conjunction with and without a 70 dB SPL stimulus presented to the left ear. See 
Table 3.1 for clarification.  
To obtain binaural interaction components (BICs), we determined that post-
filtering traces from 10 – 500 Hz was optimal. First, a midline BIC was acquired by 
summing monaural left and right ipsilateral traces (µV weighted) obtained at 70 dB 
SPL, then subtracting this summed trace from the binaural trace obtained when 70 
dB SPL was presented bilaterally. Two midline BIC traces were obtained, one from 
each ear. Subsequent ILD BIC traces were generated in a similar fashion. Left ear 
BIC were generated by adding the monaural left ipsilateral trace obtained at <70 dB 
SPL to the monaural right ipsilateral trace obtained at 70 dB SPL. The resulting 
summed monaural trace was then subtracted from the corresponding binaural trace 
(See Figure 3.1). This process was repeated for the right ear. After the completion of 
experiments, the mice were allowed to recover in a separate cage on a 39°C heating 
pad (Delta phase isothermal pad, Braintree Scientific, Braintree, MA) until they 
regained normal activity and could be placed back in their home cage.  
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Figure 3.1 – Schematic for calculation of the BIC 
 
A Binaural traces were obtained by simultaneously stimulating both ears with 
differing sound intensities and the response recorded. Left and right ear monaurals 
were obtained by individual stimulation with corresponding sound intensity and 
traces recorded. The binaural interaction component was generated by summating 
the two monaural traces and subtracting from the binaural. 
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Dextran Labeling 
CD – 1 female mice (Crl:CD1(ICR) Charles River, Wilmington, MA) were 
perfused with 10 ml of freshly oxygenated artificial cerebral spinal fluid (aCSF: 
126mM NaCl, 3mM KCl, 2mM CaCl2, 2mM MgSO4, 1.25 mM NaH2PO4, 26 mM 
NaHCO3, 10mM dextrose, pH 7.4) at a rate of 2 ml / min (PHD 22/2000 Syringe 
Pump Infusion, Harvard Apparatus, Holliston, MA). Brains were promptly removed 
and 2 ml coronal sections isolating the lower auditory brainstem nuclei were 
harvested extending from interaural -1 to -3 using a mouse anodized aluminum 
matrice (BS-AL 5000C, Braintree Scientific, Braintree, MA). Coronal sections were 
allowed to rest for an hr in a 60 x 60 millimeter petri dish (BD Falcon, Franklin Lakes, 
NJ) filled with aCSF and perfused continuously with carbox gas (95% O2, 5% CO2). 
Custom microinjection needles 10 – 20 µm in diameter were pulled from glass 
capillary tubes using a puller (Narishige, Tokyo, Japan). Needles were back-filled 
with 3 µl of a 50 mg / ml solution containing Alexa488 labeled dextran dye 
(CAT#:D22910, 10000MW, Molecular Probes, Eugene, OR) then attached onto a 
digital microdispensor (CAT#:53506-121, VRW International, Radnor, PA) clamped 
onto a micromanipulator (Narishige, Tokyo, Japan).  
Mouse brain slices were transferred, one-by-one from the resting dish to a 
separate 60 mm dish containing freshly carbox-perfused aCSF under a 
stereomicroscope (Leica Zoom 2000, Leica, Solms, Germany). Approximately 30 to 
50 nl of dextran dye was quickly injected into a single location and the brain slice 
was immediately returned to the resting dish for four hrs to allow sufficient time for 
endocytosis of the dye and transport along axons. During this time, the carbox-
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perfused aCSF was replaced every hr and pH monitored. After labeling, brains were 
immersion-fixed overnight with shaking at 4°C in a fresh 60 mm dish containing 4 % 
PFA in phosphate buffer, pH 7.2. The following day, brains underwent five x 15 min 
washes in PBS in preparation for vibratome sectioning.  
Vibratome  
Dextran dye-labeled coronal mouse brain sections were removed from PBS, 
blotted dry, placed into a 15 x 15 mm cryomold (Electron Microscopy Science, 
Thermo Fisher Scientific, Waltham, MA), and overlaid with 4 % low-melt agarose 
(Agarose Products, Nesbit, MS). The agarose was allowed to solidify at room 
temperature for 10 min before being moved to 4°C for 20 min. Molds were removed 
from 4 C, the gel excised, trimmed, and superglued to a vibratome chuck. Coronal 
sections of approximately 70 µm thick were cut at room temperature and transferred 
using an artist brush into individual wells of a 24-well dish (Fisher) containing PBS.  
Immunofluorescence staining of vibratome sections 
Individual 70 µm vibratome sections were stained in separate wells of a 24-
well plate using a minimum of 200 microliters solution during each step. Sections 
were permeabilized in blocking solution comprised of TBSGBA (1X TBS pH 7.5, 
0.1 % gelatin, 1 % BSA, 0.05 % sodium azide, 2 % goat serum) and 0.5 % triton X-
100 for one hr. Blocking solution was removed and replaced with primary antibody 
(See Table 3.2) diluted fresh in blocking solution. Primary antibody incubation was 
carried out for three overnight periods with gentle agitation at 4 C. Primary antibody 
liquid was removed and washed with PBS plus 0.5 % triton X-100, twice, for 30 min. 
Wash solution was removed and replace with the secondary antibody (See Table 
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3.3) diluted in blocking solution. Slices were incubated with secondary antibody for 
six hrs at room temp with gentle agitation. The secondary antibody liquid was 
removed and replaced with DAPI solution diluted in PBS plus 0.5 % triton X-100 for 
ten min. DAPI solution was removed and the sections washed with PBS plus 0.5 % 
triton X-100, twice, for thirty min. Sections were free-floated in PBS and carefully 
mounted to slides using a paintbrush. Sections were covered with Vectashield 
mounting medium (Vector Labs, cat#H1000), coverslipped, and sealed with nail 
polish. 
Confocal microscopy and axon diameter measurements 
Confocal fluorescence image stacks of dextran-labeled axons were captured 
using a Leica DM5500B microscope equipped with a Plan Apo 63x lens, Yokogawa 
spinning disk confocal with Argon/He/Ne lasers (QLC100, Visitech International, 
Sunderland, United Kingdom) and a Hamamatsu Orca ER2 digital camera. Confocal 
image stacks were acquired using a 63x Plan Apo oil-immersion objective lens (n.a. 
= 1.4) in 0.2 µm increments through 70 µm vibratome sections.  
After collection, stacks were quantified using Image J software. The location 
of each fiber within a stack was determined and mini stacks were flattened into 
single through-focus images for analysis of individual fibers. Axons were analyzed 
only if the entire length could be followed with confidence throughout the image 
stack. Axon diameters were manually drawn at random along the length of the axon, 
resulting in 20 – 30 measurements per fiber. To discern contralateral auditory fibers 
from pyramidal fibers, only axons attached to a calyx of Held were analyzed. 
Average axon diameters from multiple mice were used to generate the histograms 
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shown in Figures 3.5 and 3.6 using 0.2 µm as the binning factor and fit with a 
Gaussian distribution (Graphpad).  
Cryostat sectioning of PFA-perfused brain 
Cldn11-/-Tg+/- mice were injected i.p. with 400 mg / kg avertin, and monitored 
for the absence of reflexes, signifying deep anesthesia. The chest cavity was 
exposed using scissors, and mice were perfused transcardially with 4 % PFA (Sigma 
Aldrich, St Louis, MO) in 0.1 M phosphate buffer pH for 15 min. Brains were 
immediately removed and place in a 25 % sucrose solution over night at 4 C. 
Sucrose solution was changed the next morning and brains prepped for embedding 
that afternoon. Brains were removed from the sucrose solution, blotted dry on a 
Kimwipe (Kimberly-Clark Corp, Roswell, GA) placed in a plastic cryomold (Tissue-
tek, cat #4557, Torrance, CA), and covered with OCT (Tissue-tek OCT, Andwin 
Scientific, Schaumburg, IL). Blocks were gradually frozen using ice-cold 2-methyl 
butane and stored at - 80°C until cutting.  
Frozen blocks were cut using a Shandon Electric Cyrotome (Pittsburgh, PA). 
Sagittal 10 µm sections were collected on charged superfrost slides (Fisherbrand, 
Thermo Fisher Scientific, Waltham, MA) beginning at the midline and progressing 
laterally. Every fifth section (50 µm) was collected and stored at - 80°C until staining.  
Immunofluorescence staining for cryostat sections 
Superfrost slides were removed from the - 80°C and immediately thawed in a 
glass vial containing PBS and washed twice for five min. Slides were permeabilized 
with methanol for 20 min at 4°C. Slides were washed in PBS, excess liquid removed, 
outlined brains using a pap pen, and immersed with blocking solution (TBSGBA + 
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2 % goat serum) for an hr. Blocking solution was removed and replaced with primary 
antibodies (Table 3.4), diluted in blocking solution. Primary antibodies were 
incubated over night at room temperature while rocking. Primary antibody was 
removed and slides washed with PBS. Secondary antibodies (Table 3.5) diluted in 
blocking solution were placed onto sections for three hrs while rocking at room 
temperature. Slides were washed once more in PBS, the pap pen removed using a 
cotton bud soaked with chloroform, a drop of Vectashield mounting medium added 
over the section and coverslipped. Slides rested overnight, excess mounting 
medium removed, and edges of the coverslip sealed with clear nail polish the 
following day.  
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RESULTS 
Cldn11-/-Tg+/- mice have altered ABRs  
Evoked potentials can be elicited using a number of sensory modalities, but 
our interest lies in the well-characterized ascending auditory pathway. Figure 3.2A 
shows representative ABR threshold series traces from Cldn11+/-Tg+/-and Cldn11-/-
Tg+/- mice and demonstrates several characteristics of an ABR threshold series. First, 
the five characteristic peaks and troughs of the ABR are discernable for both groups 
of mice with Wave I arising approximately 1.5 – 2 msec post stimulus and each 
subsequent waveform in approximate one msec intervals thereafter. Second, the 
latency of each wave increases slightly as stimulus intensity is progressively 
decreased. Finally, the lowest stimulus intensity that elicits an identifiable Wave I is 
regarded as the hearing threshold of the mouse. Figure 3.2B shows that the hearing 
thresholds between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice are indistinguishable.  
One detectable difference in the ABR trace of Cldn11-/-Tg+/- mice compared to 
controls is the increased Wave V latency, indicated by the red ‘X’ along the x-axis 
(Figure 3.2A). The latencies of Waves I – IV in Cldn11-/-Tg+/- mice are normal at the 
level of both the absolute ABR and interpeak latencies (Figure 3.2C). Absolute 
interpeak latency, Wave V – Wave I latency, is calculated to correct for variability in 
Wave I onset. Figure 3.2C shows the absolute interpeak latency for Cldn11+/-Tg+/- 
and Cldn11-/-Tg+/- mice, illustrating a significant increase in Cldn11-/-Tg+/- mice: F9,100 
= 25.25, p < 0.0001. Post hoc testing using Bonferroni’s multiple comparisons test 
indicates significant differences are present at every intensity level (80 – 40 dB SPL) 
stimulated. When frequency of the stimulus is varied, the delay in Wave V persists 
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(data not shown). These data suggest the delay in Wave V is not a function of 
stimulus parameters, but a consequence of eliminating Cldn11 tight junctions. 
The absolute interpeak latency can be separated into two components based 
on location of signal generators: central (V – II) or peripheral (II – I) nervous system. 
Similar to absolute interpeak latency, central interpeak latency of Cldn11-/-Tg+/- mice 
is significantly increased compared to controls: F9,100 = 21.42, p < 0.0001. Bonferroni 
post hoc tests reveal significant increases for all intensity levels. Contrasting 
absolute and central interpeak latencies, peripheral interpeak latency was significant 
(F9,100 = 2.938, p = 0.0039), however post hoc analysis comparing individual 
intensities is not significant. Together, these data demonstrate that Cldn11-/-Tg+/- 
mice have an in increase Wave V latency and elongated central interpeak latency, 
suggesting slowed conduction along central components of the lower auditory 
brainstem.  
Cldn11-/-Tg+/- mice have altered neural processing in the auditory brainstem  
The characteristic waveform traces of the ABR are evoked when auditory 
information is rapidly transmitted to the generators, persevering the temporal 
accuracy of signal transmission are myelinated fibers along the auditory brainstem. 
The function of myelin is to increase the speed of signal transmission, preserving 
temporal accuracy and increasing long-range signal fidelity. The repetitive delay in 
central components of the ABR in Cldn11-/-Tg+/- mice suggests that small diameter 
myelinated fibers are present in the lower auditory brainstem and are associated 
with the transmission of electrical signals between these components. Because 
preserving temporal transmission is imperative for the processing of sound 
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Figure 3.2 – ABRs reveals delayed Wave V latency in Cldn11-/-Tg+/- mice 
 
(A) Representative ABR traces collected from Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice 
at 32 kHz, 80 – 20 dB SPL. Characteristic Waves I, III, and V are indicated in the 80 
dB SPL trace with dotted vertical lines drawn down to convey latencies. The delay in 
Wave V latency for Cldn11-/-Tg+/- mice is discernible at all intensities. (B) Threshold 
quantification for Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice are identical. (C) Total 
interpeak latency, Waves V – I, is significantly different between Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice at all intensities. Upon further examination, central interpeak 
components (Waves V – II) remain significantly latent, whereas peripheral 
components (Wave II – I) are not. Cldn11-/-Tg+/- data points in II – I are right-shifted 
about the abysses for clarification. Data values are plotted as mean + SD; 10 ≤	 n ≤ 
12; ****p < 0.0001. 
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localization cues, we explored the ramification of slowed conduction on neural 
processing. 
One method to non-invasively interrogate neural processing is to measure the 
binaural interaction component (BIC) computed from processed ABR traces (Figure 
3.1). Binaural ABR traces contain three pieces of information: ipsilateral transmitted 
from the ipsilateral ear, contralateral relayed via the MNTB, and finally binaural 
information. Binaural interaction component information is extracted from binaural 
ABR traces by summing each monaural component (ipsi- and contra- lateral) and 
subtracting from the binaural signal. The resulting BIC traces represents the output 
from LSO principle cells where bilateral information has converged from ipsilateral 
and contralateral pathways.  
Figure 3.3A shows representative BIC traces generated via interaural level 
delays (ILDs) using difference stimulus intensities for each ear of 0, 2, 5, 10, 20, and 
30 ΔdB SPL. The corresponding ABR trace at 70 dB SPL is shown above the BIC 
trace series is, and is labeled for Waves I, III and V. The characteristic BIC trough, 
known as the DN1 trough, is indicated by a black dot for each BIC generated. The 
DN1 trough represents the measured interaction component; the computed output 
from LSO principle cells to which bilateral sound information has synapsed. The 
latency of the BIC occurs between Waves IV and V of the ABR trace, indicating the 
trough is generated immediately after the information reaches the SOC, but 
precedes termination of lateral lemniscus fibers into the inferior colliculus (Wave V) 
(Appendix C.1).  
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The interaction component, DN1, contains two pieces of information reflecting 
neural processing in the SOC, the amplitude and the latency. Appendix C.2 
illustrates the raw latency and amplitude values of the DN1 trough for Cldn11+/-Tg+/- 
and Cldn11-/-Tg+/- mice. To control for initial waveform onset, each variable between 
groups, data values are normalized to either the respective latency or amplitude 
recorded when simulated sound was directly in front of the animal at the midline (Δ0 
dB SPL). Figure 3.3B shows the normalized latency of the DN1 trough for Cldn11+/-
Tg+/- and Cldn11-/-Tg+/- mice. A one-way ANOVA comparing normalized latency of 
the DN1 trough to intensity difference indicates a significant difference between 
Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice: F11,120 = 8.334, p < 0.0001. Bonferroni post 
hoc testing reveals a significant increase in latency when sound intensity varies by 
20 or 30 dB SPL for Cldn11-/-Tg+/-. 
The second feature examined was the amplitude of the DN1 trough. Figure 
3.3C shows normalized amplitude of the DN1 trough for Cldn11+/-Tg+/- and Cldn11-/-
Tg+/- mice. Unlike latency values, amplitude is highly variable, indicated by the large 
deviations present at all ILD intensities stimulated for both groups of animals. There 
are several strategies for measuring amplitude of a waveform. First, the conventional 
approach measures amplitude from the bottom of the trough to the tip of the 
subsequent waveform peak or to the preceding waveform peak. In the BIC, both 
bounding peak waveforms are inconsistent in both Cldn11+/-Tg+/- and Cldn11-/-Tg+/- 
mice. The best approach was to measure amplitude from the base of the DN1 
trough to the - 5 msec baseline recording prior to sound stimulus presentation (0 
msec). This region was unbiased during waveform manipulation. A one-way ANOVA 
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indicates normalized amplitude of the DN1 trough was similar between Cldn11+/-Tg+/- 
and Cldn11-/-Tg+/- mice, F11,120 = 0.6553, p = 0.7778.  
With neurophysiology data, latency is the stronger parameter measurement 
compared to amplitude. It is well known that amplitude values, regardless of 
calculation method, are highly variable in nature. In addition, when a sound source is 
located in the lateral hemifields (increased intensity difference), amplitude is 
imprecise in specifying a sound source due to ILDs having a maximal response over 
a broad lateral azimuth (Makous and Middlebrooks, 1990). This variability is seen 
between and within mice of both groups, indicated by raw (Appendix C.2) or 
normalized (Figure 3.3C) amplitudes. Combined, these data sound show that 
lateralization measured by the DN1 trough is significantly different between Cldn11+/-
Tg+/- and Cldn11-/-Tg+/- mice, suggesting a difference in sound lateralization ability.  
The auditory brainstem in mice contains myelinated small and large diameter 
fibers 
The significant increase in Wave V of the ABR in Cldn11-/-Tg+/- mice is 
indicative of slowed conduction velocity along the auditory pathway. Interpeak 
latency calculations show a significant increase in central, but not peripheral 
interpeak latencies. These findings corroborate previous studies examining 
compound action potentials (CAPs) of ex vivo optic nerves from Cldn11-/- mice 
indicating that conduction velocity is severely slowed along small diameter fibers (< 
1.2 µm). Furthermore, the difference in sound lateralization ability between 
CLdn11+/-Tg+/- and Cldn11-/-Tg+/- mice suggests a functional consequence to 
slowed conduction within the auditory brainstem. The literature has eluded to the 
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Figure 3.3 – Computed DN1 interaction trough indicates abnormal latency in 
Cldn11-/-Tg+/- mice 
 
(A) Representative BIC traces calculated for intensity differences ranging from 0 – 
30 dB SPL for Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice. BIC traces are aligned with 
corresponding ABR trace to substantiate BIC emergence between Waves IV and V. 
Crosshatch indicates the binaural trough, DN1. (B) Normalized latency of DN1 
trough for varying intensity differences. (C) Normalized amplitude of DN1 trough for 
varying intensity differences. Grey circles represent the normalized value for both 
Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice. Data values plotted as mean + SD; 10 ≤	 n ≤ 
12; **p < 0.01, ****p < 0.0001. 
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presence of myelinated large diameter contralateral and small diameter ipsilateral 
fibers, however direct quantitation is lacking (Doucet and Ryugo, 2003; Wu and Kelly, 
1991, 1992b; Wu and Oertel, 1984).  
Figure 3.4A illustrates the size of key brainstem nuclei using calbindin 
staining, highlighting the extent to which information must be relayed for neural 
processing. The simplified schematic in Figure 3.4B depicts the three fiber tracts are 
responsible for relaying auditory information from each ear for neural processing in 
the SOC along the contralateral pathway: between the CN and contralateral MNTB, 
the MNTB and LSO, and from the CN to the LSO along the ipsilateral pathway (blue, 
pink, and green fiber tracts respectively. Because electrophysiology data alludes to 
small diameter myelinated fibers within this relay network, methodological studies 
were undertaken to measure axon diameters between relay nuclei within this 
network.  
Contralateral fibers relaying information from the CN to the contralateral 
MNTB must be speedy, preserving temporal accuracy of signal transmission 
(Guinan and Li, 1990; Kopp-Scheinpflug et al., 2008; Wu and Kelly, 1993). Two 
features important for rapid transmission, and subsequent relaying of information, 
are the giant calyx of Held synapse and myelination of axons. Figure 3.5 confirms 
myelination of contralateral fibers by immunofluorescence staining of sagittal 
sections through the trapezoid body tract. Axons are stained with neurofilament light 
(NFL, red), myelin is indicated with myelin basic protein (MBP, green), and nuclei 
identified with DAPI (blue).  
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Figure 3.4 – Auditory brainstem schematic illustrating key fiber tracts 
transmitting binaural information  
 
(A) Calbindin staining was used to identify key brainstem nuclei associated with 
binaural interaction. Principle cells of the MNTB (outlined in blue) are pronounced, 
as well as their axonal projections. Moreover, the PON (outlined in green) and LSO 
(outlined in pink) are observable, presumably from MNTB priciple cell innervation. 
Scale bar = 200 µm. (B) Lower brainstem schematic depicting three necessary fiber 
tracts and their nuclei relays that transmit binaural information to priciple cell 
integrators in the LSO. The blue trajectory represents contralateral information 
transmitted from the AVCN to the contralateral MNTB; pink trajectory portrays the 
subsequent relay of contralateral information from the MNTB to LSO; green 
trajectory illustrates ipsilateral sound information transferred from the AVCN directly 
to the LSO. 
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Figure 3.5 – Myelinated axons are present in the auditory pathway  
 
Representative sagittal brainstem section of the trapezoid body fiber tract (see 
insert). NFL (red) is used to illustrate all axons present, myelin (green) is illustrated 
with MBP, and nuclei (blue) are visible with DAPI staining. Distinct fiber bundles are 
evident, interspersed with transverse pyramidal fibers. Scale bar = 20 µm. 
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Appendix C.3 quantifies the proportion of myelinated axons within the 
trapezoid body and pyramidal fiber tracts, prior to synapsing with, and in the 
presence of, MNTB, principle cell innervation. Because axons of AVCN bushy cells 
(forming the trapezoid body fiber tract) decussate at the midline before innervating 
contralateral MNTB principle cells, direct midline sagittal sections will contain 
trapezoid body fiber bundles in the absence of MNTB principle cells. Analyzing 
sagittal brainstem sections indicates a conservative 98.7 ± 0.64 % of axons are 
myelinated. 
A labeled fluorescent dextran conjugate dye was injected laterally to the 
MNTB, allowing axonal uptake, transport, and subsequent labeling of contralateral 
fibers forming calyces of Held. Figure 3.6A illustrates a representative calyx of Held 
synapse, complete with contralateral fiber labeling from the dextran conjugated dye 
(green) and co-stained for MNTB principle cells (Calbindin+, red) and nuclei (DAPI, 
blue). The histogram in Figure 3.6B shows contralateral axon diameters measured 
from dextran labeled fibers forming a calyx. The distribution was normally distributed, 
indicated by Gaussian curve fitting, with average diameter 3.33 ± 0.59 µm and 
ranging 2.22 – 5.13 µm. Figure 3.6C shows variability along individual contralateral 
axons, consisting of 20 – 25 measurements per fiber. As expected, and implicated 
for other species from published studies, these data confirm that contralateral fibers 
diameters are greater than a micron and conduction velocity along contralateral fiber 
would be minimally affected in Cldn11-/-Tg+/- mice.  
Ipsilateral fibers relaying information directly from the CN to the LSO have 
been alluded to in the literature as being small in diameter, however obtaining a
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Figure 3.6 – Morphometric analysis of contralateral trapezoid body fibers 
reveals axons are large in diameter 
 
(A) Dextran injected vibratome sections were visualized using spinning disk confocal 
microscopy. A contralateral dextran labeled fiber (green, arrow) is seen forming the 
characteristic calyx of Held synapse around a Calbindin+ MNTB principle cell (red, 
arrow head). Nuclei are stained using DAPI (blue). (B) Quantitation of axon 
diameters from contralateral fibers labeled with dextran dye. Histogram is fit with a 
Gaussian distribution. (C) Variation along individual contralateral fibers, labeled with 
dextran dye and seen forming a calyx of Held. Data values are plotted as mean + 
SD; n = 3 mice; 59 total axons, 20 – 25 measurements / axon. Scale bars = 20 µm.  
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numerical value for small is critical for analysis of Cldn11-/-Tg+/- mice. Previous 
studies using ex vivo optic nerves of Cldn11-/- mice indicates a predictable 
relationship between axon diameter and impact on conduction velocity. Measuring 
ipsilateral fibers diameters would allow us to build a mathematical model of neural 
processing in the auditory brainstem, taking into account distance of the fiber tract 
and axon diameter size.  
In a similar fashion to contralateral fibers, ipsilateral fibers were labeled with 
dextran dye by injecting coronal brainstem slices dorsal and lateral to the LSO. 
Figure 3.7A illustrates presumed ipsilateral fibers entering the LSO (green), 
accompanied by labeling of phosphorylated and non-phosphorylated neurofilament 
(SMI 31 / 32, red) and nuclei (DAPI, blue). The histogram in Figure 3.7B shows 
ipsilateral axon diameters measured from dextran labeled fibers that entered the 
LSO. The frequency is normally distributed, as indicated by a Gaussian curve, with 
average diameter 0.87 ± 0.37 µm and ranging 0.41 – 2.03 µm. Figure 3.7C shows 
variability along individual ipsilateral axons, consisting of 20 – 25 measurements per 
fiber. These ipsilateral fibers are less than a micron in diameter and conduction 
velocity along ipsilateral fibers would be significantly slowed in Cldn11-/-Tg+/- mice, 
and the likely the cause for the observed abnormal neural processing. 
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Figure 3.7 – Morphometric analysis of ipsilateral fibers reveals axons are small 
in diameter  
 
(A) Dextran injected vibratome sections were visualized using spinning disk confocal 
microscopy. Presumed ipsilateral dextran labeled fibers (green, arrowheads) are 
seen entering and terminating in the LSO. Insert depicts site of picture in relation to 
the LSO structure. Contrasting visualizations include all axons using SMI 31 / 32 for 
phosphorylated and non-phosphorylated neurofilament (red) and nuclei using DAPI 
(blue). (B) Quantitation of axon diameters from presumed ipsilateral fibers entering 
the LSO and labeled with dextran dye. Histogram of averages is fit with a Gaussian 
curve. (C) Axon diameter variation along individual ipsilateral fibers, labeled with 
dextran dye and seen entering the LSO. Data values are plotted as mean + SD; n = 
3 mice; 25 total axons. Scale bars = 20 µm.  
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DISCUSSION 
Over the past few decades, the mouse has emerged as an important model 
organism to investigate AEPs and auditory perception (Liu, 2006; Ohlemiller, 2006). 
With recent advances in molecular genetic manipulation in mouse models producing 
deletions, duplications, and mutations by homologous recombination and transgene 
technologies, researchers can explore the contribution of individual abnormalities on 
audition, aiming to better understand human disease. The lower auditory brainstem 
is an excellent model to study neural processing because signal transmission along 
the ascending auditory pathway and their connections are highly conserved and 
homologous across species, and well-characterized (Christensen-Dalsgaard and 
Carr, 2008). Direct stimulation and measurement of processing in such an isolated 
circuit allows extrapolation to higher brain networks that are less accessible to 
manipulation and more difficult to isolate. Herein, we use auditory brainstem neural 
circuitry to explore the consequence of dysfunctional myelin on neural processing 
and its potential ramifications.  
Characteristics of the Cldn11-/-Tg+/- ABR 
The most well studied auditory evoked potential is the ABR. Elicited within 10 
msec following auditory stimulation, the ABR is composed of five, sometimes six 
waveforms, beginning with Wave I around 1.5 – 2 msec post stimulus. Waves II – V 
appear in succession at 1 msec intervals thereafter (Willott, 2001). Chapter 2 
discusses more extensively the signal generators along the ascending auditory 
brainstem responsible for the production of each waveform.  
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The persistent delay in Wave V latency of Cldn11-/-Tg+/- mice suggests 
conduction velocity is slowed in the auditory brainstem below the level of the inferior 
colliculus. These findings recapitulate electrophysiological data collected from ex 
vivo optic nerves of Cldn11-/- mice computing a slowing of 50 % in myelinated fibers 
< 0.7 µm and 20 % for those between 0.7 and 1.2 µm (Devaux and Gow, 2008). 
These quantitative data suggest that within the auditory brainstem, small diameter 
myelinated fibers < 1.2 µm are responsible for transmission and innervation of ABR 
signal generating nuclei along the ascending auditory pathway below the level of the 
inferior colliculus.  
Binaural sound processing in the auditory brainstem 
Sound is first processed in the lower auditory brainstem at the level of the 
SOC. Two key nuclei, the MSO and LSO, integrate neural signals arriving from each 
ear to localize the origin of a sound source on the azimuth plane. Principle cell 
integrators located in the MSO are responsible for processing the temporal 
difference in the arrival of signals to each ear. The principle cells are most sensitive 
for sounds resonating at lower frequencies. In mice, higher frequencies dominate the 
hearing range resulting from a small head size which lacks the ability to deflect lower 
frequency sounds. The functional consequence to mice is an underdeveloped MSO, 
comprised on only 200 neurons (Irving and Harrison, 1967; Ollo and Schwartz, 
1979; Wu and Kelly, 1991, 1992a). Accordingly, the examination of binaural 
processing using interaural timing differences would lack sensitivity, regardless of 
frequency.  
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In contrast to the MSO, LSO principle cell integrators discriminate sound 
intensity, or level, differences arriving at each ear to localize a sound source on the 
azimuth plane. Principle cells in the LSO are specialized to discriminate higher 
frequency sounds, which is more appropriate for rodents that have poor hearing 
below 10 kHz. Equal sound intensities played to each ear simultaneously mimics a 
sound originating from directly in front, or back, of the animal. As intensity is 
decreased to one ear and held constant in the other, sound is perceived to be 
lateralized toward the ear exposed to the louder tone.  
The classic Jeffress model for neural processing outlining coincidence 
detectors and delay lines primarily describes neural processing in the MSO and 
using those principles to interpret the data presented herein may be incorrect. The 
measured response from Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice is similar to humans 
where a linear response was measured for small and medium disparities of level 
differences, but continued in a non-linear fashion for larger differences (Yost, 1981). 
This idea developed into the hemifield model where two populations of neurons are 
postulated to be responsible for sound localization. Each population / channel of 
neurons responds broadly across the left or right (ipsilateral versus contralateral) 
acoustic hemifield, and shares an overlapping boarder along the midline (Boehnke 
and Phillips, 1999; Phillips, 2008). Each auditory hemifield (left and right) also 
contains cells that respond to a sound source stemming from the ipsilateral and 
contralateral hemifield.  
The overall shape of the normalized DN1 latency curves for Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice reflect a two-neuron hypothesis of neural processing. When a 
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sound source is emulated near the midline, Δ0 – 10 dB SPL (Figure 3.3B), a steep 
linear increase in latency is evident. These data are similar to those measured in 
humans and reflect a distinct midline population of neurons that are responding. 
Because sound lateralization along the azimuth is best near the midline, responding 
neurons have a steeper response and this is reflected in both Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- data collected.  
As intensity differences are increased to Δ20 – 30 db SPL, the latency 
response of Cldn11+/-Tg+/- mice continues to increase while flattening out. These 
data reflect the hemifield neurons responding to a lateralized sound source. 
Responding neurons in the lateral hemifields are less precise, generating a broader 
response as compared to midline neurons. In Cldn11-/-Tg+/- mice, the response from 
lateral hemifield neurons remains steady with unchanging latency. These data are 
significantly different from Cldn11+/-Tg+/- mice suggesting that small myelinated fibers 
either transmit bilateral information for processing, or small myelinated fibers refine 
the output of the principle cells. These data are important in two ways. First, they 
support the two-neuron hypothesis of sound lateralization, and second, they 
highlight the importance of myelin on neural processing  
 Recent evidence from humans postulates a third group of neurons may aid in 
sound localization. Located along the midline, this third group is specialized for 
spatial tuning (Dingle et al., 2010, 2013). The initial jump in latency (Δ0 – 2 dB SPL) 
may reflect a third population of integrating neurons, however this portion of the 
curve Is generated from two data points and further resolution is not be plausible 
using far field recording techniques.  
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Morphometric analysis of auditory brainstem fiber tracts 
Several unique features are evident in the auditory pathway, allowing for 
robust temporal accuracy of signal relaying, as well as fidelity of signal transmission 
for processing. First, two large synapses, measuring five times the diameter of 
normal synapses, preserve and ensure the temporal features of signal transmission: 
the endbulbs of Held (within the CN) and the calyces of Held (in the MNTB). One 
understated attribute is the presence of myelinated fibers throughout the auditory 
pathway (Anniko and Arnesen, 1988; Dinh et al., 2014; Spoendlin and Schrott, 1989, 
1990; Wu and Kelly, 1991). Without myelin, signal transmission would be slowed by 
as much as 10-fold. Our data confirm the presence of myelinated fibers in the 
auditory pathway (Figure 3.5) and highlight their critical role in neural processing by 
demonstrating abnormal responses when slowed conduction occurs along 
myelinated fibers < 1.2 µm. 
The electrophysiology data presented suggest Cldn11-/-Tg+/- mice have small 
diameter myelinated fibers present within the lower auditory brainstem, as indicated 
by the significant delay in Wave V latency and differential output of LSO signal 
integrators. The morphometric studies presented in this chapter are the first to 
quantify axon diameters along the auditory pathway in mice, despite the widespread 
use of these animals in auditory experiments over the past few decades.  
Studies in chick show contralateral axons transmitting information from the 
AVCN to the MNTB are large in diameter, approximately 2 µm, and small diameter 
fibers of approximately 1 µm, that relay information from the ipsilateral AVCN directly 
to the LSO (Seidl et al., 2010). For mice, several published studies make mention of 
 102 
large diameter myelinated contralateral and small diameter ipsilateral fibers, but 
quantitative data have not been presented (Doucet and Ryugo, 2003; Wu and Kelly, 
1991, 1992b; Wu and Oertel, 1984). Figures 3.6 demonstrates that large 
contralateral fibers are approximately 3.3 µm in diameter, and Figure 3.7 suggests 
that the ipsilateral fibers are small, at approximately 0.87 µm in diameter. The 
significant delay in Wave V latency suggests that small diameter myelinated fibers 
are found in the auditory brainstem of mice and we confirm the presence of small, as 
well as large diameter fibers.  
There are several caveats associated with the current analysis of the 
ipsilateral fibers. Unlike the contralateral fiber analysis, where we directly confirmed 
the identity of axons giving rise to calyces of Held, direct verification of ipsilateral 
fibers synapsing with the LSO principal neurons has not been possible. These 
technical difficulties arose in the current study because of our inability to detect 
synapsing fibers. While it has been shown that LSO principle cells are aligned along 
the long axes of the nuclei (into and out of the image) (Brown and Liu, 1995; Guinan 
et al., 1972), the trajectory of ipsilateral fibers is unknown. If fibers enter the LSO, as 
seen in Figure 3.7, turn 90 degrees to synapse with a principle cell out of the plane 
of section; a confirmed synapse would not be detectable. What we can verify is a 
healthy brain slice during, and subsequent to dextran injections, robust labeling of 
healthy fibers, and correct location within the LSO. These caveats aside, these data 
suggest that all detectable ipsilateral fibers entering the LSO are small in diameter (< 
1 µm), refuting the possibility of large diameter ipsilateral fibers. 
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Morphometric data confirm the observations that contralateral fiber diameters 
are large and ipsilateral fibers are small (less than a micron) in diameter. These data 
are critical for interpreting neural processing the Cldn11-/-Tg+/- mice. Previous studies 
have extensively detailed and modeled the consequence of ablating Cldn11 tight 
junctions on conduction velocity along myelinated axons. When Cldn11 tight 
junctions within myelin sheaths are ablated, conduction velocity along small 
diameter fibers, (~0.7 µm) is severely reduced by 50 % and medium diameter fibers 
(~ 1.2 µm) by 20 %, whereas large diameter fibers (>2.1 µm) are minimally affected 
(< 5 %) (Devaux and Gow, 2008). 
In summary, Cldn11-/-Tg+/- mice have dysfunctional myelin in which resistance 
of the myelin membrane is decreased, severely affecting conduction velocity along 
small diameter myelinated fibers. Neurophysiological evidence collected in the 
auditory brainstem of Cldn11-/-Tg+/-- mice confirms a decrease in conduction velocity 
via an increase in Wave V latency of the ABR. This demonstrates the presence of 
small diameter myelinated fibers along the ascending auditory brainstem. When 
neural processing is probed using ILDs, the resulting response differs from Cldn11+/-
Tg+/-, suggesting alterations in sound lateralization. Interestingly, the response curve 
from both groups of animals lends to a newly emerged model of neural processing 
known as the two-neuron model. This model posits that the lateral position of a 
sound source cannot be encoded by which particular neurons are discharging 
maximally (population model). Instead, lateral sound is encoded by the relative 
activation of two channels of neurons: those that are activated maximally by sources 
favoring the contralateral or ipsilateral side, but both contain a steep boarder 
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towards the midline (Boehnke and Phillips, 1999; Dingle et al., 2010; McAlpine et al., 
2001; Phillips, 2008; Phillips and Hall, 2005; Yost, 1981). Data collected within the 
chapter supports a hemifield model, as opposed to the classic Jeffress model of 
population neural processing for sound lateralization. 
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CHAPTER 4 – slowed conduction velocity can alter behavior  
 
INTRODUCTION 
Behavioral disorders are simplistically defined as conduct that deviates from 
the socially accepted normal. These abnormalities range from internal conflicts to 
outward expressions of defiant episodes, both of which adversely affect and impinge 
upon daily functioning. Behavioral abnormalities are present in children and adults 
and are influenced by environmental stimuli and experiences. Common 
abnormalities include anxiety, depression, and cognitive impairments. An estimated 
half of adults will be diagnosed with a behavioral abnormality at some point in their 
lifetime (Kessler et al., 2005). This translates to an increased annual encumbrance, 
ranging in the tens of millions of dollars spent annually in the United States alone 
(W.H.O., 2001).  
Behavioral disorders result from a disconnection between brain regions  
The etiologies for many behavioral disorders are uncharacterized, however 
the leading hypothesis is that different parts of the brain do not effectively 
communicate, known as the disconnection hypothesis. Proponents of this 
hypothesis contend that behavior is the result of temporal integration of sensory 
signals; abnormal behavior results when there is a disconnection between brain 
regions or neural circuits (Friston, 1998, 1999). The disconnection hypothesis was 
originally proposed by Karl Friston to describe the etiology of schizophrenia, but 
more recently, a number of researchers have promoted and broadened this 
hypothesis to include numerous neurological illnesses including Alzheimer (Bell and 
Claudio Cuello, 2006; Bokde et al., 2009; Hof and Bouras, 1991; Reid and Evans, 
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2013), autism spectrum disorders (Frith, 2004; Just et al., 2007; Melillo and Leisman, 
2009), Parkinson disease (Cilia et al., 2011; Cronin-Golomb, 2010; Fogelson et al., 
2013) and bipolar disorder (Mahon et al., 2010). To understand the how neural 
circuits become disconnected and cause behavioral abnormalities, researchers have 
developed and investigated two main hypotheses for disconnection: altered 
neurotransmitters and aberrant neurogenesis or neuron biology. 
Disconnection can originate from altered neurotransmitters  
Neurotransmitters are small molecules that nerve cells (neurons) use to 
communicate with their targets. They extend across numerous biological categories 
including cholines, monoamines, amino acids, peptides and purines (Kandel et al., 
2000; Webster, 2001). There are several, highly regulated stages involved in 
neurotransmission. First, a molecule is synthesized from precursors in the axon 
terminal of the presynaptic neuron, or in rare cases, transported from elsewhere in 
the cell. After synthesis and before release, a neurotransmitter is packaged and 
stored in vesicles near the presynaptic terminal (De Camilli and Jahn, 1990; 
Holtzman, 1977). Upon stimulation, vesicles dock to the presynaptic membrane and 
release the neurotransmitters into the synaptic cleft (Kelly et al., 1979; Miller and 
Racker, 1976; Papahadjopoulos et al., 1977; Sudhof, 2004). Finally, 
neurotransmitters bind to receptors on the postsynaptic membrane, which pass 
current across the membrane to depolarize or hyperpolarize the postsynaptic 
terminal.  
Evidence of altered neurochemical levels in patients with behavioral 
abnormalities is evident throughout the literature. In recent years, researchers have 
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developed molecular imaging techniques to measure neurotransmitters levels in the 
brains of humans in real time. Using radiolabeled ligands, the binding of a 
radiolabeled substrate can be measured using positron emission tomography (PET). 
The amount of ligand binding is proportional to the number of unoccupied receptors 
and thus, act as a proxy for the amount of native neurotransmitter present 
(Badgaiyan, 2011). Several human and animal studies have used this technique to 
investigate diseases in which an onerous behavioral component is evident, including 
Alzheimer (Jacobs et al., 2003; Wengenack et al., 2008), Parkinson (Elsinga et al., 
2006) and schizophrenia (Andreasen et al., 1996; Davis et al., 1991). Moreover, 
behavioral abnormalities, such as anxiety, have been directly studied using PET 
demonstrating abnormal neurochemical compositions (Reiman, 1997).  
Recently, proton magnetic resonance spectroscopy (H1MRS) has allowed for 
a direct quantitation of neurochemical levels in select brain regions associated with 
behavioral abnormalities including anxiety (Mathew et al., 2004; Pollack et al., 2008), 
depression (Hasler et al., 2007; Sanacora et al., 1999) and neuropsychiatric 
disorders (Stanley, 2002). Thus, the advancement of medical imaging techniques 
has demonstrated altered brain neurochemistry in behavioral disorders suggesting 
disconnection between brain networks and the emergence of atypical behavior. 
Literature advocating for neurochemical alterations as the probable etiology 
for behavioral abnormalities has lead to the development of drug therapies targeted 
to correct neurochemical levels in patients. Neural transmission is a highly regulated 
process in which the timing of release, amount of information (quanta), and precision 
of targeting is closely monitored. If any stage in the chemical transmission process 
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becomes modified, the proper information fails to be communicated and 
subsequently relayed. Drug design has optimization signal transmission through 
compounds that reduce clearance from the synaptic cleft (Haenisch and Bonisch, 
2011; Philip et al., 2010) or inhibit removal (Feighner, 1999; Stahl, 1998; Stahl et al., 
2005), thereby modulating signal transmission. With available drug treatments, the 
major disadvantage is the significant proportion of patients whose symptoms and 
behaviors are not alleviated.  
Selecting the appropriate therapeutic treatment for a behavioral abnormality is 
complex. Longitudinal epidemiological data are not available for many therapies and 
predictions for relapse / remitting phases are complicated by factors including 
comorbid illnesses and traumatic events, which can substantially alter effectiveness. 
Data collected over a five year period are often used to project the proportion of 
patients expected to experience full remission with drug therapy. The forecasted 
level is around 40 % for most behavioral abnormalities (Foa et al., 1983; Yonkers et 
al., 2000) and, consequently, the majority of patients will struggle to find relief, 
advocating for alternative etiologies for behavioral abnormalities. 
Abnormal neuron biology generates disconnection between neural networks 
In addition to aberrant levels of neurotransmitters, abnormal neuron biology 
can be a driving factor for behavioral abnormality. Neurons are the main 
communication cell responsible for receiving, processing, and transmitting electrical 
and chemical encoded information (Waxman et al., 1995). There are different 
subtypes of neurons (motor, sensory, interneuron), totaling over 200 billion neurons 
in the adult human brain, and on average each neuron is connected to 5,000 – 
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200,000 other neurons. Altering the expansive connections established can perturb 
normal signal processing, modify integration, and conceivably disconnect neural 
circuitry. Neural connections also can be reshaped by increases or decreases in the 
number of neurons in a network. 
The most widely studied mechanism for reductions in neurons is death 
through diffuse axonal injury related to a traumatic event. Axonal injury, in its many 
forms, has a similar pattern of disruption that ultimately leads to the degeneration of 
the axon and death of the cell. In brief, an expansion of the axonal membrane is 
seen, followed by an increase in Na+ and Ca2+ ion permeability. Next, damaging 
intracellular cascades attributable to the Ca2+ influx causes swollen and ruptured 
mitochondria, and finally, potential indirect effects due to disruption of the axoglial 
interaction necessary to maintain homeostasis (Buki and Povlishock, 2006; 
Marmarou et al., 2005; Medana and Esiri, 2003).  
It has been assumed that axonal injury impairs brain function, reflecting the 
extent of damage and the number of neurons injured (Waxman et al., 1995). Axonal 
damage can be translated to deafferentation, yielding target cell dysfunction as 
illustrated by presynaptic degeneration; however, the functional significance remains 
unclear (Erb and Povlishock, 1991). On the opposite end of the spectrum, increasing 
the number of neurons may lead to dysfunctional neural circuitry via improper 
signaling cascades and competing signal information. This supposition has been 
suggested for the etiology of autism where hyperconnectivity has been 
demonstrated (Belmonte et al., 2004a; Belmonte et al., 2004b). Similarly, increasing 
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the activity of a neuron can also render circuitry dysfunctional, most notably with 
illnesses such as epilepsy (McNamara, 1999). 
White matter integrity is a key component of properly functioning neural 
circuitry 
There is clear evidence that behavioral abnormalities may arise from 
mechanisms including aberrant neurotransmitter levels, or other abnormal neuron 
biology, however, patients receiving treatments to correct these deficits do not 
always respond. Thus, there may be additional mechanisms by which behavioral 
abnormalities arise. We know from the clinical literature that white matter diseases, 
such as leukodystrophies and multiple sclerosis (MS) have known alterations to 
white matter along with prominent behavioral abnormalities (Baumann et al., 2002; 
Garside et al., 1999; Hyde et al., 1992; Petersen and Kokmen, 1989; Schiffer and 
Babigian, 1984; Schubert and Foliart, 1993). We also know that myelin is 
functionally important in temporal communication, increasing the speed and fidelity 
at which impulses propagate along a neuron and improving long-range 
communication between brain regions (Hodgkin, 1964; Hodgkin and Huxley, 1952; 
Tasaki, 1952). Dysfunctional myelin can cause a disconnection between brain 
regions, altering the processing of sensory information and contribute to behavioral 
abnormalities. To better elucidate the link between dysfunctional myelin and 
behavioral abnormalities; we investigated the Cldn11-/- mouse model of 
dysfunctional myelin. 
Animal models play an essential role in understanding the pathophysiological 
mechanism by which behavioral abnormalities arise (Petters and Sommer, 2000; 
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Phillips et al., 2002; van der Staay et al., 2009). Modeling abnormalities, whether in 
their simplest form or a prominent attribute of an illness, is quite challenging due to 
the complexity of human behavior. Genetic, pharmacological, environmental, or 
direct manipulation of neural circuitry has been employed to study behavior (Nestler 
and Hyman, 2010). We can ascertain the anthropomorphic characteristics of human 
behavior in animal models by quantitative measurements via behavioral testing. 
Numerous tests have been developed to interrogate behavioral abnormalities such 
as anxiety, depression, and cognitive ability and we will use such tests to determine 
if dysfunctional myelin can cause behavioral changes, indicating a potential etiology 
for these disorders.  
Because of the numerous proportions of patents unresponsive to current 
behavioral drug therapies targeting neurotransmitters and neurons, there must be an 
alternate hypothesis describing how brain regions become disconnected leading to 
behavioral abnormalities. Herein, we investigate the Cldn11-/- mouse model of 
dysfunctional myelin to explore the possibility that myelin is critical for the proper 
functioning of neural circuitry and dysfunction can arise when the integrity of myelin 
is altered. Our animal model provides the first direct evidence that dysfunctional 
myelin can contribute to the development of behavioral abnormalities, and can alter 
brain neurochemistry. These data provide evidence indicating dysfunctional myelin 
can contribute to the etiology of behavioral abnormalities. 
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MATERIALS AND METHODS 
Mice 
The Department of Laboratory and Animal Resources at Wayne State 
University maintained all mice in this study. All experiments on mice were performed 
in accordance with an Institutional Animal Care and Use Committee protocol 
approved by the Wayne State University Animal Investigation Committee. Up to four 
mice were housed in group I rodent polycarbonate cages (19.05 X 29.21 X 12.7 cm3, 
Ancare, Bellmore, NY), or up to nine mice housed in groupII polycarbonate cages 
(26.67 X 48.26 X 15.56 cm3, Bellmore, NY). Each cage was given a 2 X 2 in nestlet 
square (Ancare, Bellmore, NY) to promote nesting behavior and aid in 
thermoregulation. Food and water were available ad labium. Breeding mouse trios or 
pairs were provided mouse diet (#5015, LabDiet, St. Louis, MO) to support healthy 
pups and non-breeding mice were provided laboratory rodent chow (#5001, LabDiet, 
St. Louis MO). All polycarbonate cages, water bottles, and food pellets were 
changed weekly and as needed. 
The Osp20 transgene construct (GS605) comprises a 22 kb Sau3A I 
fragment of genomic sequence from 5 kb upstream of the transcription start site in 
exon 1 to 1.9 kb downstream of the first polyadenylation site in exon 3. The unique 
Acc65 I site near the 5’ end of intron 1 was blunted-out distinguishing the transgene 
from the endogenous Cldn11 gene during qPCR analysis. The genomic fragment 
was cloned between two Not I sites in a pUC18 – based vector (Gow et al., 1992) 
and was excised and phenol : chloroform-purified from an agarose gel slice for male 
pronuclear injection. This allele is referred to as Tg(Cldn11)605Gow (MGI:5306245), 
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and for the purposes of this dissertation as Tg+/-. Transgene expression was 
confirmed in testis and inner ear, but not brain (Wu et al., 2012). Additionally, this 
transgene restored the known sterility (Gow et al., 1999) and premature hearing loss 
resulting from a loss in endocochlear potential in Cldn11-/- mice (Gow et al., 2004) 
(unpublished data). Double mutant mice were generated by breeding males from 
Tg(Cldn11)605Gow with Cldn11-/- female mice to generate F1 Cldn11+/-
:Tg(Cldn11)605GowTg/+ mice, referred to as Cldn11+/-Tg+/-. These mice were sib-
mated to generate F2 (and beyond) Cldn11-/-Tg+/- mice (as well as control Cldn11+/-
Tg+/-) for experiments. These mice were used for all experiments unless noted. 
Open Field 
The open field arena consisted of a 61 x 61 x 31 cm black plexiglass box with 
a matted finish (FT Plastics, Oak Park, MI). The bottom of the arena was lined with 
white bench top paper (Whatman™ Benchkote™, cat#: 12-007-182B, ThermoFisher, 
Waltham, MA) and a clear plexigalss insert panel (61 x 61 x 1 cm3) placed over top 
for added contrast and ease of cleaning. All mice were habituated to the behavior 
room one hr before testing. Standard open field protocol consisted of two 
consecutive days in which mice were placed in the center of the arena, facing the 
same wall, and video recorded for five min (Samsung SC-MX20L/XAA). Videos were 
uploaded and the center point of the mouse was post – tracked using Ethovision 
software (version 8.5, Noldus, Leesburg, VA) to obtain various center square activity, 
total distance traveled, average velocity, and time spent in each quadrant. All 
variables for the two days were averaged for each animal. 
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Conventional center square (CS) analysis designates 50 % of the total area 
as the center portion, however we find this parameter uncommunicative. To convey 
practical criteria and a more detailed analysis, we used the average body length of a 
mobile mouse (7.5 cm) as the determinant for CS boundaries. Half a mouse body 
length away from the periphery computed to be 83 % of the total area, and thus, 
designated as 83 % CS. A similar pattern was followed to generate concentric 
squares of the OF environment, resulting in the following: 66 % (one body length 
away from the periphery), 48 % (one and a half body lengths), and 32 % (two body 
lengths).  
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Figure 4.1 – Open field schematic 
 
Open field schematic detailing size and location of the various different center 
square (CS) % used for analysis, location of quadrants and light sources. Schematic 
is drawn with respect to the mouse in the top right hand corner 
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Marble Burying 
All mice were habituated to the behavior room one hr prior to testing. Marble 
burying test was carried out in a clean home cage (19.05 X 29.21 X 12.7 cm3, 
Ancare, Bellmore, NY) layered with 2 cm of bedding (Bed O’Cobs 1/8”, Andersons 
Lab Bedding, Maumee, OH). Fifteen glass marbles were placed in a grid pattern 
formed by five rows of three marbles, evenly spaced throughout the cage (See 
schematic below). A single mouse was placed in the center of the cage and video 
recorded (Samsung SC-MX20L/XAA) for 30 min. Afterwards, photos of each testing 
environment were collected and the number of marbles buried at least two-thirds of 
the way with bedding were tallied.  
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Figure 4.2 – Marble burying schematic 
 
Marble burying schematic illustrating placement of 15 marbles at the start of testing. 
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Tail Suspension 
Tail suspension apparatus was comprised from a metal ring stand rod 
suspended approximately 18 in from the bench top between two rings stands. All 
mice were habituated to the behavior room one hr prior to testing. Prior to taping the 
mouse’s tail, a one-inch clear plastic tube was threaded over the tail and placed at 
the base of each mouse’s rear to prevent it from climbing its tail during testing. Mice 
were suspended by their tails using 15 cm of standard laboratory tape (Thermo 
Fisher Scientific, Waltham, MA) in which 2.5 – 3 cm of one end was used to secure 
the tail, and the opposing end secured to the bar. Mice were suspended for six min 
and video recorded (Samsung SC-MX20L/XAA). Videos were played back and 
scored, unbiased, for the amount of time mice spent immobile or helpless. Immobility 
was defined by a lack of movement of the forelimbs, hind limbs, and head, but not 
whiskers. Pendulum swinging in the absence of limb movement was also evaluated 
as time immobile. Total time spent immobile was recorded as time out of 360 sec.  
Sucrose Preference 
Sucrose preference testing was carried out in a polycarbonate cage (26.67 X 
48.26 x 15.56 cm3, Ancare, Bellmore, NY) and spanned a total of eight days. All 
mice were individually housed during the testing period and given one nestlet (2 X 2 
in, Ancare, Bellmore, NY). During habituation (days 1 – 4), mice were acclimated to 
the presence of two dual bearing sipper tube bottles (Lixit #QLCSA-5, Petsmart, 
Phoenix, AZ) containing water. Following habituation, one water bottle solution was 
replaced with a 2 % sucrose solution for remaining testing days. To avoid a side 
preference, the location of the sucrose solution was counterbalanced during sucrose 
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testing days (days 5 – 8). Measurements, based on weight difference, were 
calculated daily for total water, sucrose solution, and food consumption before 
replenishing. The density of a 2 % sucrose solution is 1.0060 g / cm3 and is 
negligible to the density of water (1 g / cm3). Mice were given 40 grams of rodent 
chow daily (#5001, LabDiet, St. Louis MO) and 100 milliliters of fluid in each sipper 
bottle, whether water or sucrose. After testing, mice were returned to group housing. 
To prevent fighting between males, nestlets were collected every other day from 
males originally residing in the same home cage, intermixed, divided evenly, and 
returned.  
Barnes Maze 
All mice were habituated to the behavior room one hr prior to testing. The 
Barnes maze was constructed from a circular, white plexiglass (91.4 cm diameter) 
with twenty holes (5 cm) positioned equidistance from each other and 2 cm from the 
outer edge (FT Plastics, Oak Park, MI). Located beneath one hole was a removable, 
sliding black box that served as the goal location. A mesh step was placed inside the 
black box to aid descending mice. Visual cues adorned the walls or were native to 
the testing room: a solid black circle, a solid black line, camera stand, experimenter, 
and trolley. Cues remained constant and unchanged throughout all testing days. 
Habituation (day 1): Mice are placed directly in front of the goal hole, 
enclosed in a glass beaker (Pyrex, Thermo Fisher Scientific, Waltham, MA) placed 
upside – down. Habituation lasts for five min and mice are allowed to directly explore 
the goal hole, goal box, and its surrounding environment. If the mouse has not 
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entered the goal hole after five min, the mouse is gently placed inside, the entrance 
covered, and remains for 30 sec. One hr later, acquisition training can begin. 
Acquisition Training (days 1 – 4): Acquisition training lasts five min, three 
trials per day, one hr between trials. Mice are placed onto the center of the maze, 
facing a chosen wall used throughout testing. Latency to find the goal hole, enter the 
hole, and the number or errors are recorded. If a mouse finds and subsequently 
enters the goal hole before five min time is up, the training trial can be stopped. If the 
mouse has not entered the goal hole after five min, the mouse is gently placed 
inside, the entrance covered, and remains for 30 sec. The location of the goal hole 
remains constant throughout training. All training trials are video recorded (Samsung 
SC-MX20L/XAA). 
Acquisition Probe (day 5): Before beginning, the goal box is removed and the 
Barnes maze table is rotate 90 degrees counterclockwise from the training location. 
Acquisition probe lasts for a single trial, five min in length. Mice are released onto 
the center of the maze as in prior days and allowed to explore for the full five min. 
The probe trial is video recorded and post – processed using Ethovision software 
(version 8.5, Noldus, Leesburg, VA). 
Acquisition Retraining (day 6): The goal box is replaced and the location of 
the goal hole is set up identical to training days 1 – 4. Mice undergo three training 
trials, one hr apart. If a mouse finds and subsequently enters the goal hole before 
five min time is up, the training trial can be stopped. If the mouse has not entered the 
goal hole after five min, the mouse is gently placed inside, the entrance covered, 
and remains for 30 sec. 
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Curtain Probe (day 7): Before beginning, the goal box is removed and the 
maze rotated 90 degrees counterclockwise from training locations. Additionally, 
bench coat paper is used to surround the maze in two levels, blocking all visual cues. 
The purpose of the curtain surrounding the maze was to determine if mice were 
using non-visual intra maze cues or the visual extra maze cues to help them locate 
the goal hole during training exercises. Mice are then release onto the center of the 
maze and allowed to explore for five min. Probe trials are video recorded and post – 
analyzed using Ethovision. 
Acquisition Retraining (day 8): The goal box is replaced and the location of 
the goal hole is set up identical to training days 1 – 4 and day 6. Mice undergo three 
training trials, one hr apart. If a mouse finds and subsequently enters the goal hole 
before five min time is up, the training trial can be stopped. If the mouse has not 
entered the goal hole after five min, the mouse is gently placed inside, the entrance 
covered, and remains for 30 sec. 
Reversal Training (day 9): Similar to acquisition training days, however the 
location of the goal hole is now 180 degrees from all previous training days. Mice 
undergo three training trials, one hr apart. If a mouse finds and subsequently enters 
the goal hole before five min time is up, the training trial can be stopped. If the 
mouse has not entered the goal hole after five min, the mouse is gently placed 
inside, the entrance covered, and remains for 30 sec. 
Reversal Probe (day 10): Before beginning, the goal box is removed and the 
maze rotated 90 degrees counterclockwise from reversal training location. Mice are 
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then release onto the center of the maze and allowed to explore for five min. Probe 
trials are video recorded and post – analyzed using Ethovision. 
During all phases of the Barnes maze, a number of factors are recorded 
(manually during the test, confirmed via video) including latency to the goal hole, 
time to enter the goal hole, number of errors pre-hole, and number of errors post – 
hole. During probe days (days 5, 7, and 10) Ethovision software was used confirm 
latencies and errors, as well as measure time spent in zones drawn around the goal 
hole mice were trained to locate, and the actually hole where the box can hook-in at 
(90 degrees counterclockwise). The number of acquisition training days was 
determined prior to testing with separate groups of mice. It was concluded that four 
days of acquisition training was adequate for mice to learn the location of the goal 
hole, ascend into the goal box, and retain that information. 
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Figure 4.3 – Barnes maze schematic 
 
(A) Overview of zone boundaries surrounding the trained goal hole (Goal Hole) or 
the hole where the training box attaches (Hook-in Hole). This schematic was used 
for calculating zone analysis for BM probe (day 5) and curtain probe (day 7). (B) 
Overview of zone boundaries surrounding the location of the original goal hole (Old 
Goal Hole), the location of the re-trained goal hole (Goal Hole), or the hole where the 
training box attaches (Hook-in Hole). This schematic was used for calculating zone 
analysis for BM reversal probe (Day 10). 
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High Resolution Magic Angle Spinning Proton Nuclear Magnetic Resonance 
(H1MRS) 
Mice were decapitated and brains immediately removed from the skull. Serial 
coronal slices (2 mm) were obtained using a mouse anodized aluminum matrice 
(BS-AL 5000C, Braintree Scientific, Braintree, MA) beginning at + 2 bregma and 
ending at - 8 bregma (see schematic below). Slices were promptly frozen on a block 
of dry ice. Once frozen, slices were moved onto a wet ice platform. Intact, bilateral 
punches isolating various brain regions were collected using 1.5 mm diameter 
disposable biopsy punches (Miltex Inc., Plainsboro, NJ) and stored in 1.7 ml 
microcentrifuge tubes (Thermo Fisher Scientific, Waltham, MA) at - 80°C until testing. 
For H1NMR analysis, tubes were transferred from - 80°C, one bilateral punch was 
extracted, weighed, and promptly placed into a 10 μl Bruker zirconium rotor 
containing PAFT buffer (100 mM K2HPO4 / KH2PO4, 200 mM HCOONa, 1 g / L NaN3 
diluted 50 % with D2O containing 3 mM trimethylsilyl – propionate (TSP, Sigma 
Aldrich, St Louis, MO; pH = 7.4). TSP served as an internal chemical shift reference 
(0.00 ppm), formate (8.44 ppm) was used for autophasing, and D2O was used to 
lock on the center frequency. The rotor (with sample) was placed into a Bruker 
magic angle spinning probe maintained at 4°C in a vertical wide – bore (8.9 cm) 
Bruker 11.7 T magnet, controlled with an Avance DRX-500 console (Bruker Biospin 
Corp., Billerica, MA, USA). Rotors were spun at 4.2 ± 0.002 kHz at 54.7° relative to 
the static magnetic field B0. After a pre – saturation pulse for water suppression, 
spectra were acquired with a 1-D Carr–Purcell–Meiboom–Gill pulse sequence (90-
(τ-180-τ)n-acquisition) with TR = 6210 ms, τ = 0.15 ms, and n = 12 for total echo 
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time (TE) of 3.6 ms; spectral bandwidth = 7.0 kHz (14 ppm), 16 k complex data 
points, and 256 averages for total acquisition time of 7 min 36 s. Data was acquired 
using Bruker-XWINNMR version 3.6 software. Spectra were analyzed with a custom 
LCModel version 6.1 – 4, established with a basis set of metabolites over a spectral 
range of 1.0 – 4.2 ppm. The precision of the LCModel fit to the spectral data was 
estimated with Cramér–Rao bounds, which are typically less than 10 % for the 
metabolites reported herein. 
  
 126 
Figure 4.4 – Fresh tissue punch schematic 
 
 
Illustration of individual 2 mm coronal slices and location the bilateral fresh tissue 
punches collected for H1NMR and western blots. Blue punches represent the 
relative size (1.5 mm) collected. Coronal mouse brain slices were edited from the 
Paxinos mouse atlas.  
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Western Blotting 
Mice were decapitated and brains immediately removed from the skull. Serial 
coronal slices (2 mm) were obtained using a mouse anodized aluminum matrice 
(BS-AL 5000C, Braintree Scientific, Braintree, MA) beginning at + 2 bregma and 
ending at - 8 bregma (see schematic in H1MRS above). Slices were promptly frozen 
on a block of dry ice. Once frozen, slices were moved onto a wet ice platform. Intact, 
bilateral punches isolating various brain regions were collected using 1.5 mm 
diameter disposable biopsy punches (Miltex Inc., Plainsboro, NJ) and stored in 0.7 
ml microcentrifuge tubes (Thermo Fisher Scientific, Waltham, MA) at - 80°C until use. 
Tissue punches were sonicated (Fisher Scientific sonic dismembrator Model 500) in 
50 μl buffer (tris buffered saline (TBS), 2 mM ethylenediaminetetraacetic acid 
(EDTA), 0.5 mM phenylmethylsulfonyl fluoride (PMSF, Thermo Fisher Scientific, 
Waltham, MA), 1 % triton X-100 (Thermo Fisher Scientific, Waltham, MA), and 
P8340 (Sigma Aldrich, St Louis, MO), and protein concentrations measured via 
Bradford assay on a spectrophotometer (Smartspec3000, Biorad, Hercules, CA). 
Protein concentrations of 5 – 10 µg per lane were loaded on 6 – 8 % SDS gels, 
electrophoresed (SE260, Hoefer, Holliston, MA), and transferred onto nitrocellulose 
(Whatman Protran, GE Healthcare via Thermo Fisher Scientific, Waltham, MA). 
Membranes were blocked with 5 % nonfat milk (Carnation, Nestle) for one hr, 
washed in phosphate buffered saline with 1 % tween20 (PBST), then incubated 
overnight with corresponding primary antibody diluted in 2 % nonfat milk with PBST 
Membranes were washed of the primary antibody (See Table 4.1) with PBST then 
incubated in corresponding HRP conjugated secondary antibody (See Table 4.2) for 
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an additional one hr. Once complete, membranes were washed thoroughly with 
PBST and protein visualized with enhanced chemiluminescensce (Thermo Fisher 
Scientific, Waltham, MA) and exposed on film. Film was scanned (Canon 
canoscan9000F) and band intensity quantified using ImageJ software. For proteins 
exhibiting multiple bands, intensities were combined. 
Lysis solution: TBS, 2 mM EDTA pH 8.0, 0.5 mM PMSF (Thermo Fisher 
Scientific, Waltham, MA), 1 % triton-100, 0.5 % P8340 (Sigma Aldrich, St Louis, MO). 
Sociability 
All animals were habituated to the behavioral testing room one hr prior to 
testing. Two groups of animals were used: test mice and control or unfamiliar mice. 
Control animals were of a similar mixed background strain, similar ages, gender 
matched, and housed in a separate room as the test mice. The sociability arena 
consisted of a 68.5 cm X 27.2 cm rectangular black plexiglass box (FT Plastics, Oak 
Park, MI) in which two wire mesh cups (11.11 cm X 12.86 cm, Walmart, Bentonville, 
AR) were turned upside – down in each end (see schematic below). Magnets were 
attached to the top of the cups for added weight (#BX0X08DCSPC, K&J Magnetics 
Inc, Plumsteadville, PA).  
Sociability testing was carried out in three phases: habituation, trial 1, and trial 
2. During habituation, mice were placed in the center of the sociability arena and 
allowed to explore the arena and empty cups for five min. Afterwards, mice were 
returned to their home cage. Thirty min later trial 1 began where a control, or 
unfamiliar mouse, was placed underneath one wire cup while the other remained 
empty. Test mice were allowed to explore the sociability arena for ten min, then
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Table 4.1 – Western blot primary antibodies 
Antibody Company Catalog # Species Dilution 
Glutamate decarboxylase (GAD) 
65/67 
Santa Cruz sc365180 MsIgG1 1:1000 
gamma-Aminobutyric acid A 
(GABAA) R receptor α1-6(E-8) 
Santa Cruz sc376282 MsIgG1 1:1000 
gamma- Aminobutyric acid B 
(GABAB) receptor R1(R300) 
Santa Cruz sc14006 Rb 1:1000 
Glutaminase (Gls) Abcam ab113509 Rb 1:1000 
Glutamine synthetase (GS) Millipore MAB302 MsIgG2A 1:1000 
4-aminobutyrate aminotransferase 
(ABAT) (H-161) 
Santa Cruz sc366534 Rb 1:1000 
beta-Actin Sigma A1978 MsIgG1 1:1000 
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Table 4.2 – Western blot secondary antibodies 
Antibody Conjugation Company Catalog # Dilution 
Gt α MsIgG1 HRP Southern Biotech 1070-05 1:2000 
Gt α MsIgG2A HRP Southern Biotech 1080-05 1:2000 
Gt α Rb HRP Cell Signaling 7074 1:2000 
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 returned promptly to their home cage. Thirty min later trial 2 began. The same 
control mouse was placed underneath the same wire cup as before, but this time an 
additional unfamiliar, now novel mouse, was placed underneath the previously 
empty cup. Control and novel animals were counterbalanced for side of arena and 
role as control or novel throughout the study between genotypes. Furthermore, 
control animals were habituated to residing underneath the wire cups.  
All phases of sociability were video recorded (Samsung SC-MX20L/XAA) and 
the center point of the mouse tracked using Ethovision software (version 8.5, Noldus, 
Leesburg, VA). Videos were analyzed for total distance traveled, average velocity, 
time spent in a 3.75 cm perimeter circle (half a mouse length or 1.68 X cup 
diameter) or 5.56 cm perimeter (three-fourths a mouse length, or 2 X cup diameter) 
around each cup, each zone (left, right, middle), and manual scored for grooming 
time and location. 
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Figure 4.5 – Sociability schematic  
 
 
Sociability schematic illustrating the three-chambered arena designating left, middle, 
and right segments. Zone analyses calculating time spent in the immediate vicinity of 
the wire cups (black girds) are depicted in blue (1.68 X) and green (2 X) circles 
representing half and three-fourths a mouse body lengths away from the perimeter 
of the wire cups. The arena is drawn to scale with respect to the mouse in the top 
left corner. 
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RESULTS 
Initial behavioral screens suggest Cldn11-/-Tg+/- mice have a reduced anxiety-
like phenotype 
Initial interactions with Cldn11-/-Tg+/- mice in their home cage suggested that 
they may exhibit a behavioral abnormality. When lifting the cage top of a large cage 
of mice, most scattered to the edge, while a few remained in the center. When 
genotypes of these mice were checked, they were most often Cldn11-/-Tg+/- mice. To 
quantify this anecdotal observation, we investigated the relative anxiety levels in 
these mice and littermate controls using behavioral paradigms.  
Two behavioral tests were considered, open field (OF) and marble burying 
(MB). Each test examines anxiety by eliciting a response in a novel or a familiar 
environment. In the OF paradigm, anxiety level is measured by determining the 
amount of time rodents spend in the center of a novel open arena (Figure 4.1). 
Using t-tests to compare total time, Cldn11-/-Tg+/- mice at 6 – 8 M of age spent twice 
as much time in various sized center squares (32, 48, 66, and 83 %) as controls 
(Figure 4.6, Table 4.3). To determine if this abnormal phenotype was present at 
younger ages, we examined a separate cohort of 2 and 4 M Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice in the OF paradigm. No significant differences were observed for 
any of the center square dimensions tested (Figure 4.6, Table 4.3). These data 
suggest that at 6 – 8 M of age, Cldn11-/-Tg+/- mice exhibit a less anxious phenotype 
compared to controls that is not detected in the mutants at younger ages.  
The validity of behavioral testing depends heavily on control parameters 
specific to each test. For instance, the OF paradigm relies on a mouse’s ability to
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Figure 4.6 – Cldn11-/-Tg+/- mice spend significantly more time in center squares 
of an open field arena, indicating a decreased anxiety-like phenotype  
 
Time spent in concentric center squares of an open field arena reveals that Cldn11-/-
Tg+/- were evident for center squares (A) 32 %, (B) 48 %, (C) 66 %, and (D) 83 %. 
Center square percentages were based on the average mouse body length away 
from the periphery of the arena: half (83 %), one (66 %), one and a half (48 %), and 
two (32 %) body lengths. Data values are plotted as mean + SD, 9 ≤ n ≤ 10, *p < .05, 
**p < .01. 
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Table 4.3 – Tabulated p values comparing the amount of time Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice spent in differing CS of the open field arena (Figure 4.6)  
 6 – 8 M 
Center Square (%) t17 p 
32 2.483 0.0237 
48 2.747 0.0138 
66 3.067 0.0070 
83 2.545 0.0209 
 4 M 
 t18 p  
32 0.3584 0.7242 
48 0.3020 0.7661 
66 0.2509 0.8047 
83 0.2205 0.8280 
 2M 
 t18 p  
32 0.1371 0.8925 
48 0.3874 0.7030 
66 0.5750 0.5724 
83 1.158 0.2618 
A t-test was used to identify statistically significant differences (bold, italicized). 
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 explore an unfamiliar, lit arena. The overall interpretation of CS activity can be 
influenced by two key factors: the speed a mouse travels and the total distance 
traversed. Appendix D.1 shows the total distance traveled (A) and the average 
velocity (B) of Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice at 2, 4, and 6 – 8 M of age. Both 
groups of mice traverse a similar distance at 2 (t18 = 0.2729, p = 0.7880), 4 (t18 = 
1.1063, p = 0.3021), and 6 – 8 (t17 = 1.413, p = 0.1756) M of age. Similarly, when we 
investigated the average speed of the mice, we find no significant difference at 2 (t18 
= 0.2887, p = 0.7765), 4 (t18 = 1.128, p = 0.2739), and 6 – 8 M (t17 = 1.335, p = 
0.1996). 
Additionally, because ambient lighting is a major contributing factor to anxiety 
in the OF test, we wanted to verify that differential illumination, if present, did not 
influence the results. We divided the square arena into four quadrants (Figure 4.1) 
and performed a quadrant analysis in which the average amount of time spent in 
each was compared between genotypes within each age group (Appendix D.2). A 
one-way ANOVA did not detect significant differences for time spent in any quadrant 
for mice at 2 M of age (F7, 72 = 1.330, p =0.2486). Significant overall F values were 
obtained at 4 (F7, 72 = 2.497, p = 0.0235) and 6 – 8 M of age (F7,68 = 3.248, p 
=0.0049), however, Bonferroni post hoc tests comparing individual quadrants 
between genotypes were not significant. Taken together, the lack of differences 
between any of the control parameters validates our initial interpretation of the OF 
data that Cldn11-/-Tg+/- mice appear to have a less anxious phenotype. 
 Behavioral testing aims to quantify anthropomorphic emotional responses in 
rodents and relate them to multifaceted and complex human behaviors. The 
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interpretation of behavioral phenotypes based on a single test may be misleading, 
and therefore, a secondary behavioral test is always recommended (Ramos, 2008). 
Because the OF paradigm induces anxiety-like responses through a novel 
environment, we wanted a second test that could be implemented in a more native, 
less aversive setting: a home cage. To achieve this, we chose to perform marble 
burying (MB) analysis.  
Marble burying is designed to measure the anxiety-like response of rodents 
by comparing the number of marbles buried over a designated time period. We 
analyzed the number of marbles buried for the same cohort of mice that underwent 
OF testing. Significant differences between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice 
were seen at 6 – 8 M of age (Figure 4.7). Cldn11-/-Tg+/- mice buried significantly 
fewer marbles as compared to controls, t17 = 2.723, p = 0.0145, on average about 
half as many. At 2 and 4 M of age, Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice buried a 
similar amount of marbles: t18 = 1.935, p = 0.0689 and t18 = 1.306, p = 0.2080 
respectively. These data mirror the OF paradigm, supporting the idea that Cldn11-/-
Tg+/- mice have decreased anxiety-like phenotype at 6 – 8 M of age.  
Cldn11-/-Tg+/- mice do not exhibit depression-like symptoms 
Behavioral abnormalities are common in white matter diseases, and can be 
the most debilitating feature of the disease. Changes in anxiety state are frequently 
comorbid with changes in depression (major depression, major depressive disorder, 
unipolar depression, clinical depression). A number of behavioral experiments have 
been developed for studying depression-like behaviors in animal models (Porsolt et 
al., 1977; Porsolt et al., 1987). Because we observed an altered anxiety-like 
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Figure 4.7 – Marble burying test reveals Cldn11-/-Tg+/- mice have decreased 
anxiety-like phenotype compared to controls 
 
 
Using a Student’s t-tests by age, Cldn11-/-Tg+/- mice buried significantly fewer 
marbles than controls at 6 – 8M of age. At 2M or 4M, there is no significant 
difference in the number of marbles. Data values are plotted as mean + SD, 9 ≤ n ≤ 
10, *p < .05. 
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phenotype in the Cldn11-/-Tg+/- mice, we next asked if changes in depression were 
also present. We employed two behavioral tests, the tail suspension test (TST) and 
the sucrose preference test (SPT). These tests emphasize distinct facets of 
depression, despair and anhedonia respectively.  
In a comparable template to anxiety testing, these tests investigate 
depression-like phenotypes via different strategies. The TST paradigm has been 
widely used to screen the effectiveness of antidepressant drugs for their ability to 
increase mobility time (Cryan et al., 2005; Perrault et al., 1992; Steru et al., 1987; 
Steru et al., 1985). We calculated the amount of time Cldn11+/-Tg+/- and Cldn11-/-
Tg+/- mice spent immobile over a 360 sec period at 2, 4, and 6 – 8 M of age (Figure 
4.8). The average time spent immobility was approximately 220 sec for mice at 2 
and 6 – 8 M of age, and 250 sec for mice at 4 M of age. Regardless of age, there 
was no significant difference in the amount of time spent immobile between Cldn11+/-
Tg+/- and Cldn11-/-Tg+/- mice at 2 (t18 = 1.736, p = 0.0996), 4 (t18 = 0.1603, p = 
0.8745), or 6 – 8 M (t18 = 0.5067, p = 0.6185). These data suggests a lack of 
despair-like phenotype in the Cldn11-/-Tg+/- mice.  
Eliminating the aversive stimulus, we tested anhedonia-like behavior in an 
unobtrusive setting using the SPT. Mice have a propensity for sweeter substances 
and when given the choice, preferentially drink the sugary option. A sucrose 
preference percentage was calculated (sucrose liquid consumed / total liquid 
consumed [water + sucrose]) for each test day and compared between genotypes. 
Figure 4.9 illustrates the average sucrose preference percentage for Cldn11+/-Tg+/- 
and Cldn11-/-Tg+/- mice at 2, 4, and 6 – 8 M of age. On any given test day, mice
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Figure 4.8 – The tail suspension test suggests a lack of a depression-like 
phenotype in Cldn11-/-Tg+/- mice 
 
Student’s unpaired t-test at 2, 4, and 6 – 8M of age reveal both Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice spend a similar amount of time immobile during tail suspension, 
suggesting a lack of anhedonia. Data values are plotted as mean + SD. 9 ≤ n ≤ 10. 
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 drank approximately 55 – 70 % sucrose solution compared to water. Using a 
repeated measures (RM) two-way ANOVA, no significant differences were 
calculated for preference percentage between genotypes at 2, 4, or 6 – 8 M of age: 
F1,18 = 0.04, p = 0.8536; F1,18 = 0.94, p = 0.3445; and F1,18 = 0.76, p = 0.3943 
respectively. The preference percentages calculated for Cldn11+/-Tg+/- and Cldn11-/-
Tg+/- mice is similar to published values for mice with our background strain 
performance (Pothion et al., 2004). 
The amount of sucrose solution consumed can be influenced by a number of 
variables, such as weight of the mouse, total liquid consumed, and the amount of 
food eaten. Each control parameter was monitored during testing, both during 
acclimation (1 – 4) and testing days (5 – 8) (Appendix D.3). The weight of each 
animal was normalized to weight on day 1, neutralizing the influence of gender 
(Appendix D.3, A). Using a RM ANOVA for mice at 2, 4, or 6 – 8 M of age, no 
significant differences in weight fluctuations was seen (2M: F1,16 = 0.15 , p = 0.6991; 
4M: F1,18 = 0.01, p = 0.9287; and 6 – 8 M: F1,18 = 0.58, p = 0.4576).  
Next, we examined total liquid consumed, regardless of type, across the 
testing period (Appendix D.3, B). For any given age, mice consumed approximately 
5 – 10 ml of liquid over a 24 – hr period. A RM ANOVA revealed no significant 
influence of genotype on liquid volume consumed at 2 (F1,16 = 0.17 , p = 0.6858) and 
6 – 8 M (F1,18 = 0.92, p = 0.3493) of age, however, a significant F value was 
calculated for mice at 4 M of age (F1,18 = 6.19, p = 0.0229). Bonferroni post hoc tests 
comparing genotype versus each test day indicates a lack of significance. The final 
control parameter monitored was total food intake during SP testing (Appendix D.3,
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Figure 4.9 – Sucrose preference testing demonstrates a lack of anhedonia in 
Cldn11-/-Tg+/- mice  
 
Using a RM two-way ANOVA, it was determined that both Cldn11+/-Tg+/- and Cldn11-
/-Tg+/- mice have a similar level of preference for a sucrose solution at 2, 4, and 6 – 8 
M of age. Data values are plotted as mean + SD, n = 9 at 2 M, n = 10 at 4 and 6 – 8 
M. Cldn11-/- values are shifted about the abscissa for clarification. 
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 C). In general, mice of all ages consumed approximately 4 – 6 g of food, regardless 
of phase (acclimation or testing). A RM ANOVA was preformed for each age group 
and we did not observe significant effects of genotype on food consumed at 2 or 6 – 
8 M of age (F 1,16 = 0.43, p = 0.5196 and F 1,18 = 0.59, p = 0.4510 respectively). 
Once more, the overall F values showed a significant difference at 4 M of age (F1,18 
= 3.21, p = 0.0898), but Bonferroni post hoc tests comparing genotype versus day 
was not significant. These data suggest that each constraint was neutral and did not 
influence the overall results of sucrose preference.  
A more complex analysis for the breakdown of liquid consumption must be 
completed, acknowledging the presentation of two sipper bottles and potential effect 
placement has on total liquid consumption. Appendix D.4, A shows the culmination 
of liquid drank during acclimation when water is present in both sipper bottles. In our 
arrangement, the left sipper tube is closest to the long wall of the cage and the right 
sipper tube is more towards the center. The purpose of examining the differential 
liquid drank from the left and right side is to determine if one side has preferentially 
influenced testing, especially given the inherent tendency for Cldn11-/-Tg+/- mice to 
spend more time in the center. To prevent a side preference while drinking, sipper 
bottle locations were counterbalanced throughout testing: half of the mice received 
sucrose beginning in the left sipper bottle, while others started with sucrose on the 
right. Sipper bottle placement was alternated each day and side preference was 
computed for acclimation (Appendix D.4, A) and sucrose testing (Appendix D.4, B).  
During acclimation (days 1 – 4), a two-way RM ANOVA, shows no significant 
difference between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice at 2 M (2M: F1,16 = 0.4213, 
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p = 0.68). The overall ANOVA comparing left versus right sipper bottle does yield a 
statistically significant F value (F1,16 = 0.4213, p = 0.68), however, Bonferroni post 
hoc comparing Cldn11+/-Tg+/- versus Cldn11-/-Tg+/- is not statistically significant. At 4 
M of age, statistically significant F values were tabulated for a placement difference 
between left and right (F1,18 = 11.09, p = 0.0037), as well as genotype (F1,18 = 5.09, p 
= 0.0367). Bonferroni post hoc tests indicate the only significant finding is between 
the left and right sipper bottles for both genotypes: both Cldn11+/-Tg+/- and Cldn11-/-
Tg+/- mice drank significantly more from the right sipper bottles. With respect to 6 – 8 
M animals, there was no statistically significant difference between genotype (F1,18 = 
1.66, p = 0.2141), but significance in left versus right side preference (F1,18 = 25.09, 
p = <0.0001). Both Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice preferentially drank more 
liquid from the right sipper bottle.  
Throughout SP testing days (days 5 – 8), one sipper bottle contained a 2 % 
sucrose solution. To account for a side preference, two-way RM ANOVAs were 
performed in a similar fashion as the acclimation phase. At 2 M of age, no significant 
differences were seen for left versus right liquid preference (F1,16 = 4.25, p = 0.0533), 
or between genotypes (F1,16 = 0.41, p = 0.5292). At 4 M of age, no significant 
difference were seen for liquid drank from left versus right sipper bottles (F1,18 = 1.66, 
p = 0.2144), however comparing genotypes yielded a statistically significant F value 
(F1,18 = 6.48, p = 0.0203). Performing a Bonferroni post hoc contrasting Cldn11+/-
Tg+/- versus Cldn11-/-Tg+/- revealed no significant difference. And finally, at 6 – 8 M of 
age, a two-way RM ANOVA indicated a statistically significant difference for left 
versus right preference (F1,18 = 8.71, p = 0.0086). A Bonferroni post hoc test 
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revealed that Cldn11+/-Tg+/- mice drank significantly more liquid from the right side, 
as compared to the left. No significant difference was seen between genotype (F1,18 
= 0.48, p = 0.4962). In summary, the patterning of liquid intake was similar between 
Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice, indicating side preference did not influence the 
overall sucrose preference results.  
Combining results from TS and SP, these data indicate a lack of depression-
like phenotype in Cldn11-/-Tg+/- mice. The various subcategories of depression 
examined, despair and anhedonia-like responses, are similar between Cldn11+/-Tg+/- 
and Cldn11-/-Tg+/- mice. Analyses of confounding variables indicate negligible 
differences, strongly suggesting a lack of influence of depression-like characteristics 
in Cldn11-/-Tg+/- mice.  
Cognitive learning and memory is similar between Cldn11+/-Tg+/- and Cldn11-/-
Tg+/- mice 
One of the most distressing symptoms of white matter diseases, despite the 
probable change in mood, is the loss of cognitive function. Increasing association 
between white matter dysfunction and cognitive decline / dysfunction is vastly noted 
throughout the literature, not only in normal aging patients (Gunning-Dixon and Raz, 
2000; Hedden and Gabrieli, 2004), but diseases with a predominantly white matter 
pathology. In multiple sclerosis (MS), for example, cognitive dysfunction is a frequent 
and often devastating symptom that, arguably, is the most debilitating feature of the 
disease (Jongen et al., 2012; Lovera and Kovner, 2012).  
To determine if our mouse model of dysfunctional myelin exhibited similar 
deficits, we assessed cognitive learning and memory ability using the Barnes maze 
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(BM). For this test, a circular platform containing 20 holes along the perimeter is 
used to assess a mouse’s ability to learn and remember the location of a target goal 
box located underneath a single hole (Figure 4.3). Mice are trained to locate the 
correct goal hole and the latency is computed for training, as well as probe days 
(Barnes, 1979). Using a RM ANOVA comparing the effect of genotype on latency to 
locate the goal hole throughout testing, no significant difference was discerned at 2 
(F1,17 = 1.48, p = 0.2399), 4 (F1,15 = 0.12, p = 0.7293), or 6 – 8 M of age (F1,18 = 4.03, 
p = 0.0601) (Figure 4.10). These data indicate similar cognitive learning and memory 
ability of Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice.  
During BM testing, three probe days are performed to evaluate a mouse’s 
learning and memory ability under different scenarios. For each, the goal 
compartment is removed, eliminating reinforcement of a correct selection. Because 
there is no compartment for a mouse to enter, time spent in various zones 
surrounding the trained goal hole is analyzed. Zone 0 represents the immediate 
circular vicinity around the trained goal hole, twice its diameter. Zone 1 is designated 
as the wedge-shaped portion of maze surrounding the trained goal hole, demarcated 
by one neighboring hole on each side. Zone 2 is designated as the wedge-shaped 
section surrounding the goal hole, encompassing Zone 1 and expanding the 
boundary to two holes flanking the trained goal hole (see Methods for clarification).  
The first scenario is a simple probe day (day 5) to test the mouse’s ability to 
remember the location of the trained goal hole (Appendix D.5). Employing Student’s 
t-tests to compare time spent in various zones around the trained goal hole, we 
observe no significant differences at 2, 4, or 6 – 8 M of age for time spent in Zone 0,
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Figure 4.10 – Latency to find trained goal hole throughout Barnes maze testing 
is comparable between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice demonstrating 
indistinguishable spatial learning and memory ability 
 
A two-way RM ANOVA comparing genotype by day confirms similar latency for 
Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice to reach the learned goal hole across Barnes 
maze testing at 2, 4, and 6 – 8 M of age. Data values are plotted as mean + SD; 2 
M: 9 ≤	 n ≤ 10, 4 M: 7 ≤	 n ≤ 10, 6 – 8 M: 9 ≤	 n ≤ 11. See Methods section for zone 
illustration. Cldn11-/-Tg+/- values are shifted about the abscissa for clarification; red 
numbers indicate probe days. 
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 1, or 2 around the trained goal hole (Table 4.4). These data suggest that both 
Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice not only found the goal hole is a similar amount 
of time, but spend equal time in the zone located immediately around the trained 
hole.  
The second scenario tested was a curtain probe (day 7). In a similar fashion 
to probe day, time spent in the aforementioned zones was investigated (Appendix 
D.6). For Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice at 2 M of age, a comparable amount 
of time was spent in Zone 0, 1 and 2. The cohort of mice at 4 M of age spent a 
similar amount of time in Zone 0 and 1, however, Cldn11-/-Tg+/- mice spent 
significantly more time in Zone 2, about 30 % more, as compared to Cldn11+/-Tg+/- 
mice. At 6 – 8 M of age, no significant differences were seen for time spent in any 
zone examined (Table 4.5).  
The final scenario examined during BM testing was a reversal probe (day 10). 
The reversal probe was conducted in a similar format as the probe day (day 5), and 
the time spent in the aforementioned zones was analyzed for the newly trained hole 
(Appendix D.7). At 2 M of age, Cldn11+/-Tg+/- mice spent significantly more time in 
Zone 0 (t18 = 1.314, p = 0.0334), a similar amount of time in Zone 1 (t18 = 1.944, p = 
0.0687) and significantly less time in Zone 2 (t18 = 2.118, p = 0.0492) around the 
newly trained reversal hole. For the cohort at 4 M of age, no significant differences 
were seen for the amount of time spent in any zone: Zone 0 (t16 = 0.6839, p = 
0.5045), Zone 1 (t16 = 0.1958, p = 0.8474), or Zone 2 (t16 = 0.0665, p = 0.9478). 
Similarly, at 6 – 8 M of age, no significant differences were observed (Zone 0: t17 = 
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Table 4.4 – Tabulated p values comparing the amount of time Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice spent in differing sized zones around the goal hole during 
BM probe day 5 (Appendix D.5).  
 6 – 8 M 
Zone t17 p 
0 0.1903 0.8513 
1 0.4176 0.6815 
2 0.6297 0.5373 
 4 M 
 t16 p  
0 0.8154 0.4268 
1 0.3620 0.7221 
2 0.0155 0.9878 
 2M 
 t18 p  
0 0.72 0.4808 
1 0.9633 0.3482 
2 1.062 0.3022 
A t-test was used to identify statistically significant differences (bold, italicized). 
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Table 4.5 – Tabulated p values comparing the amount of time Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice spent in differing sized zones around the goal hole during 
BM curtain probe day 7 (Appendix D.6).  
 6 – 8 M 
Zone t17 p 
0 0.7320 0.4376 
1 0.1658 0.8701 
2 0.0165 0.9870 
 4 M 
 t16 p  
0 1.178 0.2560 
1 1.819 0.0877 
2 2.236 0.04 
 2M 
 t18 p  
0 0.7701 0.4518 
1 0.1132 0.9199 
2 0.0309 0.9757 
A t-test was used to identify statistically significant differences (bold, italicized). 
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0.4643, p = 0.6480; Zone 1: t17 = 0.5227, p = 0.6075; and Zone 2: t17 = 1.063, p = 
0.3019).  
To account for undetectable intra-maze discrepancies, the maze was rotated 
90O clockwise on all probe days, ensuring that a hole aligned identically with trained 
location. To determine the presence of cues, zones were drawn around the hole 
where the box attaches, the hook-in hole (now at a different location), and zone 
analysis for time spent was completed. Appendix D.8 shows the zone analysis for 
probe day for 2, 4, and 6 – 8 M mice. Student’s t-tests revealed no significant 
differences in the amount of time Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice spent 
around the hook-in hole for Zone0, Zone1, or Zone2 at any age (Table 4.6). Appendix 
D.9 diagrams time spent in each zone around the hook-in hole during curtain probe. 
Mice at 2 and 6 – 8 M of age spent an indistinguishable amount of time in each 
region surrounding the hook-in hole, whereas at 4 M of age, Cldn11+/-Tg+/- animals 
spent significantly more time in every zone surrounding the hook-in hole (Table 4.7). 
On the final probe day, reversal probe, both groups of animals spent a similar 
amount of time in the regions around the hook-in hole (Appendix D.10, Table 4.8).  
In general, cognitive learning and memory ability of Cldn11-/-Tg+/- mice is 
indistinguishable from controls at 2, 4, and 6 – 8 M of age. Barnes maze testing 
indicates that both genotypes could be trained to locate and remember a target goal 
hole promptly. The curtain probe trial reveals the use of distal visual cues to be 
unlikely, and presumably, mice employed a remembered motor reflex to guide them 
to the target. Introducing a new target location during reversal training and 
subsequent probe day indicates that both Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice have 
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Table 4.6 – Tabulated p values comparing the amount of time Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice spent in differing sized zones around the hook-in hole 
during BM probe day 5 (Appendix D.8).  
 6 – 8 M 
Zone t17 p 
0 0.5273 0.6048 
1 0.5307 0.6025 
2 0.3143 0.7571 
 4 M 
 t16 p  
0 0.00009 0.9993 
1 0.8202 0.4242 
2 0.4174 0.6820 
 2M 
 t18 p  
0 2.406 0.0271 
1 0.04365 0.9657 
2 0.1523 0.8806 
A t-test was used to identify statistically significant differences (bold, italicized). 
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Table 4.7 – Tabulated p values comparing the amount of time Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice spent in differing sized zones around the hook-in hole 
during BM curtain probe day 7 (Appendix D.9).  
 6 – 8 M 
Zone t17 p 
0 0.3207 0.7521 
1 0.2527 0.8034 
2 0.3207 0.7521 
 4 M 
 t16 p  
0 5.733 <0.0001 
1 3.788 0.0016 
2 4.639 0.0003 
 2M 
 t18 p  
0 1.785 0.0921 
1 0.1690 0.8678 
2 0.3035 0.7652 
A t-test was used to identify statistically significant differences (bold, italicized). 
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Table 4.8 – Tabulated p values comparing the amount of time Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice spent in differing sized zones around the hook-in hole 
during BM reversal probe day 10 (Appendix D.10).  
 6 – 8 M 
Zone t17 p 
0 1.425 0.1712 
1 0.3416 0.7366 
2 0.6429 0.5284 
 4 M 
 t16 p  
0 0.7512 0.4642 
1 0.9394 0.3624 
2 1.149 0.2687 
 2M 
 t18 p  
0 0.0753 0.9409 
1 0.2331 0.8184 
2 0.2369 0.8156 
A t-test was used to identify statistically significant differences (bold, italicized). 
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similar short-term memory ability and can focus on a new challenge. This extensive 
testing and analysis advocates for a lack of cognitive differences between the two 
groups of animals, for any age examined.  
Neurochemical alterations in the brain of Cldn11-/-Tg+/- mice may be 
responsible for behavioral changes observed 
Because we observed abnormal behavior within Cldn11-/-Tg+/- mice, we 
wanted to determine if neurochemical alterations were present, which could 
conceivably drive the decreased anxiety we observe. From the same 6 – 8 M 
animals in which a decreased anxiety-like phenotype was detected, we collected ex 
vivo tissue punches and analyzed the neurochemical composition using high 
resolution magic angle spinning proton magnetic resolution (magic angle H1 NMR) 
(Table 4.9, Figure 4.11). Of importance were brain regions relating to the 
development of anxiety. Using t-tests to compare individual brain regions, Cldn11-/-
Tg+/- mice had significantly increased levels of the main neurotransmitter gamma-
aminobutryic acid (GABA) in the VHC, but not the DHC, or ACC (Figure 4.11A): 
VHC: t9 = 2.502, p = 0.0338; DHC: t9 = 0.4875, p = 0.6378; ACC: t9 = 0.1117, p = 
0.9138. Contrasting inhibitory changes, we examined the levels of the principal 
excitatory neurotransmitter, glutamate, in the VHC, DHC, and ACC, however no 
significant differences were seen (Figure 4.11B): VHC: t9 = 1.359, p = 0.2073; DHC: 
t9 = 0.0365, p = 0.9717; ACC: t9 = 2.302, p = 0.0503.  
To ascertain the mechanism by which increased levels of GABA could arise, 
we focused on the metabolic enzymes responsible for synthesizing and breaking 
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Figure 4.11– Proton Magnetic Resonance Spectroscopy quantification for various 
brain regions reveals increased GABA levels in the ventral hippocampus of Cldn11-/-
Tg+/- mice 
 
(A) gamma-aminobutryic acid (GABA) levels in select brain regions of Cldn11+/-Tg+/- 
and Cldn11-/- mice. Student’s t-test for select regions indicates that Cldn11-/-Tg+/- 
mice have significantly increased GABA levels in the ventral hippocampus (VHC), 
however comparable amount in the dorsal hippocampus (DHC) and anterior 
cingulate cortex (ACC). (B) Glutamate (Glu) levels in select brain regions of 
Cldn11+/-Tg+/- and Cldn11-/- mice. Student’s t-test for select regions indicates that 
Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice have similar glutamate levels in the VHC, DHC, 
and ACC. Data values are plotted as mean + SD; 5 ≤	 n ≤ 6; *p < .05. 
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Table 4.9 – List of brain regions collected and neurotransmitters analyzable with 
H1MRS 
    Generalized Brain Region      Neurochemical 
ACC Anterior Cingulate Cortex  Act Acetate 
AMC Anterior Motor Cortex  Ala Alanine 
AST Anterior Striatum  Asp Aspartate 
AUD Auditory Cortex  Bet Betaine 
BS Brainstem  Cre Creatine 
CB Cerebellum  Cho Cholines 
DHC Dorsal Hippocampus  GABA Gamma-aminobutryic acid 
DPST Dorsal Posterior Striatum  Gln Glutamine 
MidB Midbrain  Glu Glutamate 
NAC Nucleus Accumbens  GPC Glycerophosphocholine 
PCC Posterior Cingulate Cortex  GSH Glutathione 
PMC Posterior Motor Cortex  Ins Inositol 
SOC Superior Olivary Complex  Lac Lactate 
THAL Thalamus  NAA N-Acetlyaspartate 
VHC Ventral Hippocampus  NAAG N-Acetlyaspartatylglutamate 
VPST Ventral Posterior Striatum  PEA Phenylethylamine 
   PCh Phosphocholine 
   Suc Succinate 
   Tau Taurine 
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down GABA: glutamic acid decarboxylase 65 / 67 (GAD 65 / 67) and 4-
aminobutyrate aminotransferase (ABAT) respectively, as well as post-synaptic 
receptors. Using t-tests comparing genotype and individual brain region, no 
significant differences were seen for the either GABAA or GABAB receptor, nor the 
synthesizing enzyme GAD 65 / 67 (Figure 4.12, Table 4.10). Interestingly, when we 
compared the protein level of ABAT, a significant increase was seen in the VHC of 
Cldn11-/-Tg+/- mice (t8 = 2.570, p = 0.0331), but not the DHC (t8 = 0.8287, p = 
0.4313), or ACC (t8 = 0.9267, p = 0.3849).  
We detected neurochemical alterations at 6 – 8 M of age, correlating with the 
measureable behavior phenotype, however we wanted to evaluate if this alterations 
were present in younger animals, preceding a quantifiable behavioral phenotype. 
Fresh tissue punches were collected from 4 M animals and an abbreviated 
neurochemical assessment was completed prioritizing the VHC. Appendix D.11 
shows GABA and glutamate levels normalized to creatine levels within a given 
punch. No significant changes were observed within the VHC (GABA: t12 = 0.7879, p 
= 0.4460; Glu: t12 = 0.1128, p = 0.9120) or DHC (GABA: t15 = 0.0865, p = 0.9322; 
Glu: t15 = 1.337, p = 0.2011). These data support the idea that a neurochemical 
change may not precede the onset of a detectable behavioral phenotype.  
Repeat behavioral analyses of Cldn11-/-Tg+/- mice suggest an undetectable 
behavioral phenotype 
After the initial finding of a decreased anxiety-like phenotype and 
corresponding increase in GABA level within the VHC of Cldn11-/-Tg+/- mice, we 
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Figure 4.12 – Western blot analysis of key brain regions associated with an 
anxiety-like phenotype is similar between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice 
 
(A) Student’s t-test comparing GABA’s synthesizing protein, GAD 65 / 67, in select 
brain regions from Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice at 6 – 8 M of age suggests 
no difference in protein concentration. (B) Student’s t-test comparing protein 
concentrations of ABAT, the enzyme responsible for recycling GABA. A significant 
increase is seen in the ventral hippocampus (VHC) of Cldn11-/-Tg+/- mice, but not in 
the dorsal hippocampus (DHC) or anterior cingulate cortex (ACC). (C) Student’s t-
test comparing GABAA receptor in select brain regions from Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice at 6 – 8 M of age indicates a lack of difference in protein 
concentration. (D) Student’s t-test comparing GABAB receptor in select brain regions 
suggests no difference in protein concentration between genotypes. Representative 
western blot images are shown below each bar graph. Data values are plotted as 
mean + SD; 4 ≤	 n ≤ 6. 
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Table 4.10 – Tabulated p values comparing the protein level of select 
metabolic enzymes from fresh tissue punches from Cldn11+/-Tg+/- and Cldn11-/-
Tg+/- mice (Figure 4.12).  
 GABAA 
Punch Location t4 p 
VHC 0.3299 0.7580 
DHC 0.3340 0.7551 
ACC 0.3698 0.7303 
 GABAB 
 t4 p  
VHC 1.114 0.3276 
DHC 1.286 0.2677 
ACC 2.361 0.0776 
 GAD 65/67 
 t9 p  
VHC 1.577 0.1458 
DHC 0.5337 0.6065 
ACC 0.4957 0.6320 
A t-test was used to identify statistically significant differences (bold, italicized). 
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hypothesized that excess GABA levels may have originated from dysregulation of 
metabolizing enzymes; either an increase in synthesis or a decrease in recycling. 
Examination of the amygdala would have been preferable, however, heavy 
reciprocal connections are formed between the AMYG and VHC (O'Donnell and 
Grace, 1995; Pikkarainen et al., 1999). Recent data has uncovered the ability of the 
AMYG – VHC connection to modulate anxiety-related behaviors, as well as the 
social nature of rodents, termed sociability (Felix-Ortiz et al., 2013; Felix-Ortiz and 
Tye, 2014; Moy et al., 2004). By inhibiting AMYG output via pyramidal cells of the 
basolateral nucleus (BLA) to the VHC, increased social behavior of mice was 
observed (Felix-Ortiz and Tye, 2014).  
Interestingly, the AMYG and VHC have a bidirectional, reciprocal connections 
thought to modulate social behavior. To ascertain if Cldn11-/-Tg+/- mice have a deficit 
in social behavior, we preformed a sociability assay on a third cohort of mice 6 – 8 M 
in age (Figure 4.13). During habituation when both wire cups in the arena remain 
empty, we find that Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice spend a similar amount of 
time in the zones immediately surrounding each cup, as well as each chamber 
containing a cup (two-way ANOVA; 1.68 X: F1,10 = 0.64, p = 0.4428; 2 X: F1,10 = 1.20, 
p = 0.2948; chamber: F1,10 = 0.70, p = 0.4208). During trial 1, an unfamiliar mouse is 
placed underneath one wire cup and we observe that both Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice spend an indistinguishable amount of time around the empty cup, 
the cup housing an unfamiliar mouse, and in each arena chamber containing a cup 
(two-way ANOVA; 1.68X: F1,10 = 1.91, p = 0.1970; 2X: F1,10 = 3.01, p = 0.1133; 
chamber: F1,10 = 0.29, p = 0.6026).  
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During the final assessment (trial 2) when mice are underneath both wire 
cups (now familiar mouse and novel mouse) we find a similar amount of time is 
spent immediately around each cup and in each chamber, regardless of mouse 
familiarity (two-way ANOVA; 1.68X: F1,10 = 0, p = 0.9856; 2X: F1,10 = 0.02, p = 
0.8856; chamber: F1,10 = 0.02, p = 0.8856). These data suggest that the social 
nature of Cldn11-/-Tg+/- mice is comparable to controls.  
Examining the motor ability of Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice during sociability 
testing further supports these results. Appendix D.12 shows the total distance 
(Appendix D.12, A), average velocity traveled (Appendix D.12, B) and the time spent 
in each chamber of the sociability arena (Appendix D.12, C). Each parameter was 
monitored to ensure similarity, eliminating potential influence on time spent in each 
chamber of the sociability arena. The total distance traveled was proportional 
between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- animals during habituation (t10 = 1.40, p = 
0.3229), trial 1 (t10 = 0.9836, p = 0.3485), and trial 2 (t10 = 0.3858, p = 0.7086). In 
addition, the average velocity traversed was similar between Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice during habituation (t10 = 1.024, p = 0.33), trial 1 (t10 = 0.9141, p = 
0.3822), and trial 2 (t10 = 0.3106, p = 0.7632).  
 The last motor parameter examined was the total amount of time spent in 
each chamber of the sociability arena: left, center, and right. Using a one-way 
ANOVA to analyze each phase of testing, we find an overall statistically significant F 
value for habituation (F5,30 = 5,704, p = <0.001), trial 1 (F5,30 = 23.18, p = <0.0001) 
and trial 2 (F5,30 = 9.622, p = <0.0001), however, Bonferroni post hoc tests 
comparing genotype versus chamber is not statistically significant for any of the
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Figure 4.13 – Time spent in various zones of the sociability arena is similar between 
Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice 
 
(A) The average amount of time Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice spend within 
half a body length (1.68X) around each wire cup is similar throughout each phase of 
sociability testing: habituation, trial 1, and trial 2. (B) The average amount of time 
mice spend within a body length (2X) of each wire cup is indistinguishable between 
genotypes. (C) The amount of time Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice spend in 
each chamber of the sociability arena during each phase is not statistically different 
between genotypes. Data values are plotted as mean + SD, n = 6. THM to house 
mouse; TBE to be empty; M mouse; E empty; FM familiar mouse; NM novel mouse 
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phases. Together, these data suggest that the social nature of Cldn11-/-Tg+/- mice is 
comparable to controls and uninfluenced by motor ability or arena bias. 
Sociability testing involves examining the exploratory preference, and other 
quantifiable behaviors such as grooming, in the presence of familiar and novel mice 
(Kaidanovich-Beilin et al., 2011). A secondary analysis was completed on the 
location and length of grooming behaviors. The amount of time and location of 
grooming events indicates changes in stress and anxiety levels, differential 
grooming during various phases of testing could indicate preferential changes in 
anxiety-like behavior (Kalueff and Tuohimaa, 2005; Moyaho et al., 1995; Moyaho 
and Valencia, 2002). 
Appendix D.13, A diagrams the total time spent grooming for Cldn11+/-Tg+/- 
and Cldn11-/-Tg+/- mice. No statistically significant differences are observed between 
genotypes during habituation (t = 1.447, p = 0.1785), trial 1 (t = 1.309, p = 0.22), or 
trial 2 (t = 1.299, p = 0.2231). We evaluated the proportion of grooming time spent in 
each chamber of the sociability arena more extensively during trials 1 and 2 because 
of the added variable (additional mice) and increased overall grooming (Appendix 
D.13, B). Total grooming time during trial 1 was separated into the fraction of total 
time spent grooming in the empty chamber, the middle chamber, and the chamber 
that housed a mouse.  
A one-way ANOVA revealed a statistically significant difference in the amount 
of time spent grooming (F5,30 = 1.040, p = <0.0001) and post hoc testing indicated 
that both Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice spent significantly more time 
grooming in the empty chamber as compared to the chamber that housed a mouse 
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or the middle portion, however, there was no main effect of genotype on location. 
Total grooming during trial 2 was separated in a similar fashion, but the empty 
chamber now housed a novel mouse. An ANOVA for time spent in each location 
was not statistically significant (F5,30 = 0.2113, p = 0.5921), suggesting both 
genotypes groomed for a similar amount of time in all locations.  
The persistence of a decreased anxiety-like phenotype was also investigated 
by repeating the OF and MB paradigms with the third cohort of mice. To determine if 
the native testing environment can alter anxiety state, we conducted repeat OF 
testing in two difference locations. During the repeat OF test in location 1, Cldn11+/-
Tg+/- and Cldn11-/-Tg+/- mice spent a similar amount of time in each of center square 
designation (Figure 4.14, Location 1): 32 % (t18 = 0.2850, p = 0.7940), 48 % (t18 = 
0.3314, p = 0.7441), 66 % (t18 = 0.6956, p = 0.4956), and 83 % (t18 = 0.0774, p = 
0.9391). Control parameters, including total distance traveled, average velocity, and 
time spent in each quadrant was similar between genotypes (traveled t18 = 1.703, p 
= 0.1058; t18 = 1.647, p = 0.1169; and F1,18 = 0.03, p = 0.8709 respectively) 
(Appendix D.15, A).  
Likewise, when mice were evaluated for open field activity in a different 
environment, location 2, Cldn11+/-Tg+/- and Cldn11-/-Tg+/- spent an indistinguishable 
amount of time in each center square designations (Figure 4.14, Location 2): 32 % 
(t11 = 0.5755, p = 0.5766), 48 % (t11 = 1.109, p = 0.2910), 66 % (t11 = 1.467, p = 
0.1702), and 83 % (t11 = 1.466, p = 0.1707). Control variables were not statistically 
different between genotypes: total distance traveled: t11 = 0.4911, p = 0.6330, 
average velocity: t11 = 0.4131, p = 0.875, and quadrant analysis: F1,11 = 3.79, p = 
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0.0776 (Appendix D.14, B). These data suggest it was irrelevant which environment 
mice were tested in; there was no detectable difference in the anxiety state between 
mice, uninfluenced by motor ability or exploration constants.  
With a lack of significant difference discerned by repeating the OF test, we 
conducted MB to further investigate this new conclusion (Figure 4.15). Using a 
Student’s t-test, we find Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice bury a similar number 
of marbles (t18 = 1.036, p = 0.3140). The same cohort of OF mice completed the MB 
task, and results indicate a similar number of marbles buried between Cldn11+/-Tg+/- 
and Cldn11-/-Tg+/- mice. If we compare the MB averages from the original cohort 
(Figure 4.7) to the repeated cohort of mice, we notice that Cldn11+/-Tg+/- animals 
buried, on average, slightly fewer marbles, while Cldn11-/-Tg+/- mice buried slightly 
more marbles. Thus the averages are closer together, eliminating significance, and 
confirming the OF results of an inability to detect the less anxious phenotype in 
Cldn11-/-Tg+/- mice.  
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Figure 4.14 – Repeat analyses of open field center square percentages from two 
different locations suggest Cldn11-/-Tg+/- mice and controls are similar 
 
Repeat open field center square analyses for 6 – 8 M Cldn11+/-Tg+/- and Cldn11-/-
Tg+/- mice. Student’s t-tests indicate similar amount of time spent in (A) 32 %, (B) 
48 %, (C) 66 %, and (D) 83 % center squares, irrespective of location. Data values 
are plotted at mean + SD; Location 1: n = 10, Location 2: 6 ≤	 n ≤ 7. 
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Figure 4.15 – Repeat marble burying paradigm indicates Cldn11+/-Tg+/- and Cldn11-/-
Tg+/- mice bury a similar amount of marbles 
 
Marble burying analysis was repeated for an additional cohort of Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice. Using a Student’s t-test comparing the number of marbles buried, 
no significant differences were seen. Data values are plotted as mean + SD; n = 10. 
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Our initial neurochemical data demonstrating GABA alterations was 
compelling, and a pilot study was conducted to more precisely determine, where 
GABA changes emanated from in the brains of Cldn11-/-Tg+/- mice. For this analysis, 
1 mm coronal brain slices were generated spanning the brain segment of interest 
(bregma - 1 to - 5), and bilateral punch structures were pooled for magic angle 
H1MRS (Figure 4.16A). GABA level was controlled for tissue weight and normalized 
to the internal control, creatine. Analysis revealed stark different amount of GABA for 
all segments analyzed (Figure 4.16B): - 1 to - 2, - 2 to - 3, - 3 to - 4, and - 4 to - 5 
bregma. Given the pilot study contained only one animal from each genotype, it 
negates the possibility of statistical analysis, however, we can still discern an 
increased level of GABA for all slices, regardless of genotype. In addition, the GABA 
level for the Cldn11-/-Tg+/- mouse in the first two slices was greater than the Cldn11+/-
Tg+/-, but decreased within the last two slices. 
One momentous question remains, what happened to the behavioral 
phenotype of the Cldn11-/-Tg+/- mice? Our recent assessment of Cldn11-/-Tg+/- mice 
reveals our inability to detect a behavioral phenotype or neurochemical alteration 
within these animals. The aforementioned studies were conducted throughout 
several years and a number of variables could account for our inability to detect 
significant differences.  
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Figure 4.16 – Pilot neurochemical investigation to resolve location of altered GABA 
points to dissimilarity from original data set 
 
One Cldn11+/-Tg+/- and one Cldn11-/-Tg+/- mouse (age 6 – 8 M) were used to 
determine precise location for increased GABA expression. (A) Coronal slices were 
generated (1 mm) and bilateral region of interest (blue circles) were collected and 
analyzed via magic angle H1MRS. (B) GABA expression was quantified, adjusted for 
tissue weight, then normalized to the internal control marker, creatine.  
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DISCUSSION 
The concept that dysfunctional myelin can lead to behavioral abnormalities 
has been alluded to throughout the myelin literature. Evidence in clinical literature 
suggests that myelin may pose an as alternative mechanism for the etiology of 
behavioral abnormalities. In white matter diseases such as leukodystrophies and 
multiple sclerosis (MS), the acknowledged component is dysfunctional myelin, 
however the prominent features are the accompanying behavioral abnormalities. 
Direct evidence supporting dysfunctional myelin as a causative component for 
behavioral abnormalities is difficult to obtain due to the compound nature of 
neurological illnesses and the challenge of separating dysfunctional myelin to 
disease etiology from behavior. Our Cldn11-/-Tg+/- mouse model is ideal for 
partitioning dysfunctional myelin from a complex disease state to investigate its 
contribution to manifestation of behavioral abnormalities.  
Dysfunctional myelin has the ability to generate behavioral abnormalities 
The etiology of behavioral abnormalities is hypothesized to emanate from a 
disconnection between neural circuits. As stated in the disconnection hypothesis: 
behavior is the result of temporal integration of sensory signals; abnormal behavior 
results when there is a disconnection between brain regions or neural circuits 
(Friston, 1998, 1999). Chapter 3 of this dissertation demonstrates that dysfunctional 
myelin alters signal integration and neural processing within the auditory brainstem. 
If we extrapolating those findings and apply them to higher-order brain networks, we 
envisage a similar deficit is present. Higher-order cortical networks contain a vast 
network of small diameter, myelinated fibers, that transmit sensory information to 
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various integration centers within the brain. If integration of sensory signals becomes 
altered, a behavioral abnormality will arise. This chapter proposes evidence in favor 
of dysfunctional myelin as an etiology for manifestation of abnormal behavior 
Chronicling the behavioral abnormalities of Cldn11-/-Tg+/- mice  
Initial behavioral analyses of 2, 4, and 6 – 8 M Cldn11+/-Tg+/- and Cldn11-/-
Tg+/- mice reveals a distinct abnormality resulting from dysfunctional myelin. 
Irrespective of the inability to detect a phenotype in subsequent cohorts of animals, 
(see below), Cldn11-/-Tg+/- mice have a less anxious phenotype at 6 – 8 M. This 
reduced anxiety-like phenotype is not detectable at younger ages, 2 or 4 M. This 
robust finding is supported by two technically distinct behavioral tests eliciting 
anxiety-like responses from different methods: OF and MB. While Cldn11-/-Tg+/- mice 
have no apparent change in depressive-like phenotype based on tests of anhedonia 
and depressive-like (TST and SPT respectively), or differences in cognitive ability, 
an alteration in anxiety state is still noteworthy. Furthermore, throughout all 
behavioral tests require motor activity, we did not detect difference in distance 
traveled or velocity of Cldn11-/-Tg+/- mice, negating the known hind limb weakness 
(Gow et al., 1999). A number of mutant myelin mouse models have been generated 
and studied for abnormal phenotypes under a similar battery of behavioral analyses.  
Alternative mouse models of dysfunctional myelin emanate behavioral 
abnormalities 
Proteolipid protein (PLP) is a major myelin protein constituting about half of 
total protein within the myelin sheath. Several different mouse strains of mutated 
PLP have been generated to study potential behavioral abnormalities via gene 
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knockout (PLP1) and overexpression (Boison and Stoffel, 1994; Inoue et al., 1996; 
Readhead et al., 1994). Studies involving overexpression of PLP indicate abnormal 
anxiety-like phenotype; interestingly, an increase in anxiety is seen when evoked 
with the light / dark transition test, while a decrease is identified by the elevated plus 
maze. In addition, decreased spatial learning and memory is noted using the Barnes 
maze test (Tanaka et al., 2009). In contrast, knocking out PLP causes an increase in 
anxiety-like behavior in mice (Boison and Stoffel, 1994).  
The second major protein found within myelin sheaths is myelin basic protein 
(MBP). Mutant mice harboring genetic alterations to the MBP gene have also been 
studied for behavioral abnormalities (Privat et al., 1979; Rosenbluth, 1980). 
Variations in protein expression cause severe tremors and seizures, as well as a 
decrease learning ability via the T-maze test (Inagawa et al., 1988).  
A direct comparison between our dysfunctional myelin mutant and those is 
complex. When altered, each of these proteins (PLP and MBP) cause changes in 
the ultrastructure of the myelin membrane, along with a neurodegenerative 
phenotypes. Also pronounced are the varying degrees of shakes and tremors 
exhibited by mutant animals and premature death in MBP mutants (Kirschner and 
Ganser, 1980; Klugmann et al., 1997; Privat et al., 1979; Readhead et al., 1994).  
Consequently, these myelin mutants do not have the ability to separate out 
compounding structural and disease-causing phenotypes. It is implausible to 
separate out the contribution of dysfunctional myelin on behavioral abnormalities 
with additional variables present. These data attempt to illustrate the idea that 
dysfunctional myelin leads to behavioral abnormalities, however our data is the first 
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to show definitive evidence. The Cldn11-/- mice lack any ultrastructure abnormalities 
or neurodegenerative component at older time points; leaving a straightforward 
model to directly study the behavioral ramifications of dysfunctional myelin (Gow et 
al., 1999).  
Dysfunctional myelin causes neurochemical alterations 
The leading hypothesis for the etiology of behavioral abnormalities is largely 
based on altered neurochemical levels present in the brain. Variations include an 
increase or decrease in amount, as well as modifications in the quanta released at a 
synapse, inherently causing an imbalance and the physical manifestation of 
abnormal behavior (Sarter et al., 2007). Pharmaceutical companies have taken 
advantage of this hypothesis and developed drugs to counteract the incorrect levels 
for various illnesses including anxiety and depression. However, about 30 % of 
patients actively being treated relapse during treatment, suggesting an alternative 
explanation for the etiology must exist.  
Anxiety, like many emotion based feelings, are generated from a complex 
network of brain regions and their connections, known as the limbic system. 
Consisting of the hypothalamus, amygdala, hippocampus and limbic cortex, the 
limbic system is responsible for processing emotional and motivational behaviors 
(LeDoux, 2003; Morgane et al., 2005). Alterations in the neurochemical composition 
of certain brain regions has been connected to anxiety (Hoehn-Saric, 1982; Hyman, 
1998; Pratt, 1992) including increased norepinephrine, increased serotonin (Graeff, 
1993) and altered GABA levels (Depino et al., 2008; Hoehn-Saric, 1982).  
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While the amygdala was not analyzed, the VHC plays a critical role in 
regulation of anxiety-like phenotypes. Notably, the analyzed VHC punch is 
composed of roughly 40 % subiculum, which contains a large population of 
GABAergic neurons that perhaps account for the measured increase. The subiculum 
is the major output structure of the VHC, sending projections to cortical and 
subcortical targets such as thalamic nuclei (O'Mara, 2005; O'Mara et al., 2001; 
Witter and Groenewegen, 1990). A unique feature of the subiculum is the presence 
of long-range projection GABAergic neurons. Typically, GABAergic neurons are 
small interneurons that regulate local neural circuitry within a nucleus, however the 
subiculum is one of few nuclei in the brain containing GABAergic projection neurons 
(Buzsaki and Chrobak, 1995; Jinno et al., 2007). The target of these GABAergic 
projections is the cortical limbic system, imposing inhibition on the hypothalamic-
pituitary-adrenal (HPA) axis, which in turn, dampens the HPAs response to stress 
(Lowry, 2002). Coming full circle, there are extensive reciprocal connections 
between the AMYG and VHC regions; thus, the increase in the less anxious 
phenotype we observed is still related to the neurochemical alterations in the VHC 
punch.  
Analysis of ex vivo tissue punches indicates that Cldn11-/-Tg+/- mice have 
significantly increased GABA levels, about 20 %, in the VHC region (Figure 4.11 and 
Table 4.11). In patients suffering from anxiety disorders, a similar significant 
increase within the AMYG is noted throughout the published literature (Lydiard, 
2003; Nemeroff, 2003; Nutt and Malizia, 2001). An increase of GABA by 20 % in the 
VHC is not only statistically significant, but suggestive of being biologically relevant. 
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Evidence in the literature establishes a 10 % change in GABA levels in the AMYG is 
sufficient to cause altered detectable anxiety-like phenotype (Ackermann et al., 
2008; Sherif and Oreland, 1995). Further support has been shown when excess 
GABA remains in the synaptic cleft in the absence of GABA transporters or 
receptors (Liu et al., 2007; Sur et al., 2001). The function of inhibitory interneurons, 
and discernably GABA, is to modulate and alter the excitability of neural circuitry 
(Bloom et al., 1995). Excess neurotransmitters, whether excitatory, or in this case 
inhibitory, can have dramatic effects on overall neural circuitry, leading to 
dysregulation and the manifestation of a behavioral abnormality.  
These data support the hypothesis that dysfunctional myelin within Cldn11-/- 
mice generates detectable alterations in neurotransmitter levels. They suggest that 
dysfunctional myelin may be an important etiology for behavioral abnormalities 
because it can generate the types of neurotransmitter alterations that are found in 
patients and are commonly targeted by pharmaceutical companies. However, it 
remains to be determined what proportion of the disease burden might be 
associated with this etiology.  
The vanishing phenotype of Cldn11-/-Tg+/- mice  
Initial behavioral experiments describe a consistent story and reveal novel 
findings attributable to dysfunctional myelin. A decrease in anxiety level correlated 
with increased inhibitory GABA levels present in the VHC of Cldn11-/-Tg+/- mice at 6 
– 8 M of age. These data suggested, for the first time, that dysfunctional myelin 
plays a critical role in the etiology of behavioral abnormalities, as well as causes 
alterations in neurotransmitter levels. Undermining these findings are the ensuing 
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experiments attempting to formulate a mechanism by which an increase in GABA 
originates.  
Performing longitudinal studies on the same group of mice would have 
introduced a potential learned behavior, failing to reflect genuine behavioral 
abnormalities (Bailey et al., 2006; Bolivar et al., 2000; Voikar et al., 2004). This 
necessitates the need for separate cohorts of mice to age, replicate behavioral 
testing, and tissue collected for protein analysis to determine mechanism of GABA 
increase. The time to complete a second round of experiments can take upwards of 
a year, pending optimal breeding. During this time frame, several infections occurred, 
modifying the perspective of data collected.  
   
Second, throughout behavioral testing data collection, several infections 
occurred in the vivarium. With each ailment and subsequent management regime, 
the possibility arises that treatment could affect the behavior of both Cldn11+/-Tg+/- 
and Cldn11-/-Tg+/- mice. Most notable was the presence of pinworms (Syphacia 
muris and Aspiculuris tetraplera) and treatment with Ivermectin (MediGel IVR gel 
cups). The anthelmintic ivermectin, from the superfamily avermectin, exerts its 
antiparasitic effect by activating glutamate-gated chloride channels receptors 
(GluClRs) present exclusively in the invertebrate nervous system (Cully et al., 1994). 
Recently, our understanding of the precise location where ivermectin binds and how 
it modulates cys-loop ion channels has expanded with publication of the crystal 
structure of ivermectin bound to the C.elegans GluClR (Hibbs and Gouaux, 2011). 
Ivemectin binds at the transmembrane domain between two adjacent subunits 
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forming hydrogen bonds and van der Waals interactions with select amino acids 
within the channel’s transmembrane domain. The binding of ivermectin between 
subunits has been suggested to wedge open the pore, permitting the passing of 
chloride ions, cause hyperpolarization of the neurons, paralysis, and ultimate demise 
of the pinworm species (Fisher and Mrozik, 1992; Martin, 1997). Nevertheless, it has 
been demonstrated that ivermectin can bind to and alter glycine receptors (GlyRs), 
as well as GABAA receptors (GABAAR) in vertebrate animals (Dawson et al., 2000; 
Shan et al., 2001).  
While there may be no overt signs of a pinworm infection, such as hair loss or 
weight fluctuation, altering internal receptor modulation could influence behavioral 
outcomes in the host species, in our case the mice. It has been demonstrated that 
the mere presence of an active pinworm infection can modify the behavior of mice, 
decreasing exploration during OF testing. Likewise, treatment with ivermectin has 
been shown to have the opposite result, increasing exploration of an OF arena 
during pinworm treatment (Davis et al., 1999; McNair and Timmons, 1977). 
Consequently, if the mice became infected and behavioral analyses performed; data 
would be difficult to interpret. No behavioral test was carried out while pinworm 
treatment was in effect, however it is unknown at what point mice contracted the 
illness before being detected. Furthermore, the perpetual effect of treating animals 
with ivermectin has not been investigated. Thus, we do not know what lasting effects 
ivermectin may have on host GlyR and GABAAR. 
In spite of the difficulties with this project, our data, in part, suggests that 
dysfunctional myelin is associated with behavioral abnormalities and alters 
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neurotransmitter levels. Data collected from the initial cohorts of Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice is robust and experiments were conducted within a short time 
frame, so we do not expect technical difficulties such as infections to have 
confounded the data. These studies await re-examination using mice that have not 
been exposed to ivermectin and we plan to use a new inducible Cldn11-/- colony of 
mice currently being generated at Baylor School of Medicine.  
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APPENDIX A – Abbreviation 
aa amino acid 
ABAT 4 – aminobutyrate aminotransferase 
ABR auditory brainstem response 
ACC anterior cingulate cortex 
aCSF artificial cerebral spinal fluid 
Act acetate 
AEP auditory evoked potential 
Ala alanine 
AMC anterior motor cortex 
AMYG amygdala 
ANOVA analysis of variance 
Asp aspartate 
AST anterior striatum 
AUD auditory cortex 
AVCN anteroventral cochlear nucleus 
Bet betaine 
BIC binaural interaction component 
BLA basolateral amygdala 
BS brainstem 
CAP compound action potential 
CB cerebellum 
CH chloral hydrate 
Cho cholines 
Cldn claudin  
cm centimeter 
CN cochlear nucleus 
CNS central nervous system 
Cre creatine 
CS center square 
dB decibel 
DCM double cable model 
DCN dorsal cochlear nucleus 
DPST dorsal posterior striatum 
DTI diffusion tensor imaging 
EE excitatory-excitatory  
EEG electroencephalography 
EI excitatory-inhibitory  
fMRI functional magnetic resonance imaging 
GABA gamma-aminobutryic acid 
GAD glutamic acid decarboxylase 
Gln glutamine 
Glu glutamate 
GPC gycerophosphocholine 
GSH glutathione 
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H1MRS proton magnetic resonance spectroscopy 
HC hippocampus 
HC hippocampus 
HPA hypothalamic pituitary adrenal 
i.p. intraperiotoneal 
IC inferior colliculus 
ILD interaural level delay 
in inch 
Ins Inositol 
IPL intraperiod line 
ITD interaural time delay 
JP juxtaparanode 
kg kilogram 
kHz kilo Hertz 
Lac lactate 
LL lateral lemniscus 
LLR late / long latency response 
LNTB lateral nucleus of the trapezoid body 
LSO lateral superior olive 
M month 
MAG myelin associated glycoprotein 
MB marble burying 
MidB midbrain 
MBP myelin basic protein 
MDL major dense line 
mg milligram 
MGN medial geniculate nucleus 
min minute 
ml milliliter 
MLR middle latency response 
MNTB medial nucleus of the trapezoid body 
MS multiple sclerosis 
msec millisecond 
MSO medial superior olive 
NAA N-acetlyaspartate 
NAAG N-acetlyaspartatylglutamate 
NAC nucleus accumbens 
OF open field 
PBS phosphate buffered saline 
PCC posterior cingulate cortex 
PCh phosphocholine 
PDZ PSD95 / Dlgs / ZO-1 
PEA phenylethylamine 
PET positron emission tomography 
PLP proteolipid protein 
PMC posterior motor cortex 
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ppm parts per million 
PVCN posteroventral cochlear nucleus 
sec second 
SEP somatosensory evoked potential 
SL sensation level 
SNR signal to noise ratio 
SOC  superior olivary complex 
SP  sucrose preference 
SPL sound pressure level 
Suc succinate 
SZ Schizophrenia 
Tau taurine 
TBE 2,2,2 – tribromoethanol 
TBSGBA tris buffered saline, goat serum, bovine albumin 
THAL thalamus 
TJM tight junction model 
TS tail suspension 
TSP trimethyl silyl – propionate 
VEP visual evoked potential 
VHC ventral hippocampus 
VPST ventral posterior striatum 
ZO zonula occludens 
µm micron 
µsec microsecond 
µV microvolt 
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APPENDIX B – Chapter 2 Supplemental Figures 
Appendix B.1 – Sensation level for Wave III amplitudes is highly variable 
 
Normalized Wave III amplitudes are plotted as a function of time for calculated 
sensation level at 80 dB SPL (A), 70 dB SPL (B), 60 dB SPL (C) 50 dB SPL (D) 40 
dB SPL (E) and 30 dB SPL (F). Data for each mouse are normalized to amplitude at 
50 min and the average linear regression line constrained at (50,1) is shown (solid 
line) ± 95 % CI (dashed lines).  
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Appendix B.2 – Sensation level for Wave V amplitudes is highly variable 
 
Normalized Wave V amplitudes are plotted as a function of time for calculated 
sensation level at 80 dB SPL (A), 70 dB SPL (B), 60 dB SPL (C) 50 dB SPL (D) 40 
dB SPL (E) and 30 dB SPL (F). Data for each mouse are normalized to amplitude at 
50 min and the average linear regression line constrained at (50,1) is shown (solid 
line) ± 95 % CI (dashed lines).  
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APPENDIX C – Chapter 3 Supplemental Figures 
Appendix C.1 – Raw DN1 latency occurs between latencies of Waves IV and V  
 
(A) Raw latencies plotted for Wave IV and V, as well as the calculated DN1 trough, 
as a function of the various intensity differences (ΔdB SPL) tested for Cldn11+/-Tg+/-
Cldn11+/-Tg+/- mice. (B) Raw latencies are plotted for Wave IV and V, as well as the 
calculated DN1 trough at the various intensity differences tested (ΔdB SPL) for 
Cldn11-/-Tg+/- mice. Data values are plotted as mean + SD; 10 ≤	 n ≤ 12.  
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Appendix C.2 – Raw DN1 latency and amplitude for Cldn11+/-Tg+/- and Cldn11-/-
Tg+/- mice 
 
(A) Raw DN1 trough latency plotted as a function of intensity difference (ΔdB SPL) 
for Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice. (B) Raw DN1 amplitude plotted as a 
function of intensity difference (ΔdB SPL) for Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice. 
Data values are plotted as mean + SD; 10 ≤	 n ≤ 12  
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Appendix C.3 – Proportion of myelinated fibers in trapezoid body fiber tract  
 
Percentage of myelinated fibers traversing through the trapezoid body tract are 
displayed. Negative sign indicates sagittal cryostat section medial to the MNTB, 
whereas the plus sign indicates slides in which posses MNTB principle cells. Data 
are plotted as mean + SD; n = 3 fields / slide; ~ 100 axons / slide. 
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APPENDIX D  – Chapter 4 Supplemental Figures 
Appendix D.1 – Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice travel a similar distance 
and velocity during the open field paradigm 
 
(A) The total distance traveled during the open field test was similar between 
Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice at 2, 4, and 6 – 8 M of age. (B) Similarly, the 
average velocity was indistinguishable between genotypes at 2, 4, and 6 – 8 M. Data 
values are plotted as mean + SD, 9 ≤ n ≤ 10. 
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Appendix D.2 –Time spent in each quadrant of the open field arena is similar 
between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice 
 
The average time spent in each quadrant of the OF arena (Figure 4.1) was similar 
between Cldn11+/-Tg+/- and Cldn11-/- mice at 2, 4, and 6 – 8 M of age. Data values 
are plotted as mean + SD, 9 ≤ n ≤ 10. 
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Appendix D.3 – Standard sucrose testing variables including weight 
fluctuation, food consumed and liquid drank are indistinguishable between 
Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice 
 
(A) Normalized weight fluctuation for Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice during the 
eight days of sucrose preference testing at 2, 4, and 6 – 8 M of age. A mouse’s 
weight was normalized to its starting weight before the testing period began to 
control for gender differences. (B) Total liquid intake during the eight days of sucrose 
preference testing at 2, 4, and 6 – 8 M of age. (C) Total amount of food consumed 
during the eight days of sucrose preference testing for 2, 4, and 6 – 8 M of age mice. 
Using repeated measures ANOVAs, no statistically significant differences were seen 
for any variable, at any age tested. Shaded portion of graphs reflects portion of test 
when a sucrose solution was present. All data values are plotted as mean + SD, n = 
9 at 2 M, n = 10 at 4 and 6 – 8 M. Cldn11-/-Tg+/- values are shifted about the 
abscissa for clarification. 
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Appendix D.4 – Side preference for liquid consumption during sucrose 
preference testing is similar for Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice 
 
(A) Acclimation phase (days 1 – 4) during sucrose preference testing when water is 
present in both the L and R sipper tubes. Using a two-way repeated measures 
ANOVA, the average amount of liquid (water) drank on either the L or R side, or 
between sides within a genotype, is indistinguishable between Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice at 2 M of age. At 4 and 6 – 8 M of age, both Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice drink a similar amount of liquid (water) from either the L or R 
sipper tubes, however, within a genotype, both groups drink significantly more from 
the R sipper tube. (B) Sucrose phase (days 5 – 8) of testing when one sucrose and 
one water sipper tube was present each day, counterbalanced by day. Employing a 
two-way repeated measures ANOVA, the average amount of liquid drank, 
irrespective of type, was similar between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice at 2 
and 4 M of age. At 6 – 8 M, there was no significant difference between the amount 
of liquid drank from either the L or R sipper tubes between genotypes; however, 
within genotypes, the Cldn11+/-Tg+/- animals drank significantly more liquid from the 
R sipper tube, than L, as compared to Cldn11-/-Tg+/-. All data values are plotted as 
mean + SD, n = 9 at 2 M, n = 10 at 4 and 6 – 8 M; **p < .01, ****p < 0.0001. 
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Appendix D.5 – Zone analysis of Barnes probe trial (day 5) conveys similar 
time is spent in various sections around the goal hole 
 
Student’s unpaired t-tests reveal that at 2, 4, and 6 – 8 M of age, Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice spend a similar amount of time in (A) ‘Zone 0,’ (B) ‘Zone 1,’ and 
(C) ‘Zone 2’ during Barnes probe trial (day 5). Data values are plotted as mean + 
SD; 2 M: 9 ≤	 n ≤ 10, 4 M: 7 ≤	 n ≤ 10, 6 – 8 M: 9 ≤	 n ≤ 11. See Methods section for 
zone illustration. 
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Appendix D.6 – Zone analysis of Barnes curtain trial (day 7) conveys similar 
time is spent in various sections around the goal hole 
 
Student’s unpaired t-tests reveal that at 2, 4, and 6 – 8 M of age, Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice spend a similar amount of time in (A) ‘Zone 0’ and (B) ‘Zone 1’ 
during Barnes curtain trial (day 7). Time spent in (C) ‘Zone 2’ is similar at 2 and 6 – 8 
M of age, however, 4 M analyses of time reveals that Cldn11-/-Tg+/- mice spend 
significantly more time in ‘Zone 2’ than controls. Data values are plotted as mean + 
SD; 2 M: 9 ≤	 n ≤ 10, 4 M: 7 ≤	 n ≤ 10, 6 – 8 M: 9 ≤	 n ≤ 11; *p < .05. See Methods for 
zone illustration. 
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Appendix D.7 – Zone analysis of Barnes reversal trial (day 10) reveals 
comparable time spent in various sections around the newly learned goal hole 
 
Student’s unpaired t-tests indicate that time spent in (A) ‘Zone 0,’ (B) ‘Zone 1,’ and 
(C) ‘Zone 2’ is similar between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice at 4 and 6 – 8 
M of age. Of note, 2 M animals spend similar amount of time in ‘Zone 1,’ however 
controls spend significantly more time in ‘Zone 0’ and Cldn11-/-Tg+/- mice spend 
significantly more time in ‘Zone 2.’ Data values are plotted as mean + SD; 2M: 9 ≤	 n 
≤ 10, 4M: 7 ≤	 n ≤ 10, 6 – 8M: 9 ≤	 n ≤ 11; *p < .05. See Methods section for zone 
illustration. 
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Appendix D.8 – Zone analysis of Barnes probe trial (day 5) conveys similar 
time spent in various sections around the hook-in hole 
 
Student’s unpaired t-tests reveal that at 2, 4, and 6 – 8 M of age, Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice spend a similar amount of time in (A) Zone0, (B) Zone1, and (C) 
Zone2 surrounding the hook-in hole during the probe trial. Data values are plotted as 
mean + SD; 2 M: 9 ≤	 n ≤ 10, 4 M: 7 ≤	 n ≤ 10, 6 – 8 M: 9 ≤	 n ≤ 11. See Methods for 
zone illustration. 
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Appendix D.9 – Zone analysis of Barnes curtain probe (day 7) conveys 
Cldn11+/-Tg+/- mice spent more time around the in zones surrounding the hook-
in hole  
 
Student’s unpaired t-tests reveal that at 2 and 6 – 8 M of age, Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice spend a similar amount of time in (A) Zone0, (B) Zone1, and (C) 
Zone2 surrounding the hook-in hole during the curtain probe trial. At 4 M of age, 
Cldn11+/-Tg+/- mice spent significantly more time in each zone surrounding the hook-
in hole. Data values are plotted as mean + SD; 2 M: 9 ≤	 n ≤ 10, 4 M: 7 ≤	 n ≤ 10, 6 – 
8 M: 9 ≤	 n ≤ 11; **p < .01, ***p < .001, ****p <.0001. See Methods for zone 
illustration. 
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Appendix D.10 – Zone analysis of Barnes reversal trial (day 10) conveys 
similar time spent in various sections around the hook-in hole 
 
Student’s unpaired t-tests reveal that at 2, 4, and 6 – 8 M of age, Cldn11+/-Tg+/- and 
Cldn11-/-Tg+/- mice spend a similar amount of time in (A) Zone0, (B) Zone1, and (C) 
Zone2 surrounding the hook-in hole during the reversal probe trial. Data values are 
plotted as mean + SD; 2 M: 9 ≤	 n ≤ 10, 4 M: 7 ≤	 n ≤ 10, 6 – 8 M: 9 ≤	 n ≤ 11. See 
Methods for zone illustration. 
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Appendix D.11 – Concentration of GABA and glutamate within select brain 
regions of 4 M Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice reveals similar levels 
 
(A) gamma-aminobutryic acid (GABA) levels in the ventral and dorsal hippocampus 
of 4 M Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice. Student’s t-test for select regions 
indicates no significant difference in concentration for either brain regions. (B) 
Glutamate (Glu) levels in the ventral and dorsal hippocampus of 4 M Cldn11+/-Tg+/- 
and Cldn11-/-Tg+/- mice. Student’s t-tests indicate both groups have similar glutamate 
levels. Data values are plotted as mean + SD; 6 ≤	 n ≤ 8. 
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Appendix D.12 – Sociability testing control parameters do not influence overall 
results 
 
(A) Using a t-test, the average distance traveled during each phase of sociability 
testing (habituation, trial 1, and trial 2) is similar between Cldn11+/-Tg+/- and Cldn11-/-
Tg+/- mice. (B) Similar to average distance, the average velocity of the mice is alike 
between genotypes during each phase of testing. (C) A one -way ANOVA comparing 
total time spent each chamber of the sociability arena during habituation, trial 1, and 
trial 2 is equivalent between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice. Data values are 
plotted as mean + SD; n = 6.  
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Appendix D.13 – Grooming during sociability testing reveals similar anxiety-
like behaviors 
 
(A) Individual t-tests by session (habituation, trial 1, and trial 2) disclose similar total 
grooming time between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice. (B) Using a one – way 
ANOVA comparing genotype versus compartment, the fraction of time mice spend 
grooming is not different during trial 1 or trial 2. Individual Bonferroni post – hoc 
testing indicates select differences within a genotype between various compartments. 
Data values are plotted as mean + SD; n = 6; *p < .05, ***p < .001, ****p <.0001. H 
habituation, T1 trial 1, T2 trial 2, M mouse, E empty, Mid middle, FM familiar mouse, 
NM novel mouse  
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Appendix D.14 – Control variables during repeat open field test reveals 
parameters do not influence center square activity 
 
(A) A Student’s t-test comparing average distance traveled and velocity was similar 
between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice in Location 1. A two – way ANOVA 
comparing time spent in each quadrant of the open field was also indistinguishable 
between genotypes. (B) A Student’s t-test comparing average distance traveled and 
velocity was similar between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice in Location 2. A 
two -way ANOVA comparing time spent in each quadrant of the open field was also 
indistinguishable between genotypes. Data values are plotted as mean + SD; 
Location 1 n = 10, Location 2 6 ≤	 n ≤ 7. 
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In the current study, we have generated mutant mice that lack Claudin 11 
(Cldn11) tight junctions in CNS myelin sheaths. In myelin sheaths, Cldn11 forms 
tight junctions located along the outer and inner edges of the membrane spiral, 
preventing ions and small molecules from entering the intramyelinic space. The 
function of Cldn11 tight junctions is to improve the passive properties of the myelin 
membrane, by increasing membrane resistance and reducing capacitance, thereby 
improving the speed of saltatory conduction. In the absence of Cldn11, conduction 
velocity is slowed, most dramatically in small diameter myelinated fibers, somewhat 
analogous to reducing myelin thickness. Notably, the absence of Cldn11 is without 
degenerative myelin pathology, enabling direct study on the impact of dysfunctional 
myelin on neural processing. 
Undoubtedly, slowed conduction velocity along myelinated axons increases 
temporal dispersion and, consequently, degrades information transfer between 
neural circuits. Herein, this dissertation work explores the impact of dysfunctional 
myelin on neural processing in the conserved integration circuit of the auditory 
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brainstem. We find that dysfunctional myelin alters neural processing, generating an 
inability to lateralize sound sources on the azimuth plane. Extrapolating this 
information to higher order circuitry within the cortex, we find that dysfunctional 
myelin generates a disconnection between brain regions, manifesting in behavioral 
abnormalities and alteration in neurotransmitter levels.  
Together, these data demonstrate that non-degenerative changes in myelin 
membrane passive properties can lead to neurochemistry changes that perturb 
behavior/perception. Second, they have important implications for the etiology of 
behavioral disorders in general, and more specifically for the behavioral components 
of hypomyelinating and demyelinating diseases like multiple sclerosis. 
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